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Identifying regulators of neural stem cell fate and tumourigenesis 
Anna Elizabeth Hakes 
 
The proliferation of neural stem cells (NSCs) must be regulated precisely in order to generate 
a functional nervous system. Mis-regulated NSC division can lead to the inadequate 
production of differentiated progeny or to ectopic NSCs and tumour formation. As such, 
genes that promote the proliferative capacity of NSCs must be maintained in NSCs but down 
regulated in post-mitotic progeny.  
 
In vertebrates, the orphan nuclear receptor TLX (also known as nuclear receptor subfamily 2, 
group E, member 1 or NR2E1) is expressed in NSCs both during development and in adults. 
TLX mutations are linked to microcephaly and hereditary cases of bipolar disorder, whereas 
high TLX expression is a diagnostic marker of aggressive glioblastoma tumours and is 
correlated with poor patient prognosis. Despite the developmental and clinical importance of 
this gene, the molecular mechanisms through which it acts are not understood well.  
 
I have identified the Drosophila gene tailless (tll), the counterpart of TLX, as a key regulator 
of a subset of NSCs (known as type II) that divide in a manner analogous to mammalian 
NSCs. Human TLX and tll are highly conserved: the DNA binding domains share 81 % 
amino acid identity and conserved cofactors, such as Atrophin, mediate their activity as 
transcriptional repressors. During development, type II NSCs express Tll and divide to give 
rise to intermediate progenitors, which down-regulate Tll. In the absence of Tll, type II NSCs 
convert into a more restricted progenitor and are unable to generate full neuronal lineages. To 
identify the genes regulated by Tll in type II NSCs I used Targeted DamID to determine the 
genome-wide binding sites of Tll in vivo. My results showed that Tll binds to many of the 
genes required for type II NSC identity, suggesting that Tll is a master regulator of type II 
NSC fate. 
 
To test if the tumourigenic capacity of Tll/TLX was conserved in flies I expressed Tll or 
human TLX at high levels in the Drosophila brain, which resulted in large tumours consisting 
of type II NSCs. Through lineage analysis, I showed that Tll/TLX causes intermediate 
progenitors to revert to a NSC fate, thereby preventing differentiation and creating large 
tumours. This suggests that TLX and Tll act through conserved mechanisms to control NSC 
fate and implicates intermediate progenitors as the cell type of origin of TLX-induced 
tumours. Identifying the tumour-initiating cell for glioblastoma is vital for developing 
effective cell-type-specific treatments. 
 
Many distinct types of NSCs, which have different developmental and tumourigenic 
capacities, act in a coordinated manner to generate the Drosophila brain. The optic lobe 
neuroepithelium generates the NSCs that produce the adult visual system. The 
neuroepithelium is formed in the embryo but is not thought to generate NSCs until larval 
stages. I observed that many of the genes that regulate type II NSCs, such as tll, are also 
expressed in the optic lobe neuroepithelium. I identified that a marker of type II lineages (a 
regulatory fragment of the Fezf transcription factor earmuff) can also be used to follow the 
transition from neuroepithelium to NSCs in the optic lobe. Analysis of the division mode of 
the neuroepithelium (carried out in collaboration with Dr. Leo Otsuki) identified a new, 
embryonic phase of optic lobe NSC production. This finding shows that the neuroepithelium 
and NSCs co-exist throughout the majority of development and highlights the common 
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The division mode of neural stem cells (NSCs) must be regulated throughout development 
and in adult life. During development, NSCs divide symmetrically to expand the NSC pool or 
asymmetrically to generate neurons and glia that will form the nervous system. A small 
population of NSCs are maintained into adulthood, which divide to maintain brain 
homeostasis (for a review see (Götz et al., 2016)). Importantly, asymmetric NSC divisions do 
not give rise to neurons directly but rather generate intermediate progenitors (Fig. 1.1A). 
Intermediate progenitors maintain some properties of NSCs but are more committed to 
differentiation.  
 
The genetic programmes that control NSC fate must be downregulated in their progeny so 
that differences between NSCs and their daughter cells can be established. These differences 
allow both the maintenance of the NSC pool and for differentiation to progress in their 
progeny. Insufficient NSC divisions or precocious differentiation can occur if the genes 
controlling NSC fate are downregulated, which can result in the failure to produce the correct 
neural circuitry. Conversely, failure to downregulate NSC genes could lead to the expansion 
of the NSC population and be an initiating step in tumourigenesis (Fig. 1.1B). Therefore, 
understanding the genetic mechanisms that control NSC fate is essential for improving our 
understanding of normal brain development and the events that can lead to cancer. 
 
1.1 Brain tumours can arise from NSC lineages 
Tumours affecting the central nervous system (CNS) are among the most poorly understood 
and difficult to treat. This is in part due to the huge diversity of tumours as well as the lack of 
understanding surrounding tumour-initiating events. The recent identification of genetic 
markers, in combination with histopathological analysis, has allowed for the classification of 
CNS tumours to be refined (Louis et al., 2016). Increased understanding of the genetic 
signatures of different tumours provides more specific diagnostic techniques but developing 
treatments for CNS tumours remains extremely challenging despite these advances.  
 
1.1.1 Glioblastoma multiforme tumours are heterogeneous and difficult to treat 
Glioblastoma multiforme (GBM) is the most common malignant tumour that affects the adult 
CNS. Unfortunately, GBM has remained resistant to conventional therapies and patient 
survival has not improved beyond 15 months since the 1980s (Bondy et al., 2008). One of the 
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reasons that GBM is difficult to treat is because the premalignant lesions that develop into 
malignant tumours are not known. Identifying the tumour cell of origin is challenging across 
the cancer field (Blanpain, 2013) but the diversity of GBM tumours makes this particularly 
challenging. GBMs display heterogeneity in genetic mutations and cell type composition, 
both between patients and within individuals, which makes studying the early stages of 
tumour initiation a daunting task. However, determining which cell types are affected by 
different tumourigenic mutations that are found in distinct GBM subtypes is essential for 
improving the diagnostic tools for precancerous lesions and for the design of targeted cell-
type-specific cancer treatments (Pisapia, 2017). 
 
 
Figure 1.1: NSC fate and differentiation must be balanced during brain development 
(A) NSCs (red) divide asymmetrically to give rise to an intermediate progenitor (green). Intermediate 
progenitors more committed to neuronal fate than NSCs but often maintain the ability to self-renew. 
Neural precursors (blue) produce neurons (navy) either by differentiation or terminal division. 
(B) NSC fate must be balanced during development in order to produce the correct neurons and glia at 
the correct time and place to generate a functioning brain (centre). Reduction in the self-renewal 
capacity of NSCs can result in the failure to produce sufficient progeny (left). Conversely, aberrant 
activation of NSC fate can result in ectopic NSCs and tumour initiation (right).     
 
There are many candidates for the GBM cell of origin. Mature glial cells were once believed 
to be the only dividing cells in the adult brain and so were designated as the cell of origin for 
gliomas (review in (Stiles and Rowitch, 2008; Zong et al., 2012)). However, the identification 
of NSCs with glial identity in the adult brain provided an attractive alternative candidate for 
the GBM cell of origin (Doetsch et al., 1999; Reynolds and Weiss, 1992; Seri et al., 2001). 
This discovery suggested that aberrant reactivation of NSCs could be an important tumour 
initiating event for GBM and highlighted the importance of exploring the role of NSCs in the 
early stages of GBM generation (Sanai et al., 2005). In addition, analysis of the cell type 
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heterogeneity within GBMs led to the isolation of stem cell-like cells that were required for 
tumour growth and propagation (Johnson et al., 2014; Singh et al., 2004; Sottoriva et al., 
2013). These cells were designated glioblastoma stem cells (GSCs) because they shared many 
similarities with NSCs, namely the expression of NSC genes and their self-renewal capacity 
(Chen et al., 2012; Singh et al., 2004). It is thought that GSCs are resistant to treatment and so 
act as a reservoir of cells that can regenerate tumours following therapy (Reya et al., 2001; 
Singh et al., 2003). Understanding the genes that control GSC proliferation and survival is 
essential for developing effective treatments for GBM. The similarities between GSCs and 
NSCs suggest that many of the genetic programmes that regulate NSCs also play a role in 
cancer. 
 
1.2 TLX is an important regulator of NSCs 
The orphan nuclear receptor TLX, or NR2E1 (Nuclear Receptor Subfamily 2 Group E 
Member 1) is expressed in NSCs in the developing and adult brain (Li et al., 2008; Liu et al., 
2008; Monaghan et al., 1995; Shi et al., 2004; Yu et al., 1994). Mice that lack TLX during 
embryonic development exhibit defects in neocortex development due to decreased 
proliferation of periventricular NSCs but otherwise show no obvious defects at birth (Li et al., 
2008; Monaghan et al., 1997). However, adolescent and adult TLX null mice have smaller 
cerebral hemispheres, exhibit aggressive and hyper-excitable behaviour (Monaghan et al., 
1997; O’Leary et al., 2016; Roy et al., 2002; Young et al., 2002), and suffer from visual 
impairment (Hollemann et al., 1998; Yu et al., 2000). The majority of the defects affecting the 
CNS are due to the requirement of TLX in post-embryonic NSCs; TLX expression maintains 
NSCs in an undifferentiated, proliferative state (Li et al., 2012; Niu et al., 2011; Obernier et 
al., 2011; Qu et al., 2010; Shi et al., 2004) and is necessary for adult neurogenesis in both the 
subventricular zone (SVZ) and subgranular zone (SGZ) (Elmi et al., 2010; Liu et al., 2008; 
Zhang et al., 2008). In humans, mutations in TLX have been linked to microcephaly (Kumar 
et al., 2007a; Kumar et al., 2007b) and hereditary cases of bipolar disorder and schizophrenia 
(Dick et al., 2003; McQueen et al., 2005; Middleton et al., 2004; Wong et al., 2010), 
indicating a conserved requirement of TLX for proper neurogenesis. 
 
1.2.1 TLX in brain tumours 
In addition to the requirement of TLX for normal brain homeostasis, TLX has also been 
implicated in GBM initiation and malignancy. TLX expression is elevated in GBM (Park et 
al., 2010; Zou et al., 2012) and aggressive neuroblastomas (Chavali et al., 2014), but is absent 
from many other CNS tumours (such as medulloblastoma and lower-grade gliomas) (Zou et 
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al., 2012). The expression of TLX in brain tumours correlates with poor patient survival and, 
as such, TLX is an important diagnostic marker and a potential therapeutic target for 
malignant brain tumours (Chavali et al., 2014; Park et al., 2010). 
 
Animal models of glioma have shown that expressing TLX in NSCs at high levels is 
sufficient to induce NSC expansion and, when combined with other genetic lesions, can 
induce malignant gliomas (Liu et al., 2010; Park et al., 2010; Zou et al., 2012). TLX is also 
expressed in GSCs (Zhu et al., 2014) and the downregulation of TLX inhibits GSC self-
renewal and tumour reinitiation (Cui et al., 2016). Understanding how TLX promotes NSC 
fate is key for improving treatments for brain tumours associated with high levels of TLX. It 
is also unclear if TLX acts through common genetic pathways in development and 
tumourigenesis (Fig. 1.2).  
 
Figure 1.2: TLX in brain homeostasis  
TLX levels must be balanced to ensure correct brain development and homeostasis. TLX mutations 
are associated with microcephaly and the loss of TLX in adult mice results in decreased neurogenesis. 
Elevated levels of TLX cause the NSC pool to expand, which can be an initiating step in 
tumourigenesis. 
 
1.2.2 TLX structure and regulation 
TLX is a member of the orphan nuclear receptor sub-family of transcription factors. Its 
structure consists of a DNA binding domain (DBD) and a ligand binding domain (LBD). 
Unlike other nuclear receptors, whose activity is regulated by steroid hormones, no 
physiological ligand that binds to TLX has been identified.  
 
TLX can repress or activate the transcription of its target genes. The repressive function of 
TLX is mediated by a number of co-repressors, such as Atrophin (Haecker et al., 2007; Wang 
et al., 2006; Zhang et al., 2006; Zhi et al., 2015), B-cell lymphoma/leukemia 11A (BCL11A) 
(Estruch et al., 2012), lysine-specific histone demethylase 1 (LSD1) (Sun et al., 2010; Sun et 
al., 2011; Yokoyama et al., 2008), as well as some histone deacetylases (HDACs) (Haecker et 





al., 2007; Sun et al., 2010; Sun et al., 2011; Wang et al., 2006; Yokoyama et al., 2008) (Fig. 
1.3A). TLX co-repressors either confer repressive chromatin marks directly (e.g. LSD1) or 
recruit additional factors to do so (e.g. Atrophin recruits HDACs to TLX target genes). The 
ability of TLX to promote the transcription of its target genes is a more recent discovery and 
so far no co-activators have been identified. Both positive and negative regulation of gene 
expression by TLX is mediated through the binding of TLX to its consensus binding motif 




Figure 1.3: Human TLX and Drosophila Tll are highly conserved 
(A) TLX consists of a DBD and LBD; both domains mediate interactions with transcriptional 
corepressors (Sun et al., 2010; Wang et al., 2006; Wang et al., 2008). 
(B) Amino acid conservation between human TLX and Drosophila Tll. Sequence alignment of TLX 
and Tll performed using EMBOSS Needle and UniProt alignment tools. See Appendix 1 for full 
sequence alignment. Human TLX amino acid sequence from Jackson et al., 1998. 
 
The molecular mechanism through which TLX regulates NSC fate and tumourigenesis is not 
fully understood. The number of TLX target genes that has been identified is small and many 
targets have been identified in cell culture (reviewed in (Wang and Xiong, 2016)). This is in 
part due to the absence of genome-wide binding data for TLX, which would allow greater 
insight into its transcriptional targets in different cell types. In general, TLX is considered to 
repress genes that negatively regulate the cell cycle and activate the expression of genes that 
promote NSC proliferation; the proliferation of NSCs is reduced in the absence of TLX and 
neurogenesis is reduced significantly (Li et al., 2012; Li et al., 2008; Liu et al., 2008; Niu et 
al., 2011; Shi et al., 2004).  
 
However, the effect of the loss or overexpression of TLX on NSC fate and lineage 
progression is not known. Manipulating NSCs at the single cell level in vivo is difficult and 
performing genetic lineage tracing of NSCs in the adult mammalian brain remains technically 
challenging (Bonaguidi et al., 2011; Hippenmeyer, 2013; Zong et al., 2005).  
Drosophila Tll
Human TLX
DBD: 86 amino acids
Identity: 70/86 (81%)
Total similarity: 81/86 (94%)
LBD: 206 amino acids
Identity: 83/206 (40%)
Total similarity: 159/206 (77%)
DBD LBD









Therefore, studying the regulation of NSCs in a less complex organism has many benefits for 
investigating the fundamentals of NSC behaviour in vivo. The CNS of the fruit fly Drosophila 
melanogaster presents a comparatively simple system for studying NSCs; there are many 
lineage tracing techniques available, as well as many cell fate markers that allow lineage 
progression to be followed (for a review, see (del Valle Rodriguez et al., 2011)). Furthermore, 
nearly 75 % of disease-causing human genes have functional homologues in Drosophila 
(Pandey and Nichols, 2011). 
 
1.3 tailless is the Drosophila homologue of TLX 
Human TLX and its Drosophila counterpart Tailless (Tll) are highly conserved (Fig. 1.3B). 
Their DBDs share 81 % identical amino acids (conservation increases to 94 % when similar 
amino acid substitutions are included) and can bind to the same DNA consensus sequence 
(AAGTCA) (Jackson et al., 1998; Yu et al., 1994). The LBDs have lower amino acid identity 
at 40 % (77 % amino acid similarity) but bind to the co-repressor Atrophin via conserved 
amino acid residues in both species (Zhi et al., 2015). The high molecular conservation of 
TLX and its cofactors in Drosophila suggests that studying the function of Tll could provide 
valuable insight into the role of TLX in development and tumourigenesis.  
 
1.3.1 tailless specifies NSC fate in the embryo 
In Drosophila, tll was first identified as a gene required for correct body pattern formation 
during embryogenesis (Jürgens et al., 1984). During the early stages of embryo development, 
tll functions as one of the final products of the terminal system to promote the formation of 
the most anterior (head) and most posterior (tail) structures of the embryo (Jürgens et al., 
1984; Pignoni et al., 1990; Strecker et al., 1986). In the head region, tll expression is enriched 
in the proneural regions of the neuroectoderm from which NSCs delaminate (Pignoni et al., 
1990; Rudolph et al., 1997; Urbach and Technau, 2003; Younossi-Hartenstein et al., 1997) 
and loss of tll results in the loss of NSCs (Younossi-Hartenstein et al., 1997). As embryonic 
development progresses, tll expression becomes more restricted until it is maintained in only 
a subset of NSCs (Urbach and Technau, 2003). 
 
The role of Tll later in brain development is not well understood and appears to have diverse 
roles. The loss of tll in the NSCs that generate the olfactory system of the adult brain causes 
minor defects in the division of NSC progeny (Kurusu et al., 2009). In contrast, the loss of Tll 
in progenitors that generate the optic lobe (the visual processing centre of the brain) results in 
a major reduction in the visual ganglia (Guillermin et al., 2015). However, the high degree of 
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molecular conservation with mammalian TLX suggests that Drosophila Tll could have 
additional roles in NSC regulation, which have not yet been discovered, that more closely 
mirror the function of mammalian TLX.  
 
1.4 Drosophila neurogenesis 
1.4.1 Multiple types of NSCs generate the Drosophila brain 
The Drosophila CNS is generated in two distinct phases of neurogenesis: an embryonic phase 
(that forms the larval nervous system) and a larval phase (that forms the adult nervous 
system). There are three main types of NSCs that produce neurons and glia in Drosophila: 
type 0 neuroblasts, type I neuroblasts, and type II neuroblasts (Fig. 1.4A).  
 
All neuroblasts divide asymmetrically to self-renew and to generate a more differentiated 
daughter cell, but the neurogenic potential of neuroblasts differs between lineages. Type 0 
neuroblasts have the most restricted division mode because their progeny differentiate directly 
to neuronal fate (Fig. 1.4Ai). Type 0 division mode is rare in the Drosophila CNS; it occurs at 
the end of embryogenesis and in a small population of optic lobe NSCs (Baumgardt et al., 
2014; Bertet et al., 2014; Karcavich and Doe, 2005; Ulvklo et al., 2012). Type I neuroblasts 
are the most prevalent NSC in the Drosophila CNS. Asymmetric division of type I 
neuroblasts generates ganglion mother cells (GMCs), which undergo terminal division to 
produce two neurons (Fig. 1.4Aii) (Buescher et al., 1998). In contrast, type II neuroblasts 
exhibit a relatively rare NSC division mode, with only 16 type II neuroblasts per brain. Type 
II neuroblasts give rise to transit amplifying intermediate neural progenitors (INPs) that in 
turn divide asymmetrically to produce GMCs, which generate two neurons (Fig. 1.4Aiii). As 
such, type II neuroblasts are able to generate much larger lineages compared to type 0 and 
type I neuroblasts (Fig. 1.4B). The generation of INPs from type II neuroblasts makes their 
division mode analogous to that of mammalian NSCs.  
 
1.4.2 Type II neuroblasts 
The Drosophila brain is a well-established system for studying NSCs (Brand and Livesey, 
2011; Doe, 2008). There are extensive genetic tools that can be used to manipulate NSC 
lineages in vivo as well as many molecular markers for following cell fate changes. The 
advanced genetic toolbox combined with the relative simplicity of the CNS makes 
Drosophila an excellent organism in which to study NSCs in vivo.  
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Figure 1.4: Division modes of Drosophila NSCs 
(A) (i) Type 0 neuroblasts divide asymmetrically to self-renew and generate one neuron; (ii) 
Asymmetric division of type I neuroblasts generates a GMC, which undergoes terminal division to 
produce two neurons; (iii) Type II neuroblasts generate INPs, which maintain self-renewal capacity 
and divide asymmetrically to produce a GMC that generates two neurons. 
(B) (i) Type 0 lineages contain the smallest number of neuronal progeny; (ii) Type I lineages contain 
more neurons than type 0 lineages due to the presence of GMCs. (iii) Type II lineages have the 
greatest neuronal output as a result of transit amplifying INPs, which undergo multiple rounds of 
asymmetric cell division to generate GMCs. 
NB: neuroblast; INP: intermediate neural progenitor; GMC: ganglion mother cell. Schematic adapted 
from Doe, 2017. 
 
 
Figure 1.5: The anatomy of the Drosophila larval CNS 
(A) Orientation of the CNS within a larva; (B) The view of a brain mounted for imaging (with the 
VNC facing into the page). The majority of neuroblasts in the brain lobes, optic lobe (OL) and ventral 
nerve cord (VNC) are type I (grey). Type II neuroblasts (red) are found in the posterior region of the 
brain lobes and their lineages (green) project medially. A: anterior; P; posterior; D: dorsal; V: ventral; 
L: lateral; M: medial. 
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The division mode of type II neuroblasts is rare within the Drosophila brain; they are the only 
type of Drosophila NSC that divide asymmetrically to give rise to progenitors that can also 
self-renew (Bello et al., 2008; Boone and Doe, 2008; Bowman et al., 2008). There are only 
eight type II lineages in each lobe of the developing brain, which are found in stereotyped 
positions throughout development (Fig. 1.5A-B) (Bello et al., 2008; Boone and Doe, 2008; 
Bowman et al., 2008). In contrast, there are approximately ~85 central brain type I 
neuroblasts (Ito and Hotta, 1992). As such, type II neuroblasts have an increased proliferative 
capacity and neurogenic potential compared to the majority of neuroblasts. Identifying the 
genes that regulate the division mode and identity of type II neuroblasts will help to improve 
our understanding of NSCs in more complex organisms.  
 
Type II neuroblasts express the Hes family bHLH-O transcription factor deadpan (dpn), 
which is expressed in all self-renewing Drosophila neural progenitors (Bier et al., 1992), in a 
manner comparable to Hes1 and Hes5 expression in mammalian NSCs (Nakamura et al., 
2000; Ohtsuka et al., 2001) (Fig. 1.6A). The first gene that was identified to be expressed 
differentially between type I and type II neuroblasts was the pro-neural gene asense (ase) 
(Bowman et al., 2008). ase is one of four genes that make up the achaete-scute complex (AS-
C) (González et al., 1989), which is orthologous to the vertebrate gene achaete-scute family 
bHLH transcription factor 1 (ASCL1, also known as mammalian achaete-scute homolog 1 
(Mash-1)) (Johnson et al., 1990). ase is absent from type II neuroblasts but is expressed in 
mature INPs and type I neuroblasts (Fig. 1.6A) (Bowman et al., 2008). The expression pattern 
of ase in type II neuroblasts is analogous to that of ASCL1 in mouse NSC lineages (Calof et 
al., 1998; Gordon et al., 1995; Guillemot et al., 1993; Mumm et al., 1996; Murray et al., 2003; 
Wu et al., 2003).  
 
In addition to the repression of ase, type II neuroblasts also lack expression of the 
homeodomain gene prospero (pros) (Fig. 1.6B) (Bayraktar et al., 2010). pros is homologous 
to the mammalian gene prospero-related homeobox 1 (Prox1) and promotes neuronal 
differentiation in NSC progeny in a similar manner (Doe et al., 1991; Oliver et al., 1993; Torii 
et al., 1999). In Drosophila type I neuroblasts and INPs, Pros protein is excluded from the 
nucleus and is distributed to GMCs upon asymmetric cell division (Doe et al., 1991; Knoblich 
et al., 1995; Spana and Doe, 1995; Vaessin et al., 1991).  Therefore, type II neuroblasts lack 
the expression of two genes (ase and pros) that are expressed widely throughout the 
Drosophila CNS and promote neuronal fate. However, the repression of ase and pros is a 
consequence of type II neuroblast fate rather than a instructive signal (Bayraktar et al., 2010; 
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Bowman et al., 2008), indicating that additional genes must be required for specifying type II 
neuroblast fate. 
Figure 1.6: Differential gene expression between type II and type I neuroblast lineages 
Schematics depicting the division modes and lineages of type II and type I neuroblasts.  
(A) Type II neuroblasts, mature INPs and type I neuroblasts express the bHLH-O transcription factor 
Dpn (red). The pro-neural gene Ase (green) is not expressed in type II neuroblasts, but becomes 
activated during INP maturation. Type I neuroblasts express Ase and GMCs maintain Ase expression. 
(B) Pros (blue) is not expressed in type II neuroblasts. Pros is expressed in mature INPs and type I 
neuroblasts but is excluded from the nucleus and is segregated to GMCs at asymmetric cell division. 
Pros enters the nucleus of GMCs, where it represses self-renewal and promotes differentiation, and 
expression is maintained in young neurons. 
(C) PntP1 (orange) is expressed in type II neuroblasts and is maintained in early INPs where it 
promotes the expression of Erm (purple). Erm represses PntP1 expression during INP maturation and 
promotes lineage progression. PntP1 and Erm are not expressed in type I lineages. 
(D) btd-GAL4 (pink) is an insertion at the btd locus. In type II lineages, btd-GAL4 expression begins 
in the neuroblast but is stronger in immature INPs. btd-GAL4 is also expressed in a subset of type I 
lineages. 
 























































One candidate for a gene that promotes type II neuroblast fate is the Ets transcription factor 
pointedP1 (pntP1). PntP1 is expressed in type II neuroblasts and early-born INPs but is absent 
from type I lineages (Fig. 1.6C) (Zhu et al., 2011). The loss of PntP1 results in the 
derepression of Ase in type II neuroblasts, but this only affects 60-80 % of type II lineages 
(Xie et al., 2016; Zhu et al., 2011). In INPs, PntP1 activates expression of the Fezf factor 
earmuff (erm), which is required for the acquisition of INP fate (Weng et al., 2010). As such, 
it seems that PntP1 functions to promote lineage progression rather than specify neuroblast 
fate (Xie et al., 2016). The Sp8 homologue buttonhead (btd) is also enriched in type II 
lineages compared to type I lineages (Komori et al., 2014a; Xie et al., 2014). It has recently 
been shown that btd acts redundantly to specify type II neuroblast fate in embryogenesis and 
expressing btd ectopically is not sufficient to transform type I neuroblasts to type II 
neuroblasts (Álvarez and Díaz-Benjumea, 2018; Xie et al., 2014). As such, many of the 
transcription factors that have been identified as type II-specific genes act downstream in the 
lineage to regulate INP maturation. This suggests that as yet unidentified genes regulate type 
II neuroblast fate itself.  
 
1.5 Project aims  
The aim of this project was to study genetic regulators of NSC fate and how disregulation of 
these genes can lead to tumourigenesis. Mammalian TLX is expressed at high levels in 
aggressive human GBM and can induce NSC expansion in vivo (Chavali et al., 2014; Park et 
al., 2010; Zou et al., 2012). The molecular conservation between mammalian TLX and 
Drosophila Tll suggests that these genes act through conserved mechanisms.  The lineage 
progression of type II neuroblasts is highly comparable to mammalian NSCs and provides a 
genetically tractable system to study NSC fate in vivo. Tll has widespread roles in Drosophila 
CNS development and is a promising candidate for a type II neuroblast regulator.  
 
1.5.1 The characterisation of Tll in type II neuroblasts and tumourigenesis 
The majority of the work in this thesis was focussed on the identification of the Drosophila 
gene Tll as a regulator of type II neuroblast fate. I found that: 
1. Tll is expressed in type II neuroblasts and is required for neuroblast fate and lineage 
progression (Chapter 2); 
2. Targeted DamID of Tll in type II neuroblasts showed that Tll binds to many important 
type II-specific genes and may regulate their expression directly (Chapter 3); 
3. Tll must be down-regulated in type II lineages for differentiation to occur. Failure to 
do so results in INP reversion to neuroblast fate and tumour initiation (Chapter 4); 
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4. Expressing human TLX in INPs also results in tumourigenesis, highlighting the 
conserved mechanisms of tumour initiation and implicating intermediate progenitors 
as a cell of origin for TLX-induced tumours (Chapter 4). 
 
1.5.2 Characterising the early stages of optic lobe neuroepithelium development 
During the study of type II neuroblasts, I observed that many genes that regulate type II 
lineages are also expressed in the developing optic lobe. For example, tll is expressed in the 
optic lobe neuroepithelium throughout development and is required to maintain 
neuroepithelial cell fate (Daniel et al., 1999; Guillermin et al., 2015; Pignoni et al., 1990; 
Rudolph et al., 1997; Younossi-Hartenstein et al., 1997). I identified additional similarities 
between type II lineages and NSCs in the optic lobe, which prompted the re-examination of 
NSC behaviour in the early stages of optic lobe development. 
 
The optic lobe generates the visual processing centre of the adult brain and contains two 
populations of NSCs: (1) symmetrically dividing neuroepithelial cells, which give rise to (2) 
asymmetrically dividing neuroblasts (Fig. 1.7) (Bertet, 2017; Egger et al., 2011). Previously, 
it was thought that neuroblast generation was limited to the late stages of larval development 
(Egger et al., 2007; Egger et al., 2010; Yasugi et al., 2010; Yasugi et al., 2008). However, I 
identified a new marker that is expressed at the neuroepithelial to neuroblast transition, which 
facilitated the discovery of a new, embryonic phase of neuroblast production from the optic 
lobe neuroepithelium. This work was carried out in collaboration with Dr Leo Otsuki and is 




Figure 1.7: The development of the Drosophila optic lobe 
The optic lobe neuroepithelium is specified in the embryo and is found at the posterior-lateral sides of 
the brain lobes. Neuroepithelial cells have been reported to be quiescent during embryogenesis. In 
early larval stages, the optic lobe begins symmetric divisions and subsequently generates 
asymmetrically dividing neuroblasts in mid/late larval stages. The majority of optic lobe neuroblasts 
undergo type I division mode (the minority divide in a type 0 manner) and generate neurons and glia 








Tll is required to maintain type II neuroblast and lineage identity 
 
The orphan nuclear receptor TLX is expressed in NSCs during development and in adulthood 
(Li et al., 2012; Li et al., 2008; Liu et al., 2008; Monaghan et al., 1995; Monaghan et al., 
1997; Obernier et al., 2011). Levels of TLX must be maintained in a fine balance throughout 
life. The loss of TLX results in the reduction of NSC proliferation and neurogenesis and is 
linked to mood disorders (Davis et al., 2014; Dick et al., 2003; Li et al., 2008; Liu et al., 2008; 
McQueen et al., 2005; Middleton et al., 2004; Monaghan et al., 1997; O’Leary et al., 2016; 
Roy et al., 2002; Wong et al., 2010; Young et al., 2002). Conversely, high levels of TLX 
induce the expansion of NSCs and can lead to gliomagenesis (Liu et al., 2010; Park et al., 
2010; Zou et al., 2012). TLX is also required for the self-renewal capacity of glioblastoma 
stem cells (GSCs) (Cui et al., 2016; Zhu et al., 2014) and high TLX levels in glioblastoma and 
neuroblastoma correlate with poor patient prognosis (Chavali et al., 2014; Park et al., 2010). 
As such, determining the molecular mechanisms through which TLX controls NSC behaviour 
has implications for both normal brain development and cancer. 
 
On a population level, mammalian NSCs show reduced proliferation in the absence of TLX 
but the effect on NSC fate and lineage progression is not clear (Li et al., 2012; Li et al., 2008; 
Liu et al., 2008; Niu et al., 2011; Shi et al., 2004). Performing genetic lineage tracing of adult 
mammalian NSCs in vivo is still a relatively recent technical development and the properties 
of NSCs at the single cell level are not well understood (Bonaguidi et al., 2011; Hippenmeyer, 
2013; Zong et al., 2005). In contrast, there are many lineage tracing techniques available to 
study NSCs in the comparatively simple Drosophila CNS, as well as many cell fate markers 
that allow lineage progression to be followed (for a review, see (del Valle Rodriguez et al., 
2011)).  
 
Drosophila type II neuroblasts divide in a manner analogous to mammalian NSCs and 
provide a genetically tractable system to study factors that regulate NSCs. Type II neuroblasts 
divide asymmetrically to produce transit-amplifying intermediate neural progenitors (INPs), 
which have a more limited capacity for proliferation. Following maturation, INPs divide 
asymmetrically to give rise to ganglion mother cells (GMCs), which undergo terminal 
division to produce two neurons (Fig. 2.1A). The division mode of type II neuroblasts is 
unique within the Drosophila brain; the majority of neuroblasts generate GMCs upon 
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asymmetric division (Fig. 2.1A). Therefore, type II neuroblasts represent a Drosophila NSC 
population with an increased self-renewal and neurogenic capacity. Understanding the factors 
that regulate the ability of type II neuroblasts to produce INPs could have implications for 
mammalian NSC lineages. Although Tll has been studied extensively in Drosophila neural 
development, no role has been described for this gene in type II neuroblasts (Daniel et al., 
1999; Guillermin et al., 2015; Hartmann et al., 2001; Kurusu et al., 2009; Strecker et al., 
1988; Younossi-Hartenstein et al., 1997). Identifying a role for Drosophila Tll in type II 
lineages could provide insights into the role of its human counterpart TLX in NSCs in 
development and disease. 
 
2.1 Tll is expressed in type II neuroblasts 
To determine if Tll regulates type II neuroblasts, I assessed if tll was expressed in these cells. 
There are eight type II neuroblasts in each brain lobe of the developing CNS. Type II 
neuroblasts are located in the dorsoposterior medial region of the brain lobes (Fig. 2.1B) and 
can be identified unambiguously by co-staining for the bHLH-O factor Dpn and the pro-
neural gene Ase (type II neuroblasts are the only NSCs that express Dpn but not Ase) (Bello 
et al., 2008; Boone and Doe, 2008; Bowman et al., 2008).  
 
2.1.1 Assessing the expression of tll 
There are many tools available to examine tll expression in Drosophila. Tll-EGFP is a protein 
fusion under the control of an ~20 kb insert containing the tll coding sequence (CDS) and 
surrounding regulatory sequences (Venken et al., 2009). Importantly, this construct can rescue 
the lethality of homozygous tlll49 mutants ((Guillermin et al., 2015) and verified in this study, 
data not shown). I found that Tll-EGFP was expressed in all type II neuroblasts throughout 
larval development (Fig. 2.1C-E). Tll-EGFP was also detected in the four mushroom body 
lineages, which generate the olfactory system of the adult, consistent with a previous report of 
Tll expression in these lineages (Kurusu et al., 2009) (arrow heads in Fig. 2.1C-E). 
 
The expression of a second independent genetic reporter of tll, tll-lacZ (Liaw and Lengyel, 
1992), was also assessed. This construct contains 5.9 kb of the 5’ regulatory region of tll and 
expresses β-Gal in a comparable manner to endogenous tll during embryonic stages (Rudolph 
et al., 1997). tll-lacZ was expressed strongly in all type II neuroblasts and showed weaker 
expression in their lineages (Fig. 2.1F). Interestingly, tll-lacZ did not recapitulate endogenous 
Tll expression entirely in larval stages. Notably, mushroom body lineages lacked expression 
of tll-lacZ, despite high levels of endogenous Tll (Kurusu et al., 2009) (Fig. 2.1G-G’). This 
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indicated that the cis-regulatory region of the tll-lacZ reporter does not include all the 
enhancer elements that regulate native tll expression throughout development. However, it 
does indicate that the sequence required for tll activation in type II lineages is found within 
5.9 kb upstream of the tll transcriptional start site (TSS).  
 
Figure 2.1: tll reporters are expressed in type II neuroblasts 
(A) Schematic showing (i) Type II lineages express Dpn (red) but not Ase (blue) and divide 
asymmetrically to generate INPs. During maturation, INPs turn on Ase and, later, Dpn before dividing 
to produce GMCs. (ii) Type I neuroblasts express Dpn and Ase and divide to generate GMCs. 
(B) Schematic showing the position of the eight type II neuroblasts (red) per brain lobe and their 
associated lineages (green).  The majority of the other larval neural progenitors are type I neuroblasts 
(purple). The box corresponds to region shown in panels (C-G’). 
(C-E) Tll-EGFP (green) (Venken et al., 2009) is expressed in all type II neuroblasts (Dpn+ Ase-, 
outlined with solid white lines) and down-regulated in progeny (outlined with dotted white lines) at 24 
(C), 48 (D), or 72 (E) hours after larval hatching (ALH). pntP1-GAL4 driving UAS-myr-mRFP was 
used to identify type II lineages. Tll-EGFP expression in mushroom body lineages is indicated by 
white arrowheads. 
(F) tll-lacZ (green) (Liaw and Lengyel, 1992) is expressed strongly in type II neuroblasts (outlined 
with solid white lines) and weakly in lineages (outlined with dotted white lines). 
(G-G’) Strong tll-lacZ expression (green) overlaps with Tll (red in G; white in G’) in type II 
neuroblasts (solid outline). tll-lacZ is not expressed in mushroom body lineages (arrowheads), which 
express Tll protein. Dotted outlines indicate type II lineages. 
Note that seven of eight type II lineages are shown in panels C-F (lineage DM1 not visible). Single 
section confocal images. Scale bars represent 15 µm. 
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Figure 2.2: tll mRNA and protein is expressed in type II neuroblasts 
(A) RNA FISH against tll mRNA (red) shows expression in type II neuroblasts (outlined with solid 
white line) but not in differentiating cells in the lineage (outlined with dotted white line). pntP1-GAL4 
driving membrane-targeted GFP (green) labels type II lineages. 
(B) Immunostaining for Tll (green) shows strong expression in type II neuroblasts (Dpn+ (red) 
outlined with solid white line) and weaker expression in immature INPs (arrow heads). pntP1-GAL4 
driving membrane-targeted GFP (represented by white outlines) labels type II lineages. 
(C) Summary of tll mRNA (red) and Tll protein (green) expression in type II lineages. 
Single section confocal images. Scale bars represent 15 µm. 
 
To determine the expression pattern of Tll within type II lineages, I examined endogenous tll 
expression. I performed fluorescence in situ hybridisation (FISH) against tll mRNA, which 
showed that tll mRNA is transcribed in type II neuroblasts but not in other cells of type II 
lineages (Fig. 2.2A). Staining with an antibody raised against Tll showed that Tll protein is 
present in type II neuroblasts and at low levels in newly born progeny (immature INPs) (Fig. 
2.2B). These data show that tll is expressed at high levels in the neuroblast of all type II 
lineages and that low levels of Tll protein are present in immature INPs but not in other cells 
of the lineage (Fig. 2.2C).  
 
2.1.2 Examining the expression patterns of tll-GAL4 lines 
Using a combination of genetic tools and staining for endogenous Tll revealed a strong 
enrichment of tll expression in type II neuroblasts. To determine if I could identify new tools 
to label and manipulate type II lineages, I screened available tll-GAL4 lines for type II 
neuroblast expression (Fig. 2.3A). The Janelia FlyLight (GAL4 lines denoted with a “GMR” 
identification number) (Jenett et al., 2012; Pfeiffer et al., 2008) and VDRC Vienna Tiles 
(GAL4 lines denoted with a “VT” identification number) libraries are collections of cis-
regulatory DNA fragments ranging from ~2 kb (Vienna Tiles) to ~3 kb (FlyLight) that drive 
GAL4 expression. Constructs from both libraries are integrated in a single genomic insertion 
site (attP2) allowing for expression comparison between the two collections. There are four tll 
GAL4 lines from the FlyLight collection (GMR39A01, GMR31H09, GMR31F04, and 
GMR31D09) and seven from the Vienna Tiles collection (VT151, VT152, VT153, VT156, 
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VT157, VT158, and VT159). To determine expression in the larval CNS, flies carrying each 
GAL4 line were crossed to flies carrying UAS-mCD8-GFP and larval progeny were dissected 
at wandering third instar stage. GAL4 expression patterns are shown in Figs. 2.3B-L and are 
described in Table 2.1. All tll fragments showed some level of expression in type II lineages 
but only GMR31F04-GAL4, VT151-GAL4, VT153-GAL4, and VT159-GAL4 were 
expressed consistently in all eight lineages. 
 
GMR31F04-GAL4 and VT153-GAL4 share overlapping cis-regulatory sequences and also 
fall within the 5.9 kb sequence of tll-lacZ, allowing a putative type II element to be mapped 
within the 5’ region of tll (Fig. 2.4A bold red outline). However, upon closer analysis of 
brains from larvae that carried either GMR31F04-GAL4 (Fig. 2.4B) or VT153-GAL4 (Fig. 
2.4C), I found that the number of type II lineages was altered: the number varied between 
seven and nine lineages, and often differed between brain lobes of the same animal (data not 
shown). Therefore, although these GAL4 lines had minimal expression outside of type II 
lineages, they were not appropriate for use in functional experiments. The expression of 
VT151-GAL4 (Fig. 2.4D) in type II lineages was unexpected because this fragment is in a 
more distal 5’ position than tll-lacZ (Fig. 2.4A). The surrounding, overlapping tll fragments 
do not show comparable expression to VT151-GAL4, which means that it is not possible to 
map a type II regulatory element to this region with these tools. In addition, VT151-GAL4 is 
expressed in a few type I neuroblasts near type II lineages making it unsuitable for functional 
studies of type II lineages. VT159-GAL4 (Fig. 2.4E) was the only fragment downstream of 
the tll CDS expressed in all type II lineages. Previous characterisation of tll regulatory 
elements has focussed exclusively on the 5.9 kb upstream of the tll transcriptional start site 
(TSS) (Liaw et al., 1995; Liaw et al., 1993; Liaw and Lengyel, 1992; Rudolph et al., 1997), 
but the expression of VT159-GAL4 in type II lineages indicates that an additional type II 
regulatory element could be located downstream of tll (Fig. 2.4A dotted red outline). 
Unfortunately, VT159-GAL4 is also expressed in surrounding type I lineages and so was not 
suitable for functional experiments.  
 
Through a combination of genetic tools and staining for tll mRNA and Tll protein, I have 
shown that tll is expressed in all type II lineages. Tll protein and mRNA are enriched in the 
neuroblasts of these lineages and are downregulated in differentiating progeny. Analysis of 
available tll GAL4 lines made it possible to map putative regulatory elements required for the 




Figure 2.3: Expression of tll-GAL4 drivers in the larval CNS 
(A) Schematic showing idealised expression of a type II-specific GAL4 driver. (i) shows the entire 
CNS, which consists of the brain lobes and the VNC; (ii) shows a brain lobe, which consists of the 
optic lobe (OL) and the central brain (CB).  
(B-L) Each tll-GAL4 was crossed to flies carrying UAS-mCD8-GFP (green) and progeny were 
dissected at wandering third instar stage. A maximum projection in z across the entire brain (left-hand 
panels) and a single section confocal image showing type II lineages (right-hand panels) are shown for 
each GAL4 driver line. Type II neuroblasts were identified as Dpn+ (red) and Ase- (blue). Expression 










Few central brain type Is 




DM4 and 5 variable expression 
Optic lobe 
Some central brain type Is 
Many VNC type Is 
GMR31F04 
(Fig. 2.3D) 
All Optic lobe 
GMR31D09 
(Fig. 2.3E) 
DM4 and DM5 Midline neurons of the VNC 
VT151 
(Fig. 2.3F) 










All Optic lobe 
VT156 
(Fig. 2.3I) 
All except DM3 (occasionally 
absent from DM2) 
Few central brain type Is 
VT157 
(Fig. 2.3J) 
None (occasional weak 
expression in DM6) 
Expression in most central brain and 
some VNC type Is 
VT158 
(Fig. 2.3K) 
Very weak expression in DL1, 
DM1 and DM4 
Optic lobe: lamina 
VT159 
(Fig. 2.3L) 
All Optic lobe: lamina 
Many central brain and VNC type Is 
Table 2.1: Expression patterns of tll GAL4 lines. Description of the brain expression of tll GAL4 
lines shown in Figure 2.3. Flies carrying each GAL4 driver were crossed to flies carrying UAS-





Figure 2.4: Type II tll fragments map to overlapping genomic regions 
(A) Map of the tll locus with the regulatory fragment for each tll reporter construct shown below. The 
region in tll-lacZ is shown in purple and the genomic fragments for each tll-GAL4 are shown in green 
(VT GAL4 drivers) or yellow (GMR GAL4 drivers). VT and GMR GAL4 constructs are inserted in 
the attP2 landing site. Bold red outline highlights the presumptive 5’ type II regulatory element; 
dotted red line highlights the presumptive 3’ type II regulatory element. 
(B) GMR31F04-GAL4 is expressed strongly in type II neuroblasts (Dpn+ (red) and Ase- (blue)) but 
brain lobes contain more than eight type II lineages (white numbers). 
(C) VT153-GAL4 is expressed strongly in type II neuroblasts (Dpn+ Ase-) but brain lobes contain 
more than eight type II lineages (white numbers). 
(D) VT151-GAL4 is expressed in type II all neuroblasts (Dpn+ and Ase-, and white numbers) and a 
few nearby type I neuroblasts (arrowheads).  
(E) VT159-GAL4 is expressed in type II all neuroblasts (Dpn+ and Ase-, and white numbers) and a 
few nearby type I neuroblasts (arrowheads).  
Single section confocal images. Scale bars represent 30 µm. 
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2.2 Determining the role of Tll in type II lineages 
The enrichment of Tll expression in type II neuroblasts suggested a role for Tll in regulating 
type II neuroblast identity or proliferation. Type II neuroblasts have an increased proliferative 
capacity compared to type I neuroblasts; asymmetric division of type II neuroblasts generates 
INPs, which can also self-renew, whereas type I neuroblasts generate GMCs that undergo 
terminal division. One defining feature of type II neuroblasts is the repression of Ase, which 
is required to generate INPs (Bowman et al., 2008). Early INPs lack Ase and Dpn expression 
but turn on Ase and, later, Dpn during maturation (Fig. 2.5A). INP fate acquisition can be 
followed using a genetic reporter for the FezF transcription factor earmuff (erm), R9D11-lacZ. 
R9D11-lacZ comprises a ~4 kb fragment of the erm enhancer and becomes expressed during 
INP maturation (Fig. 2.5A) (Haenfler et al., 2012; Weng et al., 2010). In contrast, type I 
neuroblasts co-express Dpn and Ase and their lineages do not express R9D11-lacZ. 
 
2.2.1 Tll is required for type II lineage maintenance 
To determine if tll has a role in regulating type II neuroblast identity, I knocked down tll 
using two independent RNAi constructs that target different regions of the tll CDS (Fig. 2.5B). 
Expression of either tll RNAi in neuroblasts during larval development resulted in the loss of 
all type II neuroblasts in all brains (i.e. all neuroblasts expressed Dpn and Ase) (Figs. 2.5C-D). 
To confirm that the RNAi effects were due to the loss of tll and were not due to an RNAi off-
target, I assessed neuroblast identity in tlll49 mutant type II lineages. tlll49 is a point mutation 
that creates a stop codon within the DBD (Fig. 2.5B), resulting in a null mutation that is 
embryonic lethal in homozygous animals (Pignoni et al., 1990). In order to study the tlll49 
allele in larval type II neuroblasts, I generated MARCM (Mosaic Analysis with a Repressible 
Cell Marker) clones (Lee and Luo, 1999) during larval stages (Fig. 2.6A). I used wor-
GAL4,UAS-mCD8-mCherry to restrict clone visualisation to neuroblasts and the erm reporter 
R9D11-lacZ for the identification of type II lineages. I found that type II lineages were often 
labelled in wild type clones (Fig. 2.6B-B’), demonstrating that MARCM clones could 
encompass type II neuroblasts. However, I was unable to recover tlll49 mutant type II clones, 
despite tlll49 clones being visible in other neuroblasts (Fig. 2.6C). This suggested that tlll49 
type II neuroblasts underwent a cell fate transition that resulted in the loss of type II markers. 
Intriguingly, quantification of the number of type II lineages in brains with tlll49 clones 
revealed a reduction in the number of type II lineages. The number of absent type II lineages 
in brains with tlll49 clones was comparable to the number of type II lineages in wild type 
clones in control brains (Fig. 2.6D). This provided indirect evidence that tlll49 type II 
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neuroblasts lost their identifying features and that tll was required for type II lineage 
maintenance during development. 
 
 
Figure 2.5: Knockdown to tll results in the loss of all type II neuroblasts 
(A) Schematic depicting the expression of Dpn (red), Ase (green) and erm reporter R9D11 (blue) in 
type I and type II lineages. 
(B) The tll coding sequence (blue regions of tll mRNA) includes two protein domains (grey): DBD 
and LBD. tll RNAi lines miRNA[s] (Lin et al., 2009) and shRNA (VDRC) target different regions of 
tll mRNA. tlll49 contains a point mutation (x) at the 3’ end of the DBD that creates a stop codon, 
resulting in a null mutant (Diaz et al., 1996; Pignoni et al., 1990).  
(C-C’) Knockdown of tll during larval stages (wor-GAL4>tll-miRNA[s]) results in the absence of all 
type II neuroblasts. Control brains contain eight type II neuroblasts (Dpn+ (red) and Ase- (green), 
white outlines; seven visible in the section shown). In tll-miRNA[s] brains, all neuroblasts express 
Dpn and Ase. (C’) is a magnification of the boxed region in (C). n = 10 brain lobes for Control; n = 11 
brain lobes for tll-miRNA[s]. 
(D-D’) Using wor-GAL4 to drive tll-shRNA also results in the loss of all type II neuroblasts (white 
outlines in Control). (C’) is a magnification of the boxed region in (C). n = 11 brain lobes for Control 
and tll-shRNA.  




Figure 2.6: tll null type II neuroblast clones cannot be recovered 
(A) Schematic showing the genetic components of MARCM (Lee and Luo, 1999). Mitotic 
recombination can occur in all dividing cells but clone visualisation is restricted to neuroblasts through 
the use of wor-GAL4 to drive the expression of UAS-mCD8-mCherry. For control clones, a 
chromosome carrying FRT82B without tlll49 was used for recombination with FRT82B,tub-GAL80. 
(B-B’) Type II neuroblasts (Dpn+ (red) and Ase- (green)) could be encompassed within control 
MARCM clones at 72 hours after clone induction. wor-GAL4>mCD8-mCherry (white) identified 
neuroblast clones and R9D11-lacZ (blue) labelled type II lineages. (B’) shows magnifications of the 
boxed regions in (B). Type II neuroblasts (arrowheads) and their lineages marked by clones (dotted 
white outlines). 20 type II MARCM clones were observed in 24 brain lobes analysed (from 12 brains). 
(C) Central brain type I tlll49 neuroblasts could be visualised (arrowheads), but no tlll49 type II lineage 
clones could be recovered at 72 hours after clone induction. n = 20 brain lobes (from 10 brains). 
(D) Quantifications of the number of type II lineages labelled by control MARCM clones (n = 20 
clones in 24 brain lobes) compared to the number of type II lineages absent in tlll49 brains (n = 15 
absent lineages in 20 brains). Mann-Whitney U test, P = n.s. (P = 0.849). 
Single section confocal images. Scale bars represent 30 µm. 
 
2.2.2 Creating an immortalised type II-specific GAL4  
Initial experiments showed that type II lineages that do not have tll are no longer 
distinguishable from surrounding type I lineages. The next step was to follow the effect of the 
loss of tll on type II lineages in a specific manner. In order to do this, I needed to label 
specifically and permanently to allow the effect of tll loss of function on type II lineages to be 
determined. In addition, because the frequency of MARCM clones in type II lineages was 
rather low, I decided to perform further loss of function analysis with an RNAi against tll 
(specifically, tll-miRNA[s]) so that tll function could be removed from all type II lineages 
consistently. 
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Figure 2.7: pntP1>act-GAL4 – an immortalised type II GAL4 driver 
(A) pntP1-GAL4 drives UAS-mCD8-GFP expression (green) in central brain type II lineages but not 
in type I lineages at wandering third instar. Type II lineages were identified by R9D11-CD4-tdTomato 
(red), which labels type II INPs. Type II neuroblasts are highlighted with asterisks (*). 
(B) Schematic showing the genetic components of pntP1>act-GAL4, an immortalised type II GAL4. 
pntP1-GAL4 drives the expression of UAS-FLP, which excises a transcriptional (txn) stop sequence, 
resulting in the act5C promoter driving GAL4 in type II lineages. 
(C-E’) pntP1>act-GAL4 driving UAS-GFP labels type II lineages (outlined with white dotted lines) 
throughout larval development. pntP1-GAL4 is also expressed at the optic lobe transition zone, 
resulting in expression of pntP1>act-GAL4 in optic lobe neuroblasts (shaded regions). Larvae were 
raised at 29 ˚C after hatching: (C-C’) 19 h corresponds to the start of second instar; (D-D’) 30 h 
corresponds to the start of third instar and (E-E’) 72 h corresponds to the end of third instar.  
Single section confocal images. Scale bars represent 15 µm. 
 
To generate an immortalised type II driver, I used a GAL4 driver that is expressed specifically 
in type II neuroblasts (pntP1-GAL4 (Zhu et al., 2011)) (Fig. 2.7A) and immortalised its 
expression using a “FLP out” GAL4 cassette (Fig. 2.7B). pntP1-GAL4 was used to drive the 
expression of UAS-FLP, which catalyses the excision of a transcriptional stop sequence from 
the “FLP out” cassette (act5C>FRT-txnSTOP-FRT>GAL4 (Ito et al., 1997)). Subsequently, 
GAL4 expression is no longer dependent on type II neuroblast fate and act5C-GAL4 drives 
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the expression of transgenes under the control of UAS. Immortalised pntP1-GAL4 will be 
referred to as pntP1>act-GAL4.  
 
Initial characterisation of pntP1>act-GAL4 showed that this line labels all type II lineages 
throughout larval development (Figs. 2.7C-E). During early-to-mid larval stages, expression 
of pntP1>act-GAL4 is restricted almost entirely to type II lineages (Fig. 2.7C-D). At late 
third instar, pntP1>act-GAL4 labels type II neuroblasts and progeny but GAL4 expression is 
widespread throughout the CNS due to the expression of pnt at the OL transition zone 
(Yasugi et al., 2010) and in glial cells (Klaes et al., 1994; Klämbt, 1993) (Fig. 2.7E). 
 
2.2.3 Type II neuroblasts switch to type I neuroblasts in the absence of tll 
Generation of pntP1>act-GAL4 allowed the effect of tll loss of function (lof) on type II 
neuroblasts to be followed throughout larval development. tll-miRNA[s] was used to 
characterise the tll loss of function phenotype in type II neuroblasts as this construct has been 
shown to recapitulate the tll mutant phenotype in the Drosophila CNS (Guillermin et al., 
2015; Lin et al., 2009). Expressing tll-miRNA[s] using pntP1>act-GAL4 revealed that Ase 
was derepressed in all type II neuroblasts in all brains at early larval stages (Fig. 2.8A). At 
mid larval stages, I was able to determine lineage composition. In normal type II lineages, 
INPs are the progeny in closest proximity to the neuroblasts, whereas GMCs are found in a 
more distal position (control panels of Fig. 2.8B). An important distinction between INPs and 
GMCs is the differential expression of Pros: GMCs have nuclear Ase and Pros, whereas INPs 
acquire nuclear Ase during maturation but never nuclear Pros (Fig. 2.8B). In the absence of tll, 
all cells next to type II neuroblasts that expressed Ase also had nuclear Pros, indicating cells 
with GMC fate in place of INPs. In addition, in 60 % of brains, tll knockdown type II 
neuroblasts had Pros crescents (red arrow, Fig. 2.8B), which was never observed in control 
type II neuroblasts (Boone and Doe, 2008). In type I neuroblasts and INPs, however, Pros is 
localised in crescents at mitosis to distribute Pros to differentiating daughter cells (Doe et al., 
1991; Knoblich et al., 1995; Vaessin et al., 1991). Thus, the observation of Pros crescents in 
tll lof type II neuroblasts, and the presence of Pros+ progeny adjacent to these neuroblasts, 
suggests that type II neuroblasts segregate Pros to their progeny at division in the absence of 
tll. The expression of Ase and segregation of Pros to differentiating daughter cells are 
hallmarks of type I neuroblasts and INPs, suggesting that type II neuroblasts are converted to 






Figure 2.8: Loss of tll causes type II lineages to transform to type I identity 
(A) At 19 h ALH, pntP1>act-GAL4 driving tll-miRNA[s] results in the derepression of Ase (green) in 
all type II neuroblasts (Dpn+, red). Type II lineages are outlined with dotted white lines. n = 14 brains 
for Control; n = 11 brains for tll-miRNA[s] .  
(B) At 30 h ALH, type II lineages have INPs (arrowheads in Control, Ase+ and Pros-) closest to the 
neuroblast (Dpn+ and Ase-). tll-miRNA[s] results in Ase+ type II neuroblasts that generate GMCs 
(arrowheads in tll-miRNA[s], Ase+ and Pros+). tll-miRNA[s] type II neuroblasts also exhibit Pros 
crescents (red arrowhead). In each panel, dotted lines highlight three type II lineages; red asterisks (*) 
indicate neuroblasts in panels without Dpn staining. n = 10 brains for Control and tll-miRNA[s].  
(C) tll-miRNA[s] type II neuroblasts retain co-expression of Ase (green) and Dpn (red) at late larval 
stages (72 h ALH). n = 14 brain lobes for Control and tll-miRNA[s].  
(D) Quantification of the number of type II lineages. (i) The number of type II lineages is reduced 
significantly in tll-miRNA[s] brains. Kolmogorov-Smirnov test ***, P<0.001 (P = 1.66E-06). n = 14 
brain lobes for Control and tll-miRNA[s]. (ii) Co-expressing p35 cannot rescue the disappearance of 
type II lineages in tll-miRNA[s] brains. Kolmogorov-Smirnov test ***, P<0.001 (P = 0.000033). n = 
11 brain lobes for Control and tll-miRNA[s].  
(E) Schematic summarising the tll loss of function (lof) phenotype in type II neuroblasts. Without tll, 
type II neuroblasts divide in a type I manner.  




At late larval stages, tll type II lineages maintain their altered identity, as assessed by the co-
expression of Dpn and Ase, (Fig. 2.8C) but are reduced in number (Fig. 2.8D). The loss of 
type II neuroblasts cannot be rescued by co-expressing the apoptosis inhibitor p35 (Fig. 2.8D), 
suggesting that type II neuroblasts do not undergo programmed cell death upon tll knockdown. 
These data show that in the absence of tll, type II neuroblasts derepress Ase and Pros and 
divide in a type I neuroblast manner (Fig. 2.8E). As a result, INPs are no longer present 
because GMCs are generated from type II neuroblasts directly. Furthermore, the lifespan of 
type II neuroblasts is reduced. 
 
2.2.4 Removing tll prevents brat tumour formation 
Mutations in the tumour suppressor brain tumour (brat) result in ectopic type II neuroblasts at 
the expense of neuronal progeny (Bello et al., 2006; Bowman et al., 2008; Lee et al., 2006). 
Tumours arise because type II lineage progression is prevented; in the absence of brat, 
immature INPs revert back to a type II neuroblast fate (Janssens et al., 2014; Komori et al., 
2014b) (Fig. 2.9A). 
 
Since tll is required for type II neuroblast fate and INP generation, I tested if removing tll 
from type II lineages that lacked brat was able to prevent tumour formation. Control brain 
lobes contained eight type II neuroblasts (Dpn+ Ase-, n = 10 brain lobes) and showed a 
lineage progression from neuroblasts (Dpn+) to neuronal progeny (Pros+) (Fig. 2.9B, left-hand 
panel). Removing brat resulted in the generation of large tumours consisting of ectopic type II 
neuroblasts (brain lobes contained in excess of 1000 Dpn+ Ase- neuroblasts, n = 10 brain 
lobes) at the expense of neurons (Fig. 2.9B, middle panel). However, knocking down both 
brat and tll prevented the production of ectopic type II neuroblasts (Fig. 2.9B right-hand 
panel). In fact, all neuroblasts expressed Ase (i.e. there were no type II neuroblasts, n = 10 
brain lobes) and neuronal differentiation was restored (Fig. 2.9B, right-hand panel). Therefore, 
because of the requirement of tll for INP production, removing tll from type II neuroblasts 
prevents the generation of the tumour-initiating cell (INPs) for brat tumours. As a result, type 
II neuroblast lineages are no longer susceptible to tumours caused by the loss of brat. 
 
2.2.5 Repression of ase is downstream of tll 
The repression of ase in type II neuroblasts is essential for the maintenance of lineage 
identity; ectopic expression of Ase in type II neuroblasts is sufficient to prevent the 
generation of INPs (Bowman et al., 2008). In addition, expressing Ase in type II neuroblasts 
prevents type II lineages from being susceptible to tumour-inducing brat mutations (Bowman 
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et al., 2008). These data suggest that the loss of tll and ectopic expression of ase affect type II 




Figure 2.9: Removing tll prevents brat tumours 
(A) brat mutations result in tumourigenesis by causing early immature INPs to revert to type II 
neuroblast fate (Janssens et al., 2014). 
(B) Control brains contain neural lineages with one neuroblast (Dpn+, red) per lineage and multiple 
Pros+ (blue) differentiating progeny. brat RNAi causes the production of ectopic neuroblasts (Dpn+) at 
the expense of neuronal progeny (Pros+). Knockdown of both brat and tll does not result in 
tumourigenesis. n = 10 brain lobes for all conditions. 
(C) Schematics depicting the composition of normal type II lineages (left), brat lof type II lineages 
(middle), and brat and tll lof type II lineages (right). 
Single section confocal images. Scale bars represent 30 µm. 
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Figure 2.10: Tll acts upstream of ase repression in type II neuroblasts 
(A) Ase overexpression (Ase OE) in type II neuroblasts (large Dpn+ (red) cells) results in the loss of 
INPs (small Dpn+ cells in Control, arrowheads); instead, type II neuroblasts generate GMCs (Pros+ 
(green) arrowheads in Ase OE). (A’) R9D11-CD4-tdTom expression (white) is maintained in type II 
neuroblast progeny upon Ase OE, but remains absent from neuroblasts (*). Dotted outlines highlight 
three type II lineages identified by pntP1>act-GAL4 driving UAS-GFP. n = 11 brains for Control and 
Ase OE. Brains dissected 30 hours ALH. 
(B) All type II lineages are present at late larval stages in Ase OE brains and R9D11-CD4-tdTom 
remains expressed (except in DL1, DL2 and DM1 lineages). Dotted outlines highlight type II lineages, 
identified by pntP1>act-GAL4 driving UAS-GFP. n = 11 brain lobes for Control and Ase OE. Brains 
dissected 72 hours ALH. 
(C) Expressing tll-miRNA[s] in type II lineages results in the loss of R9D11-CD4-tdTom from type II 
lineages. Dotted outlines highlight type II lineages, identified by pntP1>act-GAL4 driving UAS-GFP. 
Control n = 14 brains; tll-miRNA[s] n = 11 brains. Brains dissected 19 hours ALH, images are max 
projections across 10 µm in z. 
(D) Schematic summarising the effects of ase overexpression or tll knockdown on type II lineages. 
Control lineages contain a large Dpn+ Ase- neuroblast and an associated lineage with INPs and 
differentiating progeny. Misexpression of ase causes the division mode to change type I, but the type 
II lineage marker R9D11 remains. Upon loss of tll, type II neuroblasts behave as type I neuroblasts 
and lineages lose type II identifying features. 
Single section confocal images unless specified otherwise. Scale bars represent 15 µm. 
 
However, comparison of expressing tll-miRNA[s] or UAS-ase in type II lineages revealed a 
key difference. Both genetic manipulations resulted in the failure of type II neuroblasts to 
produce INPs and GMCs were produced instead (all cells in immediate proximity to type II 
neuroblasts had nuclear Pros)  (compare Fig. 2.8B and Fig. 2.10A). However, the INP marker 
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R9D11-CD4-tdTom, which reports erm expression, was still expressed in type II neuroblast 
progeny upon ectopic expression of Ase (Fig. 2.10A) and remained so even at late larval 
stages (Fig. 2.10B). In contrast, R9D11-CD4-tdTom was absent entirely at early larval stages 
when tll was knocked down (Fig. 2.10C). Furthermore, expressing ase in type II neuroblasts 
did not effect the survival of type II lineages (eight type II neuroblast lineages were present in 
all control and UAS-ase brains). Therefore, these data confirm the previous observation that 
the repression of ase is a consequence of type II lineage specification (Bowman et al., 2008), 
strongly suggesting that Tll acts upstream of ase repression to instruct type II neuroblast 
specification (summarised in Fig. 2.10D). 
 
2.3 Chapter 2 discussion 
I have identified Tll as a new factor that regulates type II neuroblast fate and lineage identity. 
Throughout larval development, Tll is expressed at high levels in the neuroblast of type II 
lineages, weakly in immature INPs and not at all in mature INPs or the cells they give rise to. 
Removing Tll from type II neuroblasts revealed that Tll acts as an instructive signal for type 
II neuroblast fate. The loss of Tll results in the absence of all identifying features of type II 
lineages: type II neuroblasts derepress Ase, appear to segregate Pros to their progeny and 
lineages no longer express the INP marker erm. In the absence of Tll, type II neuroblasts 
undergo a cell fate transition to type I neuroblasts, which have a much lower self-renewal 
capacity and neurogenic potential. 
 
In mice, TLX is expressed in NSCs during embryonic development and in adulthood (Li et al., 
2012; Li et al., 2008; Liu et al., 2008; Shi et al., 2004). Embryonic NSCs display defects in 
proliferation in the absence of TLX (Li et al., 2008) and the loss of TLX in adult mice results 
in the depletion of the NSC pool and reduction in neurogenesis (Li et al., 2012; Liu et al., 
2008; Niu et al., 2011; Shi et al., 2004). As such, TLX has been designated as a cell cycle 
regulator but the effects of the loss of TLX on NSC fate and lineage progression have not 
been assessed robustly in vivo. The requirement of TLX for maintaining the undifferentiated 
state and self-renewal capacity of NSCs is consistent with the role of Tll in type II neuroblasts. 
If TLX and Tll act in a conserved manner, it would be predicted that the loss of TLX would 
result in NSCs switching to a more differentiated progenitor type that maintains some 
properties of NSC but with a reduced capacity for self-renewal and neurogenesis. 
 
In addition, the loss of TLX results in abnormal, aggressive behaviour in flies (Davis et al., 
2014) and mice (Monaghan et al., 1997; O’Leary et al., 2016; Roy et al., 2002; Young et al., 
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2002), and TLX mutations have been linked to hereditary cases of bipolar disorder and 
schizophrenia in humans (Dick et al., 2003; McQueen et al., 2005; Middleton et al., 2004; 
Wong et al., 2010). Despite the conserved effect that loss of TLX has on social behaviour, it 
is not clear if this is due to the regulation of NSCs by TLX or a separate mechanism. 
Therefore, it is important that we improve our understanding of how TLX controls NSC fate 
and lineage progression in different regions of the brain and at different stages of 
development. This could provide important links between mood disorders and genetic 
variants, which could improve our knowledge of the molecular causes of mental illnesses and 







Targeted DamID reveals the genome-wide binding sites of Tll in vivo 
 
Tll is expressed in type II neuroblasts and is required for the maintenance of NSC identity and 
lineage progression. I showed that in the absence of Tll, type II neuroblasts transform into 
type I neuroblasts, which have a more limited proliferation capacity and produce fewer 
neuronal progeny. In a similar manner, the loss of TLX has a negative impact on the 
proliferative capacity of vertebrate NSCs and results in a reduction in neurogenesis (Liu et al., 
2008; Shi et al., 2004; Zhang et al., 2008). 
 
TLX/Tll is an orphan nuclear receptor that acts primarily as a transcriptional repressor. There 
is no known biological ligand for TLX but its repressive function is mediated by a number of 
cofactors: Atrophin (Haecker et al., 2007; Wang et al., 2006; Zhang et al., 2006), BCL11 
(Estruch et al., 2012), LSD1 (Yokoyama et al., 2008), as well as a number of HDACs 
(Yokoyama et al., 2008). There are also a small number of genes for which TLX is a 
transcriptional activator (Chavali et al., 2014; Elmi et al., 2010; Qu et al., 2010). No cofactors 
that mediate transcriptional activation of target genes by TLX have been identified so far 
(Corso-Díaz et al., 2016). 
 
Determining the target genes of TLX is essential for understanding how TLX regulates NSC 
fate. Currently, there is no genome-wide binding data available for TLX or any of its 
homologues in other species. A number of studies have determined mouse TLX target genes 
by comparing changes in RNA levels in wild type adult NSCs with TLX null NSCs (Qu et al., 
2010; Zhang et al., 2008) or TLX overexpressing NSCs (Liu et al., 2010). However, only a 
small number of genes whose expression was altered upon TLX manipulation were found to 
be regulated directly by TLX; candidate targets were confirmed using a combination of gel 
shift, chromatin immunoprecipitation (ChIP) reverse transcription (RT)-PCR and luciferase 
reporter assays to show direct binding by TLX (Liu et al., 2008; Liu et al., 2010; Qu et al., 
2010). The change in expression of the majority of genes identified was likely due to a 
secondary effect of other TLX target genes. In addition, many of the targets were identified in 
cells in culture, meaning that additional in vivo validation was required.  Profiling the 
genomic binding sites of TLX/Tll in vivo would provide a valuable complementary data set to 
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these gene expression studies and would improve our understanding of the molecular 
mechanism of TLX. 
 
Figure 3.1: TaDa allows low, cell-type-specific expression of Dam-fusion proteins 
(A) Schematic showing the TaDa system. GAL4 (green) expression is controlled by a cell-type-
specific enhancer. GAL4 binds to UAS and activates the expression of the primary open reading frame 
(ORF, red), which is followed by two translational stop codons (TAA TAA). Low expression of the 
Dam-fusion (blue) is achieved through inefficient ribosomal re-initiation at the start codon (ATG). 
The Dam-fusion consists of the Dam coding sequence fused to the N-terminal of the protein of interest 
(hence, NDam-Tll).  
(B) NDam-Tll binds to DNA, directed by the recruitment of Tll to its genomic binding sites, and Dam 
methylates GATC sequences at binding sites (red). 
(C) In the Dam only control, Dam methylates GATC sequences at a low frequency and generates a 
reference binding profile for TaDa conditions. 
Based on (Southall et al., 2013). 
 
3.1 Designing the Tll Targeted DamID experiment 
To identify the genome wide target genes of Tll in vivo, I used Targeted DamID (TaDa) 
(Southall et al., 2013). TaDa is an adaptation of DNA adenine methlyltransferase 
identification (DamID) (van Steensel and Henikoff, 2000; van Steensel et al., 2001) that was 
developed by the Brand Lab to allow cell-type-specific profiling of DNA binding proteins. To 
perform DamID, the protein of interest is fused to the Escherichia coli DNA adenine 
methyltransferase (Dam) protein, which methylates the adenine residue of GATC sequences,  
resulting in DNA methylation at the genomic sites of Dam-fusion protein binding. TaDa is 
“targeted” because the Dam-fusion is downstream of UAS, meaning that its expression can be 
activated by a cell-type-specific GAL4 driver (Fig. 3.1A). However, expressing Dam at high 
levels is toxic and can produce nonspecific methylation (van Steensel and Henikoff, 2000). 
Low-level expression of the Dam-fusion protein is achieved in TaDa through the inclusion of 
a primary ORF (mCherry) followed by two stop codons and relying on infrequent ribosomal-
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very low levels of Dam-fusion being present in the cell-type of interest, but this is sufficient 
to methylate the DNA at sites of Dam-fusion binding (Fig. 3.1B). The control experiment for 
TaDa is the expression of the Dam protein alone under the same conditions as the Dam-fusion 
protein (Fig. 3.1C) to provide a low level of random DNA methylation, which also reveals 
open chromatin (Aughey et al., 2018).  
 
3.1.1 Creating a type II-specific GAL4 for Targeted DamID 
Profiling Tll binding sites in type II neuroblasts using TaDa requires a GAL4 driver that is 
specific to these neuroblasts. Unfortunately, many type II-specific genes are expressed in 
additional cells in the brain other than type II neuroblasts (such as pntP1 and btd, see Fig. 3.2) 
and so using their regulatory elements to drive GAL4 expression would result in Tll-NDam 
binding in additional cell types. 
  
Figure 3.2: Available type II GAL4s are not suitable for TaDa 
(A) pntP1-GAL4 driving UAS-mCD8-GFP (green) labels type II lineages (*) but is also expressed in 
the optic lobe (OL) and in cortex glia (arrow heads).  
(B) btd-GAL4 driving UAS-mCD8-GFP labels type II lineages (*) but is also expressed in the OL.  
Brains dissected at wandering third instar. Single section confocal images. Scale bars represent 30 µm. 
 
In order to target type II neuroblasts alone, I used an intersectional GAL4-based system that 
was developed by the Lee Lab (Yang et al., 2016). This approach requires multiple 
genetically encoded elements in order for GAL4 expression to be restricted to type II lineages 
(Fig. 3.3A). GAL4 expression is under the control of a dpn fragment. dpnEE is a 600 bp 
genomic fragment from dpn that drives expression in all neuroblasts outside of the optic lobes 
(Awasaki et al., 2014). GAL4 expression is prevented due to a transcriptional stop sequence 
separating the dpn enhancer and GAL4. Excision of the transcriptional stop sequence is 
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catalyzed by a KD recombinase, expression of which is driven by an enhancer of the stg gene 
(stg14, a 975 bp sequence located 8.5 kb upstream of the predicted TSS of stg) that drives 
transient expression in embryonic type II neuroblasts (Wang et al., 2014).  
I assessed the expression of this system at mid-larval stages and found that stg14 drives low 
levels of expression in type I neuroblasts, (as reported in Yang et al., 2016) (Fig. 3.3B). To 
restrict GAL4 expression to type II neuroblasts, I included asense-GAL80 (Neumüller et al., 
2011) to block GAL4 activity in type I neuroblasts (Fig. 3.3C). Assessment of the final 
genetic set-up showed that I could use this system to restrict GAL4 activity to type II lineages, 
which meant that it was suitable for performing Tll TaDa (Fig. 3.3D-D’). 
 
Figure 3.3: Testing the expression of stg ∩ dpn-GAL4 
(A) Schematic showing stg14-patterned dpn-GAL4. stg14 drives the expression of KD recombinase, 
which excises a transcriptional stop resulting in the dpnEE promoter driving GAL4. ase-GAL80 was 
included to prevent GAL4 activity in type I neuroblasts. This system results in the expression of TaDa 
constructs (under the control of UAS) in type II neuroblasts specifically. 
(B) stg14-patterned dpn-GAL4 (stg ∩ dpn-GAL4) driving UAS-mCD8-GFP (green) without ase-
GAL80 is expressed in type II neuroblasts and a small number of type I neuroblasts (arrowheads). 
Image is a projection over 61 µm in z.  
(C) stg14-patterned dpn-GAL4 (stg ∩ dpn-GAL4) driving UAS-mCD8-GFP (green) with ase-GAL80 
is expressed in type II neuroblasts (GFP+) and not in type I neuroblasts. Projection over 75 µm in z.  
(D-D’) stg14-patterned dpn-GAL4 (stg ∩ dpn-GAL4) driving UAS-mCD8-GFP (green) is expressed 
exclusively in type II neuroblasts (Dpn+ (red) and Ase- (blue) in D, marked by asterisks (*) in D’). 
Image is a projection over 30 µm in z. 




3.2 Profiling Tll binding sites in type II neuroblasts 
TaDa is a robust and reproducible technique that requires no cross-linking or antibodies 
(Southall et al., 2013; van Steensel and Henikoff, 2000; van Steensel et al., 2001). In addition, 
TaDa is highly sensitive and has been used to profile small numbers of neurons in the adult 
Drosophila brain (~100 neurons of ~150,00 per brain (Southall et al., 2013)). Type II 
neuroblasts are the minority progenitor type in the larval brain: there are 16 type II 
neuroblasts per brain, compared to ~320 type I neuroblasts in the central brain and VNC (Doe, 
2008; Ito and Hotta, 1992; Truman and Bate, 1988). Despite the small number of type II 
neuroblasts in the larval brain, the sensitivity of TaDa allowed me to determine Tll binding in 
vivo by extracting methylated DNA from an average of 45 brains per replicate, which 
corresponds to ~720 type II neuroblasts per sample.  
 
Performing peak-calling on the binding sites of Tll showed that Tll was bound at 2,495 genes 
(see Appendix 2 for full list). Gene Ontology (GO) term analysis of the gene list showed 
enrichment for genes required for nervous system development and neuron production (Table 
3.1), demonstrating that Tll binds to genes associated with neural fate during development.  
 
Term # genes p value 
nervous system development 391 2.07e-51 
neurogenesis 323 1.76e-47 
generation of neurons 310 6.04e-46 
regulation of cellular process 858 1.51e-44 
regulation of biological process 913 2.33e-43 
biological regulation 990 8.54e-42 
system development 565 1.54e-40 
cell communication 503 1.31e-37 
neuron differentiation 268 4.107e-37 
signalling 494 5.51e-37 
Table 3.1: GO term analysis of genome-wide Tll protein-coding targets. The top ten GO terms 
reveal enrichment for genes required for nervous system development. Analysis performed using 
GO::TERMFINDER (Boyle et al., 2004). 
 
3.2.1 Tll TaDa shows cell type specific binding 
A small number of genes have been identified as direct transcriptional targets of Tll in the 
early stages of embryogenesis. Tll binds upstream of knirps (kni) (Pankratz et al., 1992), 
Krüppel (Kr) (Hoch et al., 1992) and hunchback (hb) (Margolis et al., 1995) and regulates 
their transcription to define the anterior-posterior axis of the embryo. The fragments bound by 
Tll within the 5’ regulatory regions of kni, Kr, and hb were determined by in vitro DNase 
footprinting assays (Galas and Schmitz, 1978), which also revealed a consensus Tll binding 
sequence (AAGTCA) (Hoch et al., 1992; Margolis et al., 1995; Pankratz et al., 1992). 
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I assessed if Tll bound to its embryonic targets in type II neuroblasts. In the Tll TaDa data, Tll 
binding is observed at the 5’ regulatory regions of kni (Fig. 3.4A), Kr (Fig. 3.4B), and hb (Fig. 
3.4C). The binding of Tll at these genes is statistically significant and these genes are 
identified in the list of Tll targets (Appendix 2). However, with the exception of hb, the cis-
regulatory fragments to which Tll binds in type II neuroblasts do not correspond to the 
elements defined in the embryo (highlighted in green in Fig. 3.4). This demonstrates that the 
binding pattern of Tll changes over the course of development and provides initial validation 
that the binding targets identified by Tll TaDa are specific to type II neuroblasts.    
 
Figure 3.4: Tll binds to previously determined target genes 
(A) Tll binds at the TSS of kni (kni shown in grey), with binding (blue peaks) also observed across the 
first intron of the long isoform. No binding is observed at the previously characterised 5’ regulatory 
element (green) (Pankratz et al., 1992). 
(B) Tll binds at the TSS of Kr (Kr shown in grey). No Tll binding is observed at the previously 
defined 5’ element (green) (Hoch et al., 1992; Hoch et al., 1991). 
(C) Tll binds upstream of hb and binding overlaps with the embryonic 5’ regulatory fragment (green) 
(Margolis et al., 1995). 
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Figure 3.5: Tll binds to ase and l’sc, two AS-C genes 
(A) The AS-C comprises ac, sc, l’sc, and ase. Tll binds to ase (grey with dotted outline) and l’sc 
(grey) but not to ac or sc (blue). All genes of the AS-C are transcribed from left to right. 
(B) L’sc (cyan) is expressed in immature INPs (arrowheads) but is absent from type II neuroblasts 
(Dpn+, red, and outlined with solid white line). Neither L’sc expression nor INPs are present in tll-
miRNA[s] lineages. Type II lineages were identified using pntP1>act-GAL4 and are outlined with 
white dotted lines. Brains dissected 30 hours ALH. n = 13 brains for Control; n = 12 brains for tll-
miRNA[s]. 
(C) Schematic showing L’sc (cyan) expression in immature INPs. No L’sc expression is detected in 
type II lineages in the absence of Tll. 
(D) Notch signalling is active in the neuroblast (outlined with solid white line) of type II lineages, 
which is unaffected upon tll knockdown. Type II lineages were identified with pntP1>act-GAL4 and 
are outlined with white dotted lines. Arrowheads indicate immature INPs that express L’sc, which do 
not display Notch signalling. Brains were dissected 30 hours (h) ALH.  n = 13 brains for Control; n = 
12 brains for tll-miRNA[s] 
(E) Schematic depicting a model of the relationship between Tll, AS-C genes, and Notch signalling. 
Tll expression (red) and Notch signalling (green) are high in type II neuroblasts. Tll represses Ase 
expression in the neuroblast. Early born immature INPs lack Notch signalling but maintain low levels 
of Tll expression. L’sc (blue) is also expressed in early immature INPs. Tll binds to L’sc and may 
activate its expression, which is likely repressed by Notch signalling in the neuroblast.  
Control panel images are a projection of two 1 µm slices; tll-miRNA[s] panels single section confocal 
images. Scale bars represent 15 µm. 
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3.2.2 Tll binds to AS-C genes 
Tll is required for type II neuroblast fate, which is dependent on the repression of asense (ase). 
In Chapter 2, I showed that ase is derepressed in type II neuroblasts when Tll is knocked 
down suggesting that ase repression is downstream of Tll. To determine if ase could be a 
transcriptional target of Tll, I assessed the binding of Tll at the ase locus using TaDa.  
Analysis of the Tll peaks showed that Tll binds strongly at the ase locus (Fig. 3.5A). 
Therefore, Tll appears to repress ase expression directly in order to promote type II neuroblast 
fate. 
 
ase is part of the achaete-scute complex (AS-C) (González et al., 1989). The AS-C comprises 
four bHLH transcription factors, achaete (ac), scute (sc), lethal of scute (l’sc) and ase, that 
promote neural fate (Skeath and Carroll, 1994). Further analysis of Tll binding peaks across 
the AS-C showed that, in addition to binding at ase, Tll binds at l’sc but not at ac or sc loci 
(Fig. 3.5A). This suggested that l’sc could also be a direct transcriptional target of Tll. 
However no role has been described for L’sc in type II lineages. Intriguingly, a previous study 
showed that tll mutant embryos lacked regions of l’sc expression, resulting in the absence of 
neuroblasts, and identified a Tll binding site upstream of l’sc (Younossi-Hartenstein et al., 
1997). In addition, loss of tll in the developing optic lobe resulted in the loss of L’sc 
expression as neuroepithelial cells transition to neuroblasts (Guillermin et al., 2015). These 
observations suggested that Tll activates L’sc expression but provided no binding data to 
support this claim.  
 
To determine if L’sc is expressed in type II lineages, I performed immunostaining with an 
antibody raised against L’sc (Caygill and Brand, 2017). This showed that L’sc is expressed 
transiently in type II lineages: L’sc is expressed in newly-born progeny of type II neuroblasts 
(early INPs) in all lineages but not in other cells of the lineage (Control panels of Fig. 3.5B). 
To determine if Tll binding at l’sc has a functional role in type II lineages, I assessed the 
expression of L’sc in tll knockdown lineages. L’sc expression was abolished upon the loss of 
tll (Fig. 3.5B), suggesting that Tll activates L’sc expression in type II lineages. Thus, the 
regulatory relationship between Tll and L’sc in type II lineages appears to mirror the role of 
tll in the embryo and optic lobe (Guillermin et al., 2015; Younossi-Hartenstein et al., 1997). 
However, it is difficult to determine the regulatory relation between Tll and L’sc in type II 
lineages due to the loss of INPs in the absence of tll (Fig. 3.5C). Assessing the regulatory 
relationship between Tll and L’sc is complicated further by the activity of Notch signalling. 
Notch signalling represses proneural gene expression (for a review, see Bertrand et al., 2002) 
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and so the cells in which L’sc is expressed show downregulation of Notch signalling (Yasugi 
et al., 2010 and Fig. 3.5B-C). Type II neuroblasts have active Notch signalling, which is not 
disrupted upon loss of tll, and so could explain the absence of L’sc in both normal type II 
neuroblasts and in tll knockdown lineages (Fig. 3.5D). If this is the case, L’sc expression in 
early INPs could be permitted due to the maintenance of Tll (see Chapter 2) and the lack of 
Notch signalling in these cells (Knoblich et al., 1995). Since Notch signalling is not affected 
by the loss of tll (Fig. 3.5D) it is likely that the Notch pathway and Tll act in parallel 
pathways to maintain a balance between neuroblast fate and differentiation (Fig. 3.5E). It 
should be noted that ase and Notch signalling co-exist in INPs and type I neuroblasts during 
development (Zacharioudaki et al., 2012), demonstrating that ase is not repressed by Notch 
signalling in the same manner as classical proneural genes (ac, sc and l’sc).  
 
In summary, TaDa showed that Tll binds across the AS-C in type II neuroblasts. Significant 
binding was found at ase (which Tll represses) and l’sc (which Tll may activate), 
demonstrating the complexity of gene regulation by Tll. While ase has been much studied in 
type II neuroblast fate, the role of l’sc has not yet been explored. The expression of l’sc in 
early immature INPs suggests it may regulate INP maturation. 
 
3.2.3 Tll binds to genes that are expressed differentially in type II lineages: pros, pntP1, 
erm, btd, Sp1 
Repression of ase is central to the ability of tll to promote type II neuroblast fate. However, 
the loss of ase is not sufficient to induce type II neuroblast fate in type I neuroblasts (Bowman 
et al., 2008), demonstrating that additional factors are required to specify type II lineages.  
 
Type I neuroblasts exhibit cortical crescents of Prospero (Pros), a homeodomain protein that 
promotes neuronal differentiation, at asymmetric division (Choksi et al., 2006). As a result, 
Pros is segregated to differentiating daughter cells, where it enters the nucleus and both 
represses neuroblast genes and promotes neuronal fate (Knoblich et al., 1995; Spana and Doe, 
1995; Vaessin et al., 1991). In contrast, type II lineages do not express Pros, which is required 
for the generation of full neuronal lineages (Bayraktar et al., 2010). In Chapter 2, I showed 
that removing tll from type II neuroblasts results in the derepression of Pros in type II 
neuroblasts and that Pros was segregated asymmetrically upon neuroblast division into 
differentiating progeny. To determine if Tll represses pros directly, I assessed Tll binding at 
the pros locus in type II neuroblasts. TaDa revealed that Tll was bound within the pros coding 
sequence (in the first exon of the longer isoforms, which also corresponds to the TSS of the 
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shorter isoforms) (Fig. 3.6A), suggesting that Tll represses the expression of this pro-
differentiation gene directly. 
 
In contrast to Ase and Pros, which are repressed selectively in type II neuroblasts, the ETS 
transcription factor PointedP1 (PntP1) is expressed in type II but not type I neuroblasts. PntP1 
expression promotes both type II neuroblast fate and INP specification (Xie et al., 2016; Zhu 
et al., 2011). TaDa revealed that Tll bound across the pnt locus, with the majority of binding 
observed at the region immediately upstream of the shorter pntP1 isoform (Fig. 3.7A). The 
longer pnt isoform, pntP2, is not expressed in type II lineages (Zhu et al., 2011) and so the 
selective binding of Tll observed at the promoter of pntP2 suggests that Tll may promote the 
differential expression of pntP1 and pntP2 in type II neuroblasts. 
 
 
Figure 3.6: Tll binds at the pros locus 
(A) Tll binds within the coding sequence of pros, with binding enriched at the 5’ region of the shorter 
isoforms.  
 
To determine if loss of tll affects PntP1 expression, I compared PntP1 expression in control 
type II lineages and in the absence of tll. PntP1 is expressed in the neuroblast and early INPs 
in type II lineages (Zhu et al., 2011). However, loss of tll results in the absence of PntP1 in all 
cells of type II lineages (Fig. 3.7B), demonstrating that Tll is required for PntP1 expression in 
type II neuroblasts (Fig. 3.7C). 
 
PntP1 expression in type II neuroblasts is required to promote INP specification (Zhu et al., 
2011) via a feedback loop with earmuff (erm) and Notch signalling (Li et al., 2017; Li et al., 
2016; Xie et al., 2016). In maturing INPs, PntP1 activates erm expression to prevent INP 





















in Chapter 2 that type II lineages that lack tll lose erm reporter (R9D11-CD4-tdTomato) 
expression, suggesting that Tll could also be involved in this regulatory loop.  
 
Figure 3.7: Tll binds to genes required for INP specification 
(A) Tll binding at the pnt locus is enriched at the shorter pntP1 isoform (grey), which is expressed in 
type II neuroblasts. The longer isoform pntP2 (blue) is not expressed in type II lineages and does not 
have significant Tll binding near its promoter. 
(B) PntP1 (green) expression in type II neuroblasts (Dpn+, red) is lost when tll is knocked down. Type 
II lineages were identified using pntP1>act-GAL4 driving UAS-GFP (white dotted lines).  
(C) PntP1 (orange) expression in type II neuroblasts (Dpn+, red) and immature INPs is lost in the 
absence of tll. 
(Figure legend continues on next page) 
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(D) Tll binds across the erm locus (grey), with binding enriched at the 5’ region of the gene body. 
(E) Expression of the erm reporter R9D11-CD4-tdTomato (white) in INPs is lost when tll is knocked 
down.  Type II lineages were identified using pntP1>act-GAL4 driving UAS-GFP (white dotted lines).  
(F) PntP1 promotes INP maturation by activating erm expression, which in turn represses pntP1. 
Notch signalling represses erm to maintain type II neuroblast fate. Tll is required for neuroblast fate 
and PntP1 expression, but the regulatory relationship between Tll and erm is uncertain. 
Brains were dissected 72 hours ALH. n = 10 brain lobes for Control and tll-miRNA[s]. Single section 
confocal images. Scale bars represent 15 µm. 
 
Analysis of the TaDa peaks showed Tll binding across the erm locus, with enrichment at the 5’ 
region of all isoforms, suggesting that Tll could regulate erm expression directly (Fig. 3.7D). 
Type II lineages that lack tll do not express PntP1 nor do they express erm (Fig. 3.7B and Fig. 
3.7E) and so Tll could be involved in this regulatory network. Due to the overlap in 
expression of Tll and PntP1 in type II neuroblasts, Tll likely regulates the expression of pntP1 
in a positive manner.  Determining the regulatory relationship between Tll and erm is difficult 
due to the switch in lineage type. It is possible that Tll represses erm expression in type II 
neuroblasts as, unlike PntP1 and Erm, Tll and Erm are not expressed in the same cell type 
during lineage progression. However, the loss of erm in tll lof type II lineages could be 
explained due to the loss of PntP1 (which activates erm (Xie et al., 2016)) and the persistence 
of Notch signalling (which represses erm (Li et al., 2016)). This suggests that Tll acts as an 
upstream factor that is necessary for initiating the regulatory network between PntP1, Erm 
and Notch signalling (Fig. 3.7F). 
 
Tll binding is also observed at buttonhead (btd) and Sp1 loci (Fig. 3.8A). The expression of 
these genes is enriched in type II neuroblasts compared to other lineages (Carney et al., 2012). 
btd and Sp1 act redundantly to specify type II neuroblast fate in the embryo (Álvarez and 
Díaz-Benjumea, 2018) and, later in development, btd is also required for INP fate acquisition. 
Tll binding at these genes suggests that these genes may act downstream of Tll both during 
the early stages of type II fate specification and in mature type II lineages.  
Figure 3.8: Tll binds to btd and Sp1 
(A) Tll binds at the btd (grey) and Sp1 (blue) loci. btd and Sp1 are required for type II 













3.2.4 Tll binds to canonical NSC genes 
In addition to binding to genes that are regulated in a type II-specific manner, Tll binding was 
also observed at pan-neuroblast genes. The bHLH-O Hes-like transcription factor deadpan 
(dpn) is expressed in all neuroblasts (as well as mature INPs) and promotes the self-renewal 
capacity of progenitors (San-Juán and Baonza, 2011; Wallace et al., 2000; Zacharioudaki et 
al., 2012; Zhu et al., 2012). Ectopic expression of Dpn is sufficient to produce large tumours 
that consist of neuroblasts (San-Juán and Baonza, 2011; Wallace et al., 2000; Zhu et al., 
2012). Tll binding is observed upstream of the TSS of dpn and also within an intron of dpn, 
suggesting that this region could contain regulatory elements.  
 
 
Figure 3.9: Tll binds to canonical NSC genes 
(A) Tll binds upstream of dpn (grey), a bHLH-O transcription factor that promotes the self-renewal of 
neuroblasts. 
(B) Tll binds to a large region upstream of wor (grey), a Snail family transcription factor that prevents 
premature differentiation of neuroblasts. The other Snail family members, esg and sna (blue), are 
found in the same genomic region as wor. Tll does not bind to sequences upstream of esg, but does 
bind near sna. 
 
The Snail family zinc finger transcription factors worniu (wor), escargot (esg) and snail (sna) 
are required in embryogenesis to promote neuroblast delamination (Ashraf et al., 1999). 
However, wor is the only member that remains expressed in neuroblasts throughout 
development (Ashraf et al., 2004) and is required to promote cell-cycle progression and 
maintain the stem cell state of neuroblasts (Lai et al., 2012). Many Tll peaks are found 
immediately upstream of wor, suggesting that Tll could promote the expression of wor in type 























Therefore, it seems likely that Tll regulates other transcription factors that positively regulate 
general properties of NSC fate, such as self-renewal, active cell cycle progression, and 
inhibition of differentiation. This provides a more complex view of Tll as a regulator of NSC 
fate. Studies in mammalian NSCs have suggested that TLX regulates cell cycle factors 
directly (Li et al., 2008; Zhang et al., 2008), but cell cycle stalling alone does not necessarily 
induce neural differentiation from NSCs. Overall, Tll binds to many genes that must be 
coordinated to maintain type II neuroblast fate during development. 
 
3.3 Tll binds to a subset of TLX orthologues 
Drosophila Tll and mammalian TLX are highly conserved genes; their amino acid sequences 
show a high degree of similarity, they are regulated by conserved cofactors, and they can bind 
to the same DNA consensus sequence. One of the aims of performing Tll TaDa in Drosophila 
type II neuroblasts was to identify conserved target genes that are also regulated by vertebrate 
TLX. I identified 2945 Tll targets using TaDa and validated a small number of these in type II 
neuroblast lineages.  
 
To determine if Tll bound any of the previously identified TLX targets, I compiled a list of 
the known mouse TLX target genes and determined the orthologous Drosophila genes. I used 
DIOPT (Drosophila RNAi Screening Center Integrative Ortholog Prediction Tool) (Hu et al., 
2011) to predict orthologous gene pairs, which does so by comparing sixteen published 
databases (updated from the nine reported in Hu et al., 2011). A ‘DIOPT score’ (the number 
of databases out of sixteen that identify the match) and a ‘DIOPT rank’ (based on the DIOPT 
score and if the orthologue prediction occurs both ways) are generated for each pair 
prediction, which provides a simple way to filter potential orthologues. The full list of TLX 
target genes and their Drosophila orthologues is provided as Table 3.2. I compared the 
Drosophila orthologue list with the Tll TaDa gene list (Appendix 2) and found that Tll bound 
to six of the ten TLX target genes orthologues in type II neuroblasts (Table 3.2). Most 
notable was the binding of TLX to ASCL1 (Elmi et al., 2010), which is orthologous to genes 
of the AS-C (ac, sc, l’sc and ase). As shown above, Tll binding was observed at l’sc and ase 
in type II neuroblasts. Interestingly, TLX has been reported to show the opposite regulatory 
relationship with ASCL1 (TLX activates ASCL1 expression in rat adult hippocampal-derived 
progenitors (Elmi et al., 2010)) compared to Tll and ase (Tll represses ase to maintain type II 
neuroblast fate). However, Tll could activate l’sc expression and l’sc shows the highest 
conservation with ASCL1 of the genes of the AS-C (Table 3.2). This strongly suggests that 
the regulation of proneural genes is a conserved function of Tll/TLX from flies to mammals. 
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Intriguingly, Tll binding was not observed at the cell cycle regulators (Tctp/p21 and Pten) 
(Table 3.2). This was surprising because the regulation by TLX has been shown in multiple 
cell types and these orthologues showed high conservation between mice and flies (the 
orthologues had DIOPT scores of 13 or 16) (Sun et al., 2010; Sun et al., 2007; Yokoyama et 
al., 2008; Zhang et al., 2006). The other TLX targets that did not show Tll binding were the 
orthologues of Sirt1 and VEGF (Table 3.2). However, TLX regulation of Sirt1 and VEGF 
was determined in HEK293 (a kidney-derived cell line) and in neuroblastoma cell lines under 
hypoxic stress, respectively, suggesting that these regulatory relationships may not occur 














ASCL1 activated ac 7 moderate n 
  
sc 6 moderate n 
  
l’sc 8 high y 
  
ase 5 moderate y 
MMP-2 activated mmp2 3 moderate y 
  
mmp1 2 low n 
Oct-4 repressed vvl 3 moderate y 
  
nub 2 low y 
  
pdm2 2 low y 
p21 repressed Tctp 13 high n 
Pax2 repressed sv 6 moderate y 
  
poxn 2 low y 
Pou5f1 activated vvl 3 moderate y 
  
nub 2 low y 
  
pdm2 2 low y 
PTEN repressed pten 13 high n 
Sirt1 activated sirt1 10 high n 
  
sirt2 2 low n 
VEGF activated pvf1 2 low n 
Wnt7a activated wnt2 12 moderate y 
  
wnt10 3 low n 
  
wnt4 2 low y 
  
wnt5 2 low n 
  
wg 2 low y 
  
wnt6 2 low n 
Table 3.2: Tll binds to a subset of TLX targets. Drosophila orthologues of TLX target genes were 
determined using DIOPT (Hu et al., 2011). Orthologues that are bound by Tll in type II neuroblasts 
are highlighted in blue. The DIOPT score indicates the number of databases that identify the 
orthologue pair (the maximum DIOPT score is 16). DIOPT ranks are high (DIOPT score ≥ 2 and best 
score both ways), moderate (DIOPT score ≥ 2 with similar scores both ways or DIOPT score ≥ 4), or 
low (all others). 
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Therefore, Tll binds to a subset of TLX target orthologues in type II neuroblasts (Table 3.2). 
The absence of Tll binding from PTEN (phosphatase and tensin homolog) and p21 suggests 
that Tll may have a more prominent role in regulating NSCs fate rather than cell cycle 
progression in a developmental context. Identifying potential TLX target genes based on the 
Tll TaDa gene list will require functional validation of more Tll targets. 
 
3.4 Chapter 3 discussion 
Overall, TaDa has revealed that Tll binds to many genes that are required for type II 
neuroblast fate (ase, pros, pntP1, btd and Sp1) as well as genes that promote lineage 
progression (such as erm). Tll also binds to transcription factors that are expressed in all 
cycling neuroblasts, such as dpn and wor, suggesting that Tll may also have a more general 
role in maintaining neuroblast identity and self-renewal.  
 
Tll TaDa led to the discovery that the proneural gene L’sc is expressed in immature INPs. 
Immature INPs are a transient state within type II lineages, which can mean that genes 
expressed in the early stages of INP maturation are difficult to profile. TaDa showed that Tll 
binds at the l’sc locus, indicating that Tll could regulate l’sc expression in type II lineages. 
However, it has not been possible to determine the regulatory relationship between Tll and 
l’sc since the loss of Tll affects the progression of the entire lineage. Further experiments are 
required to assess if Tll promotes l’sc expression, as has been observed during early embryo 
development and in the optic lobe (Guillermin et al., 2015; Younossi-Hartenstein et al., 1997), 
and also to investigate if l’sc has a functional role in INP maturation. 
 
3.4.1 Tll binds to many genes throughout the genome 
TaDa showed that Tll binds widely across the genome with around 2,500 target genes. Tll 
binds to DNA through the recognition of the consensus sequence (AAGTCA) (Pankratz et al., 
1992), which is found at a high frequency throughout the Drosophila genome (data not 
shown). Vertebrate TLX can also bind to the Tll binding sequence due to the high 
conservation of the DBDs (Monaghan et al., 1995; Yu et al., 1994). However, while the 
consensus binding sequence is required to recruit Tll to its target genes, the repressive activity 
of Tll/TLX is mediated by a number of cofactors. In vertebrates, TLX has a number of co-
repressors but the only one for which a Drosophila counterpart is known so far is Atrophin 
(Zhang et al., 2002). Drosophila Atrophin and mammalian Atrophin-2 have highly similar 
molecular structures and both proteins interact with the LBD of Tll/TLX via their C-terminal 
domains (Wang et al., 2006; Zhi et al., 2015). Atrophin is expressed widely throughout the 
 51 
Drosophila CNS (data not shown), which would allow it to act as a co-repressor for different 
transcriptional regulators, in particular Tll. It is also possible that there are unidentified 
cofactors of Tll (such as orthologues of the vertebrate cofactors BCL11A (CG9650, dCTIP), 
LSD1 (Su(var)3-3) or certain HDACs) that could bind to Tll and mediate its repressive 
function. The functional role of Atrophin and additional co-repressor candidates in type II 
neuroblasts should be evaluated (e.g. by RNAi or assessing mutants) as an initial step. 
 
Due to the high number of Tll target genes, and the likely role of cofactors in coordinating 
gene expression control, it is difficult to determine the biological significance of Tll binding 
at every target gene identified in this TaDa experiment. One approach that may help to 
identify repressive targets would be to determine the binding sites of Tll co-repressors in type 
II neuroblasts. For example, profiling the binding sites of Atrophin with TaDa would provide 
complementary data that could be used to identify common binding sites. However, 
performing separate TaDa experiments would not show that two proteins bind at the same 
loci at the same time. Split DamID (SpDamID) is an adaptation of DamID that can be used to 
determine the recruitment of cofactors to common target genes (Hass et al., 2015). In 
SpDamID, the N-terminal D half is fused to one interacting partner (e.g. Tll) and the C-
terminal AM half is fused to the other (e.g. Atrophin). As a result, the Dam protein is 
reconstituted only when the two interacting partners come together and so GATC fragment 
methylation occurs at shared target genes. In this way, genes repressed by Tll-Atrophin 
complexes could be determined in vivo, and a similar approach could be used to characterise 
other potential Tll cofactors.  
 
3.4.2 Implications for vertebrate TLX 
Tll TaDa performed here has provided the first genome wide binding data for Tll/TLX in any 
species. In addition, the binding data was generated in vivo and in a cell-type-specific manner. 
The binding of Tll at AS-C genes was of particular interest for studies of TLX, as TLX has 
been shown to bind the ASCL1 promoter in adult rat hippocampus-derived progenitors (Elmi 
et al., 2010). Tll bound to two members of the AS-C – ase and l’sc – and likely has opposite 
effects on the transcription of these genes, which highlights the complex regulatory roles of 
Tll in the nervous system.  
 
Comparing the known TLX targets with the Tll TaDa gene list showed that Tll binds to a 
subset of TLX targets. However, generating binding data for Tll provides an opportunity to 
determine new transcriptional targets of TLX. A number of studies have assessed gene 
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expression changes upon the manipulation of TLX (through overexpression or loss of 
function) in NSCs using RNA sequencing. It would be interesting to perform a more detailed 
comparison of the putative TLX targets identified in those studies and the Drosophila Tll 
targets identified by TaDa here (Liu et al., 2010; Qu et al., 2010; Zhang et al., 2008). In 
addition, the Brand Lab has recently published Mammalian Targeted DamID (MaTaDa), 
which can be used to profile transcription factors in cells in culture (Cheetham et al., 2018), 
and this system is being developed for in vivo profiling of DNA binding proteins (van den 
Ameele et al., in preparation). It would be interesting to perform in vivo TaDa with mouse 
TLX during brain development and compare the binding targets with the Tll TaDa gene list 
from Drosophila type II neuroblasts. Furthermore, MaTaDa could be used to profile human 
TLX binding in glioblastoma stem cells (GSCs) to identify if the transcriptional targets 
identified during development are conserved in cancer. As such, Tll TaDa has provided an 
insight into the role of Tll in type II neuroblasts and there are many avenues that could extend 





Tll/TLX initiates tumourigenesis from intermediate neural progenitors 
 
TLX promotes the self-renewal and proliferation of neural stem cells (NSCs) during 
development and into adulthood (Li et al., 2012; Li et al., 2008; Liu et al., 2008; Monaghan et 
al., 1995; Monaghan et al., 1997; Obernier et al., 2011). High TLX expression has also been 
identified in human brain tumours, in particular aggressive glioblastoma and neuroblastoma 
tumours, and TLX expression correlates with poor patient survival (Chavali et al., 2014; Park 
et al., 2010; Zou et al., 2012). Intriguingly, a subset of glioblastoma samples showed an 
increase in the copy number of TLX and studies in mice have demonstrated that the number 
of NSCs correlates with TLX copy number (Liu et al., 2010). 
 
The life expectancy of patients with aggressive brain tumours has not improved since the 
1980s (Bondy et al., 2008). One reason for this is a population of NSC-like cells, known as 
cancer stem cells, that are resistant to treatment and are capable of reinitiating tumours 
following therapy (Reya et al., 2001; Singh et al., 2003). As such, being able to target cancer 
stem cells is essential for improving the survival from tumours affecting the central nervous 
system (CNS). It is likely that cancer stem cells hijack normal developmental programmes 
that are active in NSCs. Interestingly, TLX is expressed in glioblastoma stem cells (GSCs) 
and is required for their self-renewal capacity (Zhu et al., 2014). Removing TLX from GSCs 
inhibits tumourigenicity and prevents tumour reinitiation upon GSC transplantation (Cui et al., 
2016; Zhu et al., 2014). As such, TLX is a promising therapeutic target for treating aggressive 
glioblastomas. It is important that we understand the molecular mechanisms through which 
TLX regulates stem cells in normal development and in tumourigenesis so that we can realise 
the therapeutic potential of TLX. 
 
In vivo mouse models have shown that high levels of TLX expression in NSCs are sufficient 
to expand the NSC pool and can lead to glioblastoma when combined with additional 
mutations (Liu et al., 2010; Park et al., 2010; Zhu et al., 2014; Zou et al., 2012). Although this 
implicates NSC lineages as the origin of TLX-induced tumours, the cell type of origin within 
the lineage is not known. The cell of origin likely differs between different driver mutations 
and so identifying the cell type of origin of TLX-induced glioblastoma is an important step in 
developing targeted therapies. However, following cell fate and lineage progression of 
specific mammalian NSCs in vivo is technically challenging. The high conservation between 
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mammalian TLX and Drosophila Tll, combined with the extensive genetic tools available in 
Drosophila, means that the fly brain provides an excellent system in which to study the role 
of TLX/Tll in NSCs. I showed that Tll is expressed in type II neuroblasts to maintain their 
division mode. Type II neuroblasts show many parallels with mammalian NSCs and provide a 
simple system in which to study NSCs and tumour initiation.  
 
4.1 Assessing the tumourigenic capacity of Tll in Drosophila type II lineages 
During development, Tll is expressed in the neuroblast of type II lineages but is 
downregulated concomitantly with differentiation. Tll is required for type II neuroblast fate 
and regulates key type II genes directly (Chapters 2 and 3). Given that high levels of TLX 
results in ectopic NSCs (Liu et al., 2010; Park et al., 2010; Zhu et al., 2014; Zou et al., 2012), 
the first step was to investigate if expressing high levels of Tll was sufficient to prevent 
differentiation of type II lineages and lead to tumourigenesis in Drosophila. 
 
Figure 4.1: Molecular markers for following type II lineage progression 
(A) Schematic showing markers for different cell fates in type II lineages. Type II neuroblasts are 
Dpn+ (red), PntP1+ (orange) and Ase- (green). R9D11 (blue) is a fragment of the 5’ regulatory region 
of erm, which is expressed in maturing INPs (Pfeiffer et al., 2008; Weng et al., 2010). R9D11 can be 
used to drive the expression of GAL4 or fluorescent reporters.  
(B) btd-GAL4>myr-mRFP (red) labels all type II lineages (asterisks, *) at wandering third instar (Xie 
et al., 2014). Type II lineages express R9D11-mCD8-GFP (green). btd-GAL4 and R9D11-mCD8-
GFP are also both expressed in the optic lobe (OL). 
(C) btd-GAL4>myr-mRFP (white, and indicated by dotted outline) is expressed in the neuroblast 
(arrowhead) of type II lineages and is maintained in INPs (Dpn+ Ase+). R9D11-mCD8-GFP (blue) is 
absent from type II neuroblasts (arrowhead) but is expressed in INPs coincident with Ase expression.  
Single section confocal images. Scale bars represent 30 µm in B; 10 µm in C. 
 
There are many molecular markers that can be used to follow cell fate transitions in type II 
lineages (Fig. 4.1A). Type II neuroblasts express the bHLH-O factor Deadpan (Dpn) and the 
Ets transcription factor PointedP1 (PntP1) but are negative for pro-neural factor Asence (Ase) 
(Bowman et al., 2008; Zhu et al., 2011). Their immediate progeny, immature intermediate 
neural progenitors (INPs), maintain PntP1 but not Dpn. During maturation, INPs turn off 
PntP1 as they begin to express the FezF transcription factor Earmuff (Erm) and later turn on 
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Ase (Janssens et al., 2014, Li et al., 2016). Mature INPs express Dpn and Ase and divide 
asymmetrically to generate Ase+ GMCs, which in turn divide to produce neurons. 
 
4.1.1 High levels of Tll in type II lineages results in tumours 
To express Tll at high levels throughout type II lineages, I used buttonhead (btd)-GAL4 to 
drive UAS-tll. btd-GAL4 is a GAL4 enhancer trap line inserted 753 bp upstream of the 
transcription start site of btd (Estella et al., 2003). btd-GAL4 is expressed in all type II 
neuroblasts (Fig. 4.1B) and expression is maintained throughout INP maturation (Xie et al., 
2014) (Fig. 4.1C). Expressing UAS-tll with btd-GAL4 resulted in a large expansion in type II 
neuroblasts (Fig. 4.2A): control brain lobes always had 8 Dpn+ Ase- type II neuroblasts (n = 
8) whereas Tll overexpression (Tll OE) brain lobes had at least 250 (n = 12). These ectopic 
type II neuroblasts were generated at the expense of neurons (as assessed by Elav (Embryonic 
lethal abnormal vision) staining Fig. 4.2B). This shows that preventing the downregulation of 
Tll in type II lineages is sufficient to induce ectopic neuroblasts and tumourigenesis.  
 
Figure 4.2: High levels of Tll cause tumours in type II lineages 
(A) Overexpressing tll with btd-GAL4 (Tll OE) results in the expansion of type II neuroblasts (Dpn+ 
(red) and Ase- (green)). Dotted white lines indicate btd-GAL4>myr-RFP expression in type II lineages. 
Arrowheads indicate type II neuroblasts. n = 8 brain lobes for Control; n = 6 brain lobes for Tll OE.  
(B) Tll OE with btd-GAL4 results in the loss of neurons (Elav, green). Dotted white lines indicate type 
II lineages identified by btd-GAL4>myr-RFP. n = 10 brain lobes for Control and Tll OE.  
Single section confocal images. Scale bars represent 30 µm. 
 
4.1.2 Tll can generate type II neuroblasts from INPs  
It has been observed previously that the asymmetric division of neuroblasts is not affected by 
high levels of Tll; neuroblasts that expressed high levels of Tll exhibited normal cortical 
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localisation of aPKC, Pins, Brat, and Mira (Kurusu et al., 2009). This indicates that Tll 
tumours do not arise from disruptions to the asymmetric division of type II neuroblasts and 
suggests that the tumour-initiating cell is not the type II neuroblast itself. As such, this 
implicates the dedifferentiation of a more committed cell type as the route to tumourigenesis. 
Figure 4.3: Tll is sufficient to induce type II neuroblast fate from INPs 
(A) In Control, all Dpn+ cells within R9D11-GAL4>mCD8-GFP express Ase (arrowheads). Tll OE in 
INPs results in Dpn+ cells that lack Ase (arrowheads). Dotted white lines indicate R9D11-
GAL4>mCD8-GFP. n = 10 brain lobes for Control and Tll OE.  
(B) Quantification of the number of type II neuroblasts (i) Total number of Dpn+ Ase- cells; (ii) GFP-
negative Dpn+ Ase- cells. Kolmogorov-Smirnov test ***, P<0.001 (P=0.000091). 
(C) In Control lineages, PntP1 (green) is expressed in neuroblasts (solid white outlines) and immature 
INPs. Tll OE results in Dpn+ INPs activating PntP1 (arrowheads in Tll OE). Dotted white lines 
indicate R9D11-GAL4>mCD8-GFP. n = 10 brain lobes for Control and Tll OE.  
(D) Schematic showing the effect of Tll OE in INPs (using R9D11-GAL4, blue) on PntP1 expression. 
In Control lineages, PntP1 (orange) and Dpn (red) overlap only in the neuroblast, but INPs maintain 
PntP1 expression in Tll OE lineages. 
(E) Tll OE with R9D11-GAL4>mCD8-GFP (blue) results in ectopic type II neuroblasts (Dpn+ Ase-, 
white outlines) outside of the GAL4 domain. n = 10 brain lobes for Control and Tll OE.  
(F) Schematic showing the effect of expressing Tll in INPs on type II lineages. Ectopic type II 
neuroblasts that do not express R9D11-GAL4 could arise from INP reversion to neuroblast fate or 
from a cell non-autonomous effect.  
Single section confocal images. Scale bars represent 10 µm in A, C; 30 µm in E. 
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To investigate if Tll is able to cause de-differentiation of INPs, I expressed UAS-tll in INPs 
and assessed the effect on lineage progression. To target UAS-tll to INPs, I used the R9D11 
fragment to drive GAL4 expression. R9D11 is a regulatory region of erm, a gene that is 
expressed in maturing INPs but is absent from type II neuroblasts (See Fig. 4.1) (Pfeiffer et 
al., 2008; Weng et al., 2010). Expressing Tll in INPs resulted in ectopic type II neuroblasts 
(Fig. 4.3A); the total number of Dpn+ Ase- cells increased from 8 (in control) to 44.5±5.97 (in 
Tll OE) per brain lobe (Fig. 4.3Bi). Furthermore, ectopic expression of Tll in INPs also 
resulted in the reinitiation of PntP1 expression in Dpn+ INPs (Fig. 4.3C), whereas PntP1 is 
restricted to type II neuroblasts and Dpn- INPs in control lineages (Fig. 4.3D).  
 
Although Tll was able to generate neuroblasts from INPs, the number of ectopic type II 
neuroblasts induced from INPs was much lower than that produced by expressing Tll 
throughout the lineage with btd-GAL4 (btd-GAL4 Tll OE >250 type II neuroblasts; R9D11-
GAL4 Tll OE ~44.5 type II neuroblasts). However, upon closer analysis, I observed an 
important difference between the ectopic neuroblasts generated in each experiment. When 
UAS-tll was expressed throughout the lineage with btd-GAL4, all ectopic neuroblasts 
expressed btd-GAL4 (Fig. 4.2A). In contrast, I found that many of the ectopic type II 
neuroblasts that resulted from expressing UAS-tll in INPs were found outside of the GAL4 
expression domain (i.e. they were negative for R9D11-GAL4>mCD8-GFP) (Fig. 4.3Bii).  In 
control brain lobes, the eight type II neuroblasts were negative for R9D11-GAL4, but in Tll 
OE brains there was an average of 17.6±1.694 type II neuroblasts that did not express R9D11-
GAL4 (Fig. 4.3E). To determine the origin of these R9D11-GAL4-negative type II 
neuroblasts in Tll OE brains, I used lineage tracing techniques to follow the effect of Tll on 
INPs. 
 
4.2 Tll/TLX causes INPs to revert to type II neuroblast fate 
I found that expressing Tll in type II INPs resulted in ectopic type II neuroblasts. Tll caused 
R9D11-GAL4+ INPs to acquire characteristics of type II neuroblasts (Dpn+ INPs repressed 
Ase and expressed PntP1), indicating that INPs were de-differentiating to neuroblast fate. 
However, there was also a significant proportion of ectopic type II neuroblasts that did not 
express R9D11-GAL4 in Tll OE brains. I considered two explanations for the origin of 
R9D11-GAL4-negative type II neuroblasts: (1) Tll caused INPs to revert fully to neuroblast 
fate (which would include lack of expression of the INP marker R9D11) or (2) that these cells 




Figure 4.4: G-TRACE reveals that INPs revert to type II neuroblast fate in response to Tll 
(A) Schematic showing the genetic components of the G-TRACE system. 
(B) Schematic showing the cell colour of lineages when G-TRACE is expressed. 
(C) In Control lineages, type II neuroblasts (Dpn+ (red) and Ase- (green), solid outlines) are negative 
for both components of G-TRACE (bottom panels) and lineages show a transition from current (RFP) 
to historic (GFP) expression. In Tll OE brains, a subset of ectopic type II neuroblasts (Dpn+ Ase-) 
express the historic (GFP) component of the G-TRACE only. n = 8 brain lobes for Control; n = 10 
brain lobes for Tll OE. 
(D) Quantification of type II neuroblasts expressing G-TRACE memory only. Kolmogorov-Smirnov 
test ***, P<0.001 (P=0.000103). n = 7 brain lobes for Control; n = 10 brain lobes for Tll OE.  
(E) Schematic showing G-TRACE labelling of Control type II lineages compared to Tll OE. The 
neuroblast (NB) and early progeny do not express R9D11-GAL4 and so are not labelled. 
Single section confocal sections. Scale bars represent 15 µm. 
 
4.2.1 G-TRACE shows that Tll causes INPs to revert to neuroblasts 
I investigated if Tll caused INPs to revert back to neuroblast fate and turn off R9D11-GAL4 
expression as a consequence of this fate change. To do this required a GAL4 memory cassette. 
I used the GAL4 technique for real-time and clonal expression (G-TRACE) (Evans et al., 
2009), which reports current and historic expression of any GAL4. When the G-TRACE 
cassette is expressed, GAL4 drives the expression of (1) UAS-RFP (real-time expression) and 
(2) UAS-FLP, which excises a transcriptional stop sequence to allow a Ubi promoter to drive 
EGFP expression (historic expression) (Fig. 4.4A). In other words, the current to historic 
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GAL4 expression is reported by an RFP-only (real-time), to RFP and EGFP co-expression 
(lineage), to EGFP-only (historic) transition (Fig. 4.4B). 
 
When G-TRACE was expressed using R9D11-GAL4, the eight type II neuroblasts in control 
brain lobes were negative for both real-time and historic G-TRACE components because they 
had never expressed R9D11-GAL4 (Fig. 4.4C). Control type II lineages showed a transition 
from RFP to EGFP as differentiation progressed; INPs expressed the GAL4 in real-time 
GAL4 (RFP) and differentiated cells, such as neurons, showed historic expression (EGFP) 
(Control panels of Fig. 4.4C). However, type II lineages in Tll OE brains no longer showed a 
clear progression from RFP to EGFP expression; lineages consisted mostly of cells that 
expressed both components of the G-TRACE cassette (Tll OE panels of Fig. 4.4C). 
Importantly, there were type II neuroblasts that showed historic expression of R9D11-GAL4 
but did not express it currently (Fig. 4.4C-D). In addition, many of these INP-derived type II 
neuroblasts had lineages associated with them that showed current R9D11-GAL4 expression, 
indicating that the ectopic neuroblasts were able to generate new INPs. Overall, these data 
show that expressing Tll in mature INPs reactivates type II neuroblast fate, which includes the 
inactivation of an INP-specific marker (R9D11-GAL4) (summarised in Fig. 4.4E).  
 
4.2.2 GAL4 immortalisation reveals tumourigenic capacity of Tll from INPs 
Expressing high levels of Tll resulted in INPs acquiring type II neuroblast characteristics 
(such as the repression of Ase). The G-TRACE cassette showed that the dedifferentiation of 
INPs includes the inactivation of R9D11-GAL4, which is active in INPs but is not expressed 
in type II neuroblasts (Weng et al., 2010). This indicates that, while Tll is able to induce type 
II neuroblast fate from INPs, the true tumourigenic capacity of Tll may be limited due to 
fluctuations in GAL4 level caused by cell fate changes. 
 
To ensure that GAL4 expression remains constant in INPs, I combined R9D11-GAL4 with a 
“FLP-out” cassette to immortalise GAL4 expression (Fig. 4.5A). In this system, R9D11-
GAL4 was used to drive the expression of UAS-FLP, which catalyses the excision of a 
transcriptional stop sequence from the “FLP-out” cassette (act5C>FRT-txnSTOP-
FRT>GAL4 (Ito et al., 1997)). Subsequently, act5C-GAL4 drives the expression of 
transgenes under the control of UAS and the expression of GAL4 is no longer dependent on 
cell fate. Immortalised R9D11-GAL4 will be referred to as R9D11>act-GAL4. Using 
R9D11>act-GAL4 to manipulate type II lineages will prevent changes in GAL4 expression as 
UAS-tll levels increase in INPs (Fig. 4.5B).  
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Figure 4.5: R9D11>act-GAL4 is an immortalised INP driver 
(A) Schematic showing the genetic components of R9D11>act-GAL4, an immortalised INP GAL4. 
(B-B’) Theoretical representation of GAL4 levels (green) and the effect on UAS-tll expression (red) 
with (B) R9D11-GAL4 or immortalised (B’) R9D11>act-GAL4. 
 
In control brain lobes, the eight type II neuroblasts (Dpn+ Ase-) were negative for 
R9D11>act-GAL4 (Fig. 4.6A-B). However, expressing UAS-tll with R9D11>act-GAL4 
resulted in a large expansion of type II neuroblasts; there were 109±12.12 type II neuroblasts 
per brain lobe (n = 10 brain lobes) (Fig. 4.6A-B). In addition, Tll OE lineages exhibited a 
reduction in differentiated progeny such as ganglion mother cells (GMCs) (as assessed by 
Pros) (Fig. 4.6C) and neurons (as assessed by Elav) (Fig. 4.6D). As such, high levels of Tll in 
INPs induced type II neuroblast fate and inhibited neuronal differentiation (Fig. 4.6E). 
Furthermore, the number of type II neuroblasts resulting from R9D11>act-GAL4 driving 
UAS-tll (109±12.12) was much higher than when UAS-tll was expressed by R9D11-GAL4 
alone (44.5+5.97). This provides supporting evidence that fluctuating GAL4 levels were 
restricting the ability of tll to induce type II neuroblast fate from INPs. Thus, ectopic 
expression of Tll is sufficient to repress the differentiation programme of INPs and causes 
reversion to type II neuroblast fate (Fig. 4.6F). 
 
4.2.3 Non-autonomous contribution to tumourigenesis 
Two independent genetic techniques (G-TRACE and R9D11>act-GAL4) showed that INPs 
respond to high levels of Tll directly and revert to type II neuroblast fate. However, both 
methods also revealed a small contribution of cell non-autonomy to the generation of ectopic 
type II neuroblasts. The original eight type II neuroblasts are not labelled using either 
technique, as was observed in control brain lobes. However, in Tll OE G-TRACE brain lobes, 
I observed a very small number of unlabelled (negative for RFP and EGFP) type II 
neuroblasts in addition to the endogenous eight (0.3±0.15 extra G-TRACE-negative 
neuroblasts, i.e. 3 of 10 brain lobes contained 9 unlabelled neuroblasts in total). Similarly, in 
R9D11>act-GAL4 Tll OE brains there was a small number of additional unlabelled type II 
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neuroblasts (1.5±0.48 extra GFP-negative type II neuroblasts per brain lobe, i.e. 7 of 10 brain 
lobes contained between 9 and 13 unlabelled type II neuroblasts in total). The origin of these 
non-INP-derived type IIs is unknown but suggests a role for a density or distance-dependent 
signalling molecule that specifies type II neuroblast fate. Although the contribution of non-
autonomy compared to direct INP reversion is very low, this observation has implications for 
the potential of Tll/TLX to initiate tumourigenesis in a non-autonomous manner. 
 
Figure 4.6: Immortalised INP GAL4 results in large Tll OE tumours  
(A) Tll OE with R9D11>act-GAL4 results in a large expansion of type II neuroblasts, as identified by 
Dpn+ (red) and Ase- (green). Arrowheads in Tll OE (zoom) highlight ectopic type II neuroblasts. 
Dotted white lines indicate R9D11>act-GAL4 expression. n = 10 brain lobes for Control and Tll OE. 
(B) Quantification of the number of type II (Dpn+ Ase-) neuroblasts in Control or Tll OE brains. (i) 
Total number of type II neuroblasts (P=0.000091); (ii) type II neuroblasts within R9D11>act-GAL4 
expression domain (P=0.000091). Kolmogorov-Smirnov test ***, P<0.001. n = 10 brain lobes for 
Control and Tll OE. 
(C) Using R9D11>act-GAL4 to express high levels of Tll results in the loss of differentiating progeny 
compared to Control, as assessed by Pros staining (white). n = 10 brain lobes for Control and Tll OE. 
(D) High levels of Tll reduces the production of neurons, as assessed by staining for Elav (white). n = 
13 brain lobes for Control; n = 12 brain lobes for Tll OE. 
(E) Schematic showing the effect on type II lineages of expressing Tll with R9D11>act-GAL4. 
(F) A model for the effect of expressing Tll in INPs. Tll prevents differentiation and causes INPs to 
revert to type II neuroblast fate, thereby initiating tumour formation.  
Single section confocal images. Scale bars represent 30 µm. 
 62 
4.2.4 Human TLX can induce tumours from Drosophila INPs 
Drosophila Tll and human TLX are highly conserved genes: (1) their amino acid sequences 
are extremely similar (81 % identity in the DBD and 40 % in the LBD) (Jackson et al., 1998), 
(2) they can bind to the same consensus DNA motif (Yu et al., 1994), and (3) they can be 
regulated by conserved cofactors (such as Atrophin (Zhi et al., 2015)). TLX is expressed in 
NSCs and intermediate progenitors in the adult mouse brain, which is highly comparable to 
the pattern of Tll expression I found in type II lineages (compare Figs. 4.7A-B). Expressing 
high levels of TLX in the adult mouse brain causes the expansion of NSCs (Liu et al., 2010; 
Park et al., 2010; Zhu et al., 2014; Zou et al., 2012), which mirrors the effect of 
overexpressing Tll in type II lineages. I investigated if human TLX could also induce 
dedifferentiation and tumourigenesis from Drosophila INPs, given the high molecular 
conservation of TLX and Tll. 
 
Figure 4.7: Tll and TLX show comparable expression in NSC lineages 
(A) TLX is expressed in NSCs and intermediate progenitors (IP) in the adult mouse brain (based on 
previously published data (Li et al., 2012; Liu et al., 2008)).  
(B) Drosophila Tll is expressed in type II neuroblasts and early immature INPs (this study).  
 
Expressing UAS-TLX in Drosophila INPs with R9D11-GAL4 resulted in a large expansion of 
type II neuroblasts; TLX OE resulted in the generation of many ectopic neuroblasts (Dpn+) 
that did not express Ase (Fig. 4.8A) but were positive for PntP1+ (Fig. 4.8B). In addition, a 
large number of these ectopic type II neuroblasts were found outside of the R9D11-GAL4 
expression domain (Fig. 4.8A’ and B’). To determine the lineage relationship between INPs 
and the ectopic type II neuroblasts, I expressed TLX in combination with the G-TRACE 
cassette. This showed that many of the ectopic Dpn+ Ase- cells induced by expressing TLX in 
INPs were positive for historic R9D11-GAL4 expression but no longer expressed it currently 
(Figs. 4.9A-B). These results showed that Tll and TLX are conserved in tumourigenic 
capacity and likely act through conserved molecular mechanisms.  
 
















Tll expression in Drosophila:BA
 63 
I have shown that Tll is required for type II neuroblast and lineage fate; in the absence of Tll, 
type II neuroblasts switch to type I identity and INPs are no longer generated. During 
development, Tll expression is downregulated concomitant with differentiation. However, 
tumours arise if Tll is expressed at high levels within type II lineages. I found that this is due 
to the reversion of INPs to neuroblast fate and the inhibition of differentiation. Furthermore, 
the ectopic expression of TLX causes type II INPs to revert to neuroblast fate, resulting in 
tumours. However, one notable difference is that the tumourigenic capacity of TLX appears 
to be more severe than Tll as TLX generates much larger tumours from INPs. Overall, this 
indicates that INPs are the tumour cell of origin for Tll/TLX-induced tumours in type II 
neuroblast lineages. This finding has implications for the cell of origin of TLX-induced 
tumours from neural lineages and suggests that mammalian intermediate progenitors could 
show a similar fate transition in response to high levels of TLX, leading to tumour initiation. 
 
Figure 4.8: Human TLX initiates tumourigenesis from type II INPs 
(A) TLX overexpression (TLX OE) in INPs with R9D11-GAL4 results in large tumours consisting of 
neuroblasts that are Dpn+ (red) and Ase- (green). Dotted white lines indicate R9D11-GAL4>mCD8-
GFP. n = 10 brain lobes for Control and TLX OE. 
(A’) Many ectopic type II neuroblasts in TLX OE brains do not express R9D11-GAL4 (arrowheads). 
R9D11-GAL4>mCD8-GFP expression is represented by dotted white lines and white shading. Images 
are magnifications of the boxed regions highlighted in (A). 
(B) Neuroblast tumours generated by TLX OE also express PntP1+ (green) in Dpn+ cells. Dotted white 
lines indicate R9D11-GAL4>mCD8-GFP. n = 10 brain lobes for Control and TLX OE. 
(B’) Type II lineages express PntP1 (green) in the neuroblast (Dpn+, asterisk). Ectopic neuroblasts 
generated by TLX OE express PntP1. Dotted white lines indicate R9D11-GAL4>mCD8-GFP. Images 
are magnifications of the boxed regions highlighted in (B). 




Figure 4.9: Type II INPs revert to neuroblast fate in response to human TLX 
(A) G-TRACE reveals TLX causes INP reversion to neuroblast fate. In Control lineages, type II 
neuroblasts (Dpn+ Ase-, solid outline) are negative for both components of G-TRACE (bottom panel) 
and lineages show transition from current (RFP) to historic (GFP) expression. In TLX OE brains, 
many ectopic type II neuroblasts (solid outlines) express the historic (GFP) component of the G-
TRACE only. n = 10 brain lobes for Control and TLX OE. 
(B) Schematic depicting G-TRACE expression in Control type II lineages compared to TLX OE. 
Single section confocal images. Scale bars represent15 µm. 
 
4.3 Assessing the tumourigenic capacity of Tll in other Drosophila neural progenitors  
The majority of the neural progenitors in the Drosophila larval brain are type I neuroblasts 
(Fig. 4.10A). Type I neuroblasts divide in the same manner as type II INPs and express many 
of the same molecular markers; both progenitors express Dpn and Ase and segregate Pros into 
their daughter cells (GMCs) upon asymmetric division (Fig. 4.10B). Expressing high levels of 
Tll/TLX in type II INPs was sufficient to induce type II neuroblast fate, and subsequent 
tumourigenesis. Given the similarities between type II INPs and type I neuroblasts, I tested if 
Tll/TLX could initiate tumours from type I neuroblasts in a similar manner. 
 
4.3.1 Tll and TLX induce type II neuroblast fate from type I neuroblasts  
As an initial step, I expressed UAS-tll in neuroblasts throughout the CNS. This resulted in 
ectopic neuroblasts that persisted into adulthood at the expense of neuronal progeny (Fig. 
4.10C). Tll OE adult flies died within one day of eclosion, demonstrating that expressing Tll 
in larval neuroblasts resulted in lethal brain tumours. Analysis of Tll tumours during larval 
stages showed that these tumours affected neuroblasts in the majority of the CNS (as assessed 
by Dpn staining, Fig. 4.10D). Of particular interest was the presence of large Dpn+ tumours in 
the ventral nerve cord (VNC) as this region consists entirely of type I neuroblasts. To 
investigate Tll induced tumours from type I VNC neuroblasts by inducing type II neuroblast 
fate, in a similar manner to tumour initiation from INPs, I assessed Ase expression. Ase is 
repressed in type II neuroblasts (Bowman et al., 2008) and I found that the ectopic neuroblasts 
in Tll OE VNCs were negative for Ase almost entirely (Fig. 4.11A). Type II neuroblasts also 
lack Pros expression (Bayraktar et al., 2010) and Tll-induced tumours exhibited 
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downregulation of Pros (Fig. 4.11A). This indicated that Tll induced type II neuroblast 
tumours from type I neuroblast through a similar mechanism as from type II INPs, suggesting 
that Tll is an instructive signal for type II neuroblast fate.  
 
Figure 4.10: Tll can induce tumours outside of type II lineages 
(A) Schematic of a third instar larval brain when mounted dorsal-side up (right) or ventral-side up 
(left) for imaging. Type II neuroblasts (red) and their lineages (green) are visible in brain lobes in the 
dorsal view. Type I neuroblasts are shown in grey. VNC: ventral nerve cord. 
(B) Type II vs type I lineage comparison. Type II neuroblasts express Dpn but lack Ase. INPs and 
type I neuroblasts divide in the same manner both express Dpn and Ase and segregate Pros to their 
progeny (GMCs). 
(C) Control adult brains do not contain neuroblasts (Dpn+, white) and consist mostly of neurons (Elav+, 
green). Tll overexpression (Tll OE) brains contain large tumours consisting of neuroblasts (Dpn+) and 
very few neurons (Elav+). Tumours induced at mid third instar stage. n = 7 for Control and Tll OE.  
(D) Tll OE in neuroblasts throughout larval development results in neuroblast tumours (Dpn+) that 
affect the larval VNC and brain lobes. n = 10 VNCs for Control and Tll OE. 
Single section confocal images. Scale bars represent 100 µm in C; 30 µm in D. 
 
4.3.2 Co-operativity with btd is required for tll to induce tumours 
Expressing Tll in VNC type I neuroblasts caused a large expansion of Dpn+ cells, the majority 
of which were negative for Ase. However, Ase+ neuroblasts and Pros+ cells could still be 
observed when Tll was expressed throughout the developing CNS (Fig. 4.11A-A’’’). This 
indicated that some type I lineages may be unresponsive to Tll-induced tumourigenesis and 
remained able to generate differentiated progeny. In addition, the regions of ectopic Dpn+ 
Ase- cells were found often with regular organisation and Pros+ cells were found at the edges 
of the tumours (Fig. 4.11A-A’’). This suggested that not all type I neuroblasts in the VNC 
were competent to respond to high levels of Tll.  
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Figure 4.11: Tll tumours lack Ase and Pros 
(A-A’’’) Larval neuroblast tumours (Dpn+, red) induced by expressing UAS-tll throughout the VNC 
with wor-GAL4 show downregulation of the Ase (green) and Pros (blue).  
Differentiation, as assessed by Ase (A’) and Pros (A’’), can be observed at the edges of Dpn+ tumours 
(A’’’).  n = 10 VNCs for Control and Tll OE. 
Single section confocal images. Scale bars represent 30 µm. 
 
To assess how individual type I lineages responded to ectopic Tll in the early stages of 
tumour initiation, I expressed UAS-tll throughout the VNC for a short period (24 hours) of 
time. This showed that Tll-induced tumours began as small clusters of Dpn+ Ase- cells (Fig. 
4.12A). However, this also showed that the majority of neuroblasts retained Ase expression 
and did not produce ectopic neuroblasts (Fig. 4.12A-B). There was also a small number of 
lineages that repressed Ase but did not generate ectopic neuroblasts (Fig. 4.12B). Together, 
this suggested that an additional factor was required to mediate Tll-induced tumourigenesis 
from type I neuroblast lineages.  
 
One candidate gene for a Tll competency factor was the Sp8 transcription factor btd, which is 
expressed in a subset VNC type I neuroblasts (Xie et al., 2014). Importantly, btd is expressed 
in type II lineages, where it promotes type II neuroblast specification in the embryo (Álvarez 
and Díaz-Benjumea, 2018). The role of btd in type II neuroblasts and its restricted expression 
in type I lineages suggested that btd could mediate Tll-induced tumourigenesis. 
 
 67 
Figure 4.12: Tumour initiation by Tll occurs in btd+ VNC lineages 
(A) Driving Tll OE with wor-GAL4 for a short pulse at the end of the third instar resulted in ectopic 
Dpn+ cells (red) that lacked Ase (green) (dotted outlines in Tll OE). Many Tll OE neuroblasts remain 
Ase+ (arrowheads), as is observed in Control. n = 7 VNCs for Control; n = 8 VNCs for Tll OE. 
(B) Quantification of the percentage of VNC lineages that contain a single Dpn+ Ase+ neuroblast 
(blue), a single Dpn+ Ase- neuroblast (green), or multiple Dpn+ Ase- neuroblasts (i.e. a cluster) in 
Control and Tll OE VNCs. n = 7 VNCs for Control; n = 8 VNCs for Tll OE. 
(C) btd-GAL4 driving UAS-myr-mRFP (white) is expressed in a subset (38±1.5) of VNC type I 
neuroblasts (Dpn+, red). Image is a projection over 15 µm in z. 
(D) btd-GAL4 driving Tll OE for a short pulse at the end of the third instar results in the repression of 
Ase (green) in all btd-GAL4+ neuroblasts (white dotted outlines). ~60 % of Tll OE lineages contain 
ectopic Dpn+ (red) Ase- neuroblasts. n = 8 VNCs for Control; n = 10 VNCs for Tll OE. 
(E) Control neuroblasts express Dpn (red) and Ase (green) and progeny express Ase (green 
arrowheads). Dpn+ cells in Tll OE btd+ lineages do not express Ase. Tll OE lineages that contain only 
one neuroblast (white arrowhead) generate progeny that express Ase (green arrowhead). Images are 
magnifications of the boxed regions in (D).  
(F) Tll OE btd+ lineages with ectopic neuroblasts (Dpn+, red) have very few Pros+ (white) progeny 
(yellow arrowheads) or lack them entirely (outlined in yellow). Tll OE btd+ lineages with only one 
neuroblast (outlined in green) have Pros expression in adjacent cells in a comparable manner to 
control. n = 8 VNCs for Control; n = 10 VNCs for Tll OE. Images are magnifications of the boxed 
regions in (D).  
(G) Schematic depicting the effect of expressing Tll in btd+ type I neuroblasts. Tll represses Ase in all 
btd+ lineages but only induces tumours in 60 % of lineages, which is accompanied by the loss of Pros. 
Single section confocal images unless indicated otherwise. Scale bars represent 30 µm in A, C, D; 




I assessed the expression of btd-GAL4 and found that it was expressed in 38±1.5 (n = 8 
VNCs) VNC type I neuroblasts (in contrast to 31 that had been reported previously (Xie et al., 
2014)) (Fig. 4.12C). To determine the competency of btd+ lineages to generate tumours, I 
expressed UAS-tll with btd-GAL4 for a short pulse. This resulted in the repression of Ase in 
all btd-positive neuroblasts (Fig. 4.12D). However, only 60.5±3.1 % of Tll OE btd lineages (n 
= 348 btd+ Tll OE lineages) contained clusters of Dpn+ cells, which were also negative for 
Ase. Despite the repression of Ase, the remaining ~40 % of btd lineages contained only one 
Dpn+ cell (Fig. 4.12E). Surprisingly, btd+ lineages with only one neuroblast had small Ase+ 
cells adjacent to the neuroblast (Fig. 4.12E) and these Ase+ progeny also expressed Pros+  
(Fig. 4.12F), suggesting that differentiation was not perturbed. In contrast, lineages with 
ectopic Dpn+ Ase- cells lacked Ase+ Pros+ progeny, indicating that differentiation was 
inhibited (Fig. 4.12F).  
 
This showed that Tll is sufficient to repress ase in all btd+ neuroblasts. However, only the 
subset of btd+ neuroblasts in which pros is also repressed generate ectopic neuroblasts and 
initiate tumourigenesis (Fig. 4.12G). These data suggest that tll requires cooperation with btd 
to repress ase but that an additional, unknown factor is required to repress pros and initiate 
tumourigenesis. In addition, these data also suggest that the expression of Ase in neuroblast 
progeny (GMCs) is downstream of differentiation, since Ase+ progeny can be generated from 
Ase- neuroblasts. This is consistent with the observation that the repression of ase alone does 
not inhibit differentiation and is not sufficient to induce type II neuroblast fate or 
tumourigenesis (Bowman et al., 2008) (confirmed in this study, Figs. 4.13A-B).  
 
To follow the tumourigenic capacity of Tll in btd+ lineages, I drove UAS-tll with btd-GAL4 
throughout larval development. Tll OE VNCs contained large Dpn+ tumours (Fig. 4.14A) that 
were almost entirely negative for Ase and Pros (Fig. 4.14A’). These late-stage tumours also 
showed a large reduction of neurons (as assessed by Elav Fig. 4.14B), consistent with the 
repression of differentiation observed in early tumours. I attempted to follow these tumours in 
the adult but all btd-GAL4 Tll OE animals failed to complete pupariation (both when Tll 
expression was driven throughout larval development or only for a short pulse at late larva 




Figure 4.13: Loss of ase from type I lineages is not sufficient to induce type II fate 
(A) Control MARCM clones (mCherry+, red) contain one Dpn+ (green) Ase+ (white) type I neuroblast. 
ase1 clones contain one Dpn+ cell, despite the loss of Ase. Dotted yellow outline indicates a type I 
neuroblast encompassed within a MARCM clone. n = 13 wild type clones; n = 20 ase1 clones. 
(B) Control MARCM clones (mCherry+) contain one Dpn+ cell (green) and Pros (white) is expressed 
in the differentiating cells of the lineage. Pros expression is not affected in ase1 clones and no defects 
in differentiation are observed. Dotted yellow outline indicates a type I lineage encompassed within a 
MARCM clone. n = 29 wild type clones; n = 52 ase1 clones. 
Single section confocal images. Scale bars 15 µm.  
 
 
Figure 4.14: Tll OE in btd+ type I neuroblasts generates large type II neuroblast tumours 
(A-A’) btd-GAL4 driving UAS-tll throughout larval development results in large tumours that consist 
of Dpn+ (red in A) cells that do not express Ase (green in A’) or Pros (red in A’). 
(B) Ectopic neuroblasts resulting from Tll OE are generated at the expense of neurons (Elav, green). 
(C) Schematic showing the stages of tumour progression cause by Tll OE in btd+ lineages. 
Single section confocal images. Scale bars 30 µm. 
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Overall, these experiments indicate that btd mediates the ability of Tll to induce type II 
neuroblast fate and tumourigenesis. The generation of ectopic neuroblasts occurs at the 
expense of differentiation (notably, through the inactivation of ase, pros and elav) (Fig. 
4.14C). During normal development, btd + type I neuroblasts are Ase+ and produce Pros+ 
progeny. When Tll is expressed in btd+ lineages, ase is repressed in all neuroblasts and a 
subset also represses pros, which results in tumour initiation. If these tumours are allowed to 
progress, they grow into large expansions of Dpn+ Ase- cells. 
 
4.4 Tll-induced tumours are prevented by promoting differentiation 
The repression of ase is central to the mechanism through which Tll regulates type II 
neuroblast fate during development and tumour initiation. This suggests that developmental 
NSC programmes become reactivated during tumour initiation and highlights the importance 
of studying NSC factors in tumourigenesis. TLX is expressed at high levels in aggressive 
brain tumours in humans and is required for the self-renewal capacity of GSCs, the treatment-
resistant cells that can re-initiate tumourigenesis (Cui et al., 2016; Zhu et al., 2014). 
Excitingly, a recent study has also identified that a subset of GSCs show downregulation of 
ASCL1 (the mammalian homologue of ase (Guillemot and Joyner, 1993; Johnson et al., 
1990)) (Park et al., 2017). This study found that the self-renewal capacity of GSCs could be 
attenuated if ASCL1 expression was induced in GSCs (Park et al., 2017). Intriguingly, ASCL1 
restricts tumour growth by promoting neuronal differentiation (Park et al., 2017). So far, no 
link has been made between TLX and ASCL1 in glioblastoma tumours or GSCs but it is an 
attractive hypothesis that GSCs with high TLX correspond to those with low ASCL1, in a 
parallel manner to Tll-induced type II tumours. 
 
4.4.1 Ase can rescue Tll tumours 
Ectopic expression of ASCL1 in GSCs can prevent tumour growth by inducing neuronal 
differentiation (Park et al., 2017). ASCL1 is orthologus to members of the achaete-scute 
complex, which includes ase. To assess if expressing ase could restrict the growth of Tll-
induced tumours, I co-expressed Tll and Ase in neuroblasts. I found that ectopic expression of 
Ase prevented the formation of ectopic clusters of Dpn+ cells and VNC lineages resumed type 
I identity (Fig. 4.15A). In addition, neuronal differentiation was restored (Fig. 4.15B), which 
occurred despite Tll protein remaining present at high levels, indicating that Tll cannot 
override neuronal differentiation induced by Ase  (Fig. 4.15C). Therefore, ectopic expression 
of Ase rescued Tll tumours by promoting neuronal differentiation in a comparable manner to 
ASCL1 in GSCs (Fig. 4.15D). 
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Figure 4.15: Expressing Ase in Tll tumours prevents tumour formation 
(A) Ase rescues Tll tumours by promoting differentiation  (Pros, green). n = 9 brains for Control; n = 
10 brains for Tll OE and Ase rescue. 
(B) Expressing Ase in Tll tumours is sufficient to restore the production of neurons (Elav, green) from 
type I neuroblasts (Dpn+, red). n = 10 brains for all conditions. 
(C) Tll expression is maintained when Ase is co-expressed. n = 10 brains for all conditions. 
(D) Schematic showing the lineage progression of normal development, Tll tumours, and in tumours 
that have high levels of Ase. 
Single section confocal images. Scale bars represent 30 µm. 
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4.4.2 Differentiating cells are resistant to Tll-induced tumourigenesis 
Tll tumours induced in type I neuroblasts could be prevented by reinstating differentiation by 
ectopically expressing Ase. During normal lineage progression, type I neuroblasts divide 
asymmetrically to generate GMCs, which express Ase and Pros. GMCs undergo terminal 
division to generate post-mitotic neurons. Given that inducing differentiation via ectopic Ase 
expression blocked Tll-induced tumours, I investigated if the differentiation state acquired 
during development also conferred resistance to Tll-induced tumourigenesis.  
 
To target UAS-tll to GMCs I used GMR71C09-GAL4, a GAL4 driver that is expressed in 
GMCs but not in type I neuroblasts in the VNC (Li et al., 2014). Strikingly, expressing high 
levels of Tll in GMCs did not generate ectopic Dpn+ cells and type I lineage progression was 
not disrupted (Fig. 4.16A). Therefore, despite the ability of GMCs to divide, this cell type can 
not respond to high levels of Tll. To restrict UAS-tll to neurons I used vGlutOK371-GAL4, a 
GAL4 enhancer trap inserted ~9 kb upstream of the VGlut gene that is expressed in 
glutamatergic neurons (Mahr and Aberle, 2006)). I found that expressing Tll in neurons also 
did not result in ectopic neuroblasts (Fig. 4.16B). These results demonstrate that cells that are 
committed to neuronal identity are resistant to Tll-induced tumourigenesis (Fig. 4.16C). 
 
Figure 4.16: Differentiating cells do not generate tumours in response to high levels of Tll  
(A) Expressing Tll in GMCs (GFP, white) does not result in ectopic neuroblasts. All neuroblasts in the 
VNC express Dpn (red) and Ase (green). n = 10 brains for Control; n = 12 brains for Tll OE. 
(B) Expressing Tll in neurons with vGlutOK371-GAL4>mCD8-GFP (green), does not result in ectopic 
neuroblasts (Dpn, red). n = 4 brains for Control and Tll OE.  
(C) Schematics summarising the tumourigenic capacity of Tll in type I lineages. (i) Tll can induce 
tumours from type I neuroblasts; (ii) Tll cannot induce tumours from GMCs; (iii) nor can Tll induce 
tumours from neurons. 
Single section confocal images. Scale bars represent 30 µm. 
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Figure 4.17: TLX induces tumours from type I neuroblasts and GMCs but not from neurons 
(A) TLX overexpression (OE) in neuroblasts throughout larval development results in neuroblast 
tumours (Dpn+, white) that affect the entire CNS. n = 10 brains for Control and Tll OE. 
(B) TLX tumours induced in type I neuroblasts are negative for the proneural gene Ase (white). n = 10 
brains for Control and Tll OE. 
(C) Differentiation, as assessed Pros (white), is prevented in TLX tumours. n = 10 brains for Control 
and Tll OE. 
(D) Expressing TLX in GMCs causes direct conversion to type II neuroblast fate. n = 10 brains for 
Control and Tll OE. 
(E) Expressing TLX in neurons with vGlutOK371-GAL4>mCD8-GFP (green), does not result in ectopic 
neuroblasts (Dpn, red). n = 8 brains for Control and Tll OE. 
(F) Schematics summarising the tumourigenic capacity of TLX in type I lineages. (i) TLX can induce 
tumours from type I neuroblasts and GMCs; (ii) TLX cannot induce tumours from neurons. 
Single section confocal images. Scale bars represent 30 µm. 
 
4.5 TLX has a stronger tumourigenic capacity than Tll 
Expressing Drosophila Tll or human TLX in type II INPs resulted in the same transition of 
INPs to neuroblast fate, indicating that Tll and TLX initiate tumourigenesis through a 
conserved mechanism. However, expressing TLX in INPs resulted in a more severe 
tumourigenic phenotype, with more ectopic type II neuroblasts generated compared to 
expressing Drosophila Tll under the same conditions. To investigate the tumourigenic 
capacity of human TLX in other Drosophila lineages, I expressed human TLX throughout the 
developing CNS. Expressing UAS-TLX with wor-GAL4 caused almost the entire CNS to 
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consist of Dpn+ neuroblasts (Fig. 4.17A). Furthermore, all ectopic Dpn+ cells in the VNC 
(where all neuroblasts are normally type I and express Ase) were negative for Ase (Fig. 
4.17B). Tumours induced by TLX also occurred at the expense of differentiation, as assessed 
by Pros staining (Fig. 4.17C). Therefore, TLX can also induce type II neuroblast tumours 
from type I neuroblasts in a similar manner to Tll. However, the tumourigenic capacity of 
TLX does not appear to be restricted to certain type I lineages, as was the case for Tll.  
 
Intriguingly, I found that expressing TLX in GMCs resulted in large tumours that consisted of 
type II neuroblasts (Dpn+ Ase-) (Fig. 4.17D). This appeared to be a direct conversion of 
GMCs to type II fate as type I neuroblasts were still present and Dpn+ Ase- cells were found 
in place of GMCs (Fig. 4.17D). However, TLX was unable to induce tumours from neurons, 
showing that post-mitotic cells cannot reinitiate the NSC programme in response to TLX 
(Figs. 4.17E). Taken together, these results indicate that, while TLX and Tll appear to act 
through conserved molecular mechanisms to induce tumourigenesis, TLX has an increased 
capacity to induce tumourigenesis (Fig. 4.17F). Importantly, post-mitotic neurons are resilient 
to tumour initiation by high levels of Tll or TLX suggesting that promoting neuronal 
differentiation could be an effective treatment for brain tumours with high TLX expression.  
 
4.6 Chapter 4 discussion 
Tll and TLX are important regulators of NSCs that must be kept in a fine balance to ensure 
that sufficient neuronal progeny are generated but that tumours do not arise. I found that Tll is 
expressed in type II neuroblasts to maintain neuroblast fate but is downregulated as the 
lineage progresses. Preventing Tll downregulation in type II lineages resulted in tumour 
initiation through the reversion of type II INPs to neuroblast fate. This has significant 
importance for the role of TLX in tumour initiation. Overexpression of TLX in the mouse 
brain causes expansion of the NSC population and can lead to glioblastoma (GBM) when 
combined with addition mutations (Park et al., 2010). However, how TLX affects lineage 
progression is not clear and so the tumour cell of origin has not been identified.  
 
Both Tll and TLX can induce tumours from type II INPs and appear to act through conserved 
molecular mechanisms: both genes repress ase and pros to induce tumours that consist of type 
II neuroblasts. This shows that INPs present a genetic weak point during lineage progression; 
they maintain some aspects of NSC behaviour and so can re-initiate NCS gene pathways in 
response to Tll/TLX. The similarity of type II lineage progression with mammalian NSC 
lineages and the ability of Tll/TLX to promote tumours from INPs implicates intermediate 
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progenitors as a potential cell of origin for TLX-induced tumours in mammals. It would be 
interesting to investigate if TLX induces gliomas from intermediate progenitors in 
mammalian NSC lineages and if this occurs via reversion to NSC fate. Identifying the cell of 
origin for different tumour subtypes is crucial for developing therapies that can be targeted to 
specific cell-types. 
 
Although Tll and TLX induce tumours through conserved molecular mechanisms, TLX has a 
higher tumourigenic capacity. Tll-induced tumours are restricted to type II lineages and type I 
lineages that express btd. However, TLX appears to induce tumours from type II INPs, all 
type I neuroblasts and GMCs. The reason for the differences in cell types in which Tll/TLX 
can initiate tumours is not known. One possible explanation could be the lower conservation 
of the LBD between TLX and Tll (LBDs share 40 % identical amino acids; DBDs share 81 % 
identity). Although TLX and Tll are regulated by conserved co-repressors (such as Atrophin, 
(Zhi et al., 2015)) the binding affinity for their cofactors differs between species (Wang et al., 
2006). As such, it is possible that the differences in the LBDs between human TLX and 
Drosophila Tll are sufficient to result in different transcriptional regulation by these genes.  
 
The repression of ase was central to the ability of Tll/TLX to induce tumourigenesis. ase 
promotes neurogenesis in a comparable manner to its homologue ASCL1 (Guillemot et al., 
1993; Torii et al., 1999). I found that ectopic expression of Ase was able to block the 
formation of Tll-induced tumours, which could provide an important link between two 
aspects of glioblastoma genetics. Firstly, TLX is expressed in a subset of aggressive GBM 
tumours and correlates with poor patient prognosis (Park et al., 2010; Zou et al., 2012). Of 
particular significance is the requirement of TLX for the self-renewal capacity of GSCs (Cui 
et al., 2016; Zhu et al., 2014). Secondly, an independent study found that ASCL1 is 
downregulated in a subset of GSCs, which resulted in failure to respond to differentiation 
signals (Park et al., 2017). However, introducing ASCL1 to these GSCs was sufficient to 
induce neuronal differentiation, which restricted GSC self-renewal and prevented tumour 
growth (Park et al., 2017). Therefore, in light of my results, it would be interesting to 
investigate if GSCs with low ASCL1 also exhibit high TLX expression and vice versa. If this 
is the case, this could implicate differentiation therapy as a treatment for aggressive GBM 









The optic lobe generates a newly discovered neural stem cell population during 
embryogenesis 
 
Statement on collaboration: 
The majority of the work in this chapter was carried out in collaboration with Dr Leo Otsuki, 
a former member of the Brand Lab. Together, we discovered embryonic optic neuroblasts 
(EONs). This work has been published in Development (the paper is attached as Appendix 4 
for reference). We are co-first authors on this paper; we designed the experiments and 
analysed the data together. Figure panels in this thesis provided by Dr Leo Otsuki (LO) are 
indicated under each figure; those provided by me are denoted AEH. 
 
 
During development, NSC divisions must be regulated precisely to generate a functioning 
nervous system. Symmetric NSC divisions increase the number of NSCs, whereas 
asymmetric NSC divisions generate post-mitotic progeny. Disruption to the mode of NSC 
divisions can result in insufficient progeny or overgrowth and tumourigenesis. Understanding 
how NSCs are regulated during normal development is of key importance for improving our 
knowledge of how disorders and diseases affecting the CNS arise. 
 
During the early stages of brain development symmetrically dividing neuroepithelial cells 
expand the NSC pool in the mammalian cerebral cortex and the Drosophila visual system 
(Egger et al., 2007; Noctor et al., 2004). Neuroepithelial cells later transform into 
asymmetrically dividing NSCs (called neuroblasts in Drosophila) that generate neurons and 
glia (Brand and Livesey, 2011; Egger et al., 2011; Noctor et al., 2004). The developing 
Drosophila visual system has proved to be a valuable system for investigating the 
fundamental mechanisms of NSC regulation (Bertet, 2017). 
 
5.1 The optic lobe and type II neuroblasts are regulated by common factors  
During development, the optic lobe neuroepithelium gives rise to neuroblasts that produce the 
neurons and glia of the medulla, the largest ganglion of the adult visual processing system 
(Dillard et al., 2018; Egger et al., 2007; Egger et al., 2010; Kawamori et al., 2011; Reddy et 
al., 2010; Yasugi et al., 2008; Yasugi et al., 2010). Neuroepithelial cells are converted to 
neuroblasts at mid larval stages (~48 hours ALH) through the progression of a proneural wave 
(Yasugi et al., 2008) (Fig. 5.1A).  
 
The transition from neuroepithelial cells to neuroblasts shares many parallels with lineage 
progression from type II neuroblasts. In both systems, NSCs (neuroepithelial cells or type II 
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neuroblasts) undergo a transition that results in progenitors with a more restricted self-
renewal capacity (type I optic lobe neuroblasts or type II INPs) (Fig. 5.1A-B). In addition, 
there are many molecular similarities between the optic lobe and type II neuroblasts that 
regulate parallel fate transitions in both systems. For example, tll is expressed in the optic 
lobe neuroepithelium throughout development, where it is required for neuroepithelial cell 
survival (Daniel et al., 1999; Guillermin et al., 2015). In Chapters 2-4, I showed that tll is 
expressed in type II neuroblasts and promotes neuroblast fate and lineage identity. Looking 
for additional similarities between these systems could enhance our understanding of the 
genes that regulate the NSCs in the optic lobe and type II lineages in Drosophila as well as 
NSCs in other species. 
 
Figure 5.1: Division modes of stem cells in the optic lobe and type II neuroblasts 
(A) During larval development, symmetric divisions expand the optic lobe neuroepithelium (NE, grey). 
The proneural wave (blue arrow) converts neuroepithelial cells to neuroblasts (NB, red) at the 
transition zone (TZ). Neuroblasts divide asymmetrically to generate post-mitotic progeny.   
(B) In type II lineages, the neuroblast (NB) divides asymmetrically to generate immature INPs.  
Following maturation, INPs (red, small) divide asymmetrically to generate post-mitotic progeny. 
All panels provided by AEH. 
 
5.1.1 Earmuff is an optic lobe transition zone marker 
The transition from neuroepithelial cells to optic lobe neuroblasts is defined by the expression 
of lethal of scute (l’sc); timely expression of l’sc is required for the generation of medulla 
neuroblasts (Yasugi et al., 2008). I discovered that optic lobe transition zone marker L’sc is 
also expressed in type II INPs during maturation (see Chapter 3). This suggested that INP 
maturation could be considered as a “transition zone” in type II lineages whereby INP fate is 
acquired. In addition to L’sc, immature INPs express the Fezf transcription factor Earmuff 
(Erm) (Fig. 5.2A), which is required for INP maturation (Janssens et al., 2014; Weng et al., 
2010). I assessed the overlap between L’sc and Erm in immature INPs and I found that these 
genes were co-expressed in immature INPs (Fig. 5.2A’-A’’). erm expression can also be 
followed using the genetic reporter R9D11-mCD8-GFP, which was activated after Erm/L’sc 
in type II INPs (Fig. 5.2A-A’’). 
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Figure 5.2: Maturing type II INPs and the optic lobe transition zone express Erm and L’sc 
(A-A’’) Type II neuroblasts (Dpn+, red, solid white outline) generate immature INPs that express Erm 
(blue, dotted white outlines) (Weng et al., 2010). Younger Erm+ INPs also express L’sc (red) but older 
Erm+ INPs do not (arrowhead). Type II lineages express R9D11-mCD8-GFP (R9D11GFP, green, dotted 
green outlines), which comes on after Erm and L’sc. 
(B-B’’) The transition from neuroepithelial cells (NE) to neuroblasts (NB, Dpn+, blue) in the optic 
lobe is marked by the expression of L’sc (red) (Yasugi et al., 2008). R9D11GFP  (green) is expressed at 
the transition zone (TZ) after the initiation of L’sc expression. 
(C-C’’) Erm (blue) is also expressed at the optic lobe TZ, after the initiation of L’sc expression and is 
maintained in neuroblasts. 
(D-E) Schematics summarising type II INP maturation and the optic lobe neuroepithelium to 
neuroblast transition. L’sc and Erm are coexpressed in both systems. L’sc has a more limited 
expression window compared to Erm, which is maintained in maturing INPs and optic lobe 
neuroblasts (Dpn+). R9D11GFP is expressed during the cell fate transition in both systems.  
Single section confocal images. Brains dissected 72 hours ALH. All panels provided by AEH. 
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Given the overlap of Erm and L’sc in type II lineages, I investigated whether these factors 
were also co-expressed in the optic lobe. Indeed, the erm reporter R9D11-mCD8-GFP was 
expressed at the transition zone (Fig. 5.2B) and overlapped with L’sc expression (Fig. 5.2B’-
B’’). Staining with an antibody raised against Erm showed that the protein was present at the 
transition zone (Fig. 5.2C) and was maintained in optic lobe neuroblasts (Fig. 5.2C’-C’’). 
This showed that Erm overlapped with L’sc at the optic lobe transition zone and during INP 
maturation in type II lineages (Fig. 5.2D-E). The expression of the erm reporter R9D11-
mCD8-GFP in the optic lobe provided an easily identifiable marker for the neuroepithelial to 
neuroblast transition. As such, R9D11-mCD8-GFP could be used to follow the generation of 
neuroblasts from the neuroepithelium during the early stages of optic lobe development.  
 
5.2 The optic lobe neuroepithelium divides in the embryo 
The optic lobe neuroepithelium is specified in the embryo, initially as a patch of dense cells in 
the head ectoderm of stage 11 embryos (Hartenstein and Campos-Ortega, 1984; Poulson, 
1950; Turner and Mahowald, 1979). These cells undergo four cell divisions before 
invaginating from the ectoderm as a neuroepithelial sheet and attaching to the lateral surface 
of the brain between embryonic stages 12 and 13 (Fig. 5.3A) (Green et al., 1993). After this 
stage, the neuroepithelium has been reported to be dormant until symmetric divisions begin 
during the first larval instar (12-15 hours ALH) (Datta, 1995; Ebens et al., 1993; Hofbauer 
and Campos-Ortega, 1990; Prokop and Technau, 1994; White and Kankel, 1978), following 
which the proneural wave converts neuroepithelial cells to neuroblasts (Yasugi et al., 2008) 
(Fig. 5.3B).  
 
5.2.1 Neuroepithelial cells divides throughout embryogenesis 
Neuroepithelial cells can be identified in the embryo by their expression of Fasciclin II (FasII), 
the orthologue of neural cell adhesion molecule (N-CAM) (Grenningloh et al., 1991; 
Younossi-Hartenstein et al., 1997). To determine the proliferation pattern of neuroepithelial 
cells during embryogenesis, we co-stained for FasII and the cell division marker phospho-
histone H3 (pH3). We found pH3+ neuroepithelial cells at all developmental stages between 
optic primordium invagination and the end of embryogenesis (Fig. 5.4Ai-iii, quantified in 
Fig. 5.4B). Thus, the neuroepithelium divides throughout embryogenesis, in contrast to a 
previous suggestion that the optic primordium is dormant in the embryo (Green et al., 1993). 
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Figure 5.3: Existing model of neuroepithelium dynamics 
(A) Schematic showing the position of neuroepithelium (purple) after invagination from the head 
ectoderm. The neuroepithelium attaches to the lateral posterior sides of the brain lobe (CNS shown in 
blue). A: anterior; P: posterior; D: dorsal; V: ventral. 
(B) Previous studies inferred that no cell divisions occurred in the neuroepithelium (grey) during 
embryogenesis. Symmetric divisions began during early larval stages, to expand the neuroepithelium, 
and the generation of neuroblasts (red) was restricted to mid-late larval stages. The asymmetric 
division of neuroblasts resulted in the generation of post-mitotic progeny. 
Panel (A) provided by LO; panel (B) provided by AEH. 
 
 
Figure 5.4: The neuroepithelium divides throughout embryogenesis 
(Ai-iii) The optic lobe neuroepithelium (FasII+, white) divides throughout embryogenesis, as assessed 
by staining for pH3 (red). Dividing neuroepithelial cells are indicated by arrowheads. 
(B) Quantification of the number of neuroepithelial cell divisions (pH3+ FasII+) per brain lobe between 
embryonic stages 12 and 17. n = 10 embryos per stage, except stage 12 for which n = 5. Red lines 
indicate medians. 
(Ci-iii) All embryonic neuroepithelial cells (FasII+) express the G2 cyclin (Cyclin A, blue) soon after 
invagination (Stage 12). The neuroepithelium loses Cyclin A expression over time. 
(D) Quantification of the number of neuroepithelial (FasII+) cells per brain lobe between embryonic 
stages 12 and 17. n = 10 embryos per stage, except stage 12 for which n = 5. Red lines indicate 
medians. 
All panels provided by LO. 
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Previous studies used BrdU incorporation assays to follow cell divisions of the 
neuroepithelium (Green et al., 1993). BrdU is a synthetic thymidine analogue that can be used 
to label cells as they complete S phase of the cell cycle. As such, it would be possible for 
neuroepithelial cells to divide without incorporating BrdU if they arrested in G2 phase as they 
invaginated from the ectoderm (i.e. had already completed S phase). To determine the cell 
cycle phase of neuroepithelial cells, we stained for Cyclin A (CycA), a G2 phase cyclin and 
found that neuroepithelial cells were all CycA+ as they underwent invagination (Fig. 5.4Ci). 
Neuroepithelial cells lost CycA expression over time, concomitant with cell divisions (Fig. 
5.4Cii), until all were CycA- at the end of embryogenesis (Fig. 5.4Ciii). Our results show that 
neuroepithelial cells invaginate in G2 and subsequently undergo mitosis. This is consistent 
with previous observations (Green et al., 1993) and, furthermore, we infer that neuroepithelial 
cells divide once each as they do not undergo S phase in the embryo after invagination (Green 
et al., 1993). 
 
5.2.2 The embryonic neuroepithelium generates neuroblasts  
We next assessed the role of neuroepithelial cell divisions in the embryo. We found no 
significant increase in the number of neuroepithelial cells over time (Fig. 5.4D), indicating 
that the role of these cell divisions is not to increase the size of the neuroepithelium. We 
therefore tested whether the embryonic neuroepithelium produces neuroblasts, in a similar 
manner to the neuroepithelium in larval development. 
 
We found neuroblasts (Dpn+ cells) in close association with the neuroepithelium beginning at 
embryonic stage 12 (Fig. 5.5A). These neuroblasts expressed the transition zone marker 
R9D11-mCD8-GFP (Fig. 5.5B), suggesting that they were produced by the neuroepithelium. 
To test if the neuroblasts were derived from the neuroepithelium, we expressed red 
fluorescent protein (RFP) in the neuroepithelium and assessed whether the Dpn+ cells 
inherited RFP. Interestingly, we found that GAL4 lines that label the larval neuroepithelium 
(GAL4c855a (Egger et al., 2007) and ogre-GAL4 (Dillard et al., 2018)) were not expressed in 
the embryonic neuroepithelium (data not shown). However, we found that a GAL4 driver 
under the control of a regulatory region of tll, GMR31H09-GAL4 (identified in Chapter 2, 
referred to as R31H09-GAL4 here) labelled the embryonic neuroepithelium (Fig. 5.5B’). 
When we expressed RFP using R31H09-GAL4, we found that the Dpn+ cells inherited RFP 
(Fig. 5.5B’). In addition, R9D11-mCD8-GFP+ cells initially express Eya (Fig. 5.5C), which is 
a robust marker of the embryonic neuroepithelium (Erclik et al., 2008). Therefore, we 
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conclude that the embryonic neuroepithelium produces neuroblasts and refer to these 
neuroblasts as EONs (embryonic optic neuroblasts). 
 
EONs were produced continuously from invagination (stage 12) until the end of 
embryogenesis and we found a final number of 8.6±0.7 EONs per brain lobe (Fig. 5.5D). 
EONs were initially visible in the neuroepithelial plane and then extruded medially towards 
the interior of the brain, upon which they downregulated FasII expression (Fig. 5.5Ei-iii). 
Importantly, our results demonstrate that neuroepithelial cells produce neuroblasts much 
earlier (~60 hours earlier) than described previously (Fig. 5.5F).  
 
Figure 5.5: The embryonic neuroepithelium divides to give rise to EONs 
(A) Neuroblasts (Dpn+, red, yellow arrowheads) are found in close proximity to the neuroepithelium 
(FasII+, white) in the embryo.  
(B-B’) Neuroblasts in close association with the neuroepithelium (white arrowheads) express the 
transition zone marker R9D11-mCD8-GFP (green) and inherit myr-mRFP (cyan) expressed in the 
neuroepithelium (R31H09-GAL4>myr-mRFP). 
(C) EONs (R9D11-mCD8-GFP+) initially express Eya (white), which is expressed in the 
neuroepithelium (Erclik et al., 2008). 
(D) Quantification of the number of EONs between embryonic stages 12 and 17. n = 10 embryos/stage, 
except stage 12 for which n = 5. Red lines indicate medians. 
(Ei-iii) EONs (Dpn+, R9D11-mCD8-GFP+) are generated throughout embryogenesis and remain in 
close contact with the neuroepithelium (FasII+). 
(F) Schematic depicting the early stages of neuroepithelium development and the generation of EONs. 
Single section confocal images. All panels provided by LO (except C and F, provided by AEH). 
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Figure 5.6: The dVsx1 and wg domains of the embryonic neuroepithelium produce EONs 
(A) The larval neuroepithelium is spatially patterned along the A-P axis by the expression of dVsx1, 
Optix, dpp, and wg. The ventral but not dorsal half of the neuroepithelium expresses hh. A: anterior; P: 
posterior; D: dorsal; V: ventral. 
(B) The wg, dVsx1 and hh domains are present in the embryonic neuroepithelium but the Optix and 
dpp domains are not yet established. D: dorsal; V: ventral. 
(C) The majority of EONs (R9D11-mCD8-GFP+, green) arise from the dVsx1+ (red) domain of the 
neuroepithelium. 
(D-D’) EON production (R9D11-mCD8-GFP) spans the dorsal-ventral boundary of the 
neuroepithelium (FasII+), as defined by hh::lacZ expression. 
(E-E’) A small proportion of EONs (R9D11-mCD8-GFP) are generated by the wg domains of the 
neuroepithelium (FasII+), as assessed by wg-lacZ.  
(F) Optix is not expressed in the embryonic neuroepithelium as assessed by immunostaining with an 
antibody raised against Optix. 
(G) dpp is not expressed in the embryonic neuroepithelium, as assessed by dpp-lacZ expression. 
Single section confocal images. Panels (A, B, E, E’) provided by AEH; panels (C, D, D’, F, G) 




5.3 Characterising EON production 
5.3.1 EONs derive from two spatial domains of the neuroepithelium 
The larval neuroepithelium is patterned into distinct spatial domains: dVsx1, Optix, 
decapentaplegic (dpp) and wingless (wg) are expressed in discrete regions to pattern the 
neuroepithelium along the anterior-posterior axis (Fig. 5.6A) ((Erclik et al., 2008; Gold and 
Brand, 2014; Kaphingst and Kunes, 1994); reviewed by (Bertet, 2017)) and the ventral (but 
not dorsal) half of the neuroepithelium expresses hedgehog (hh) (Fig. 5.6A) (Chen et al., 
2016; Evans et al., 2009). All spatial domains of the neuroepithelium generate neuroblasts 
during the progression of the proneural wave in mid-late larval stages. However, we observed 
EON production from distinct regions of the embryonic neuroepithelium. This suggested that 
only a subset of the neuroepithelial spatial domains gave rise to EONs (Fig. 5.6B). 
 
We found that almost all EONs originated from the central region, which corresponds to the 
dVsx1+ domain (Fig. 5.6C). The central domain of EONs also overlapped the dorsal-ventral 
boundary, as defined by hh expression (Fig. 5.6D). We observed that the wg+ tips of the 
neuroepithelium were also competent to produce EONs, albeit fewer than the central domain 
(Fig. 5.6E-E’). We could not detect expression of Optix (Fig. 5.6F) or dpp (Fig. 5.6G) in the 
embryonic neuroepithelium, suggesting that the patterning of these domains occurs later in 
development. Therefore, we conclude that the central domain, and to a lesser extent the tips, 
of the embryonic neuroepithelium produce neuroblasts. 
 
5.3.2 The embryonic neuroepithelium expresses transition zone markers 
The transformation of neuroepithelial cells to neuroblasts occurs at a transition zone in larvae. 
Cells at the transition zone express R9D11-mCD8-GFP (this study, see Fig. 5.2), l’sc (Yasugi 
et al., 2008), and the microRNA miR-7 (Caygill and Brand, 2017) (Fig. 5.7A). In addition, the 
transition is regulated by epidermal growth factor receptor (EGFR) and Notch signalling (Fig. 
5.7A) (Egger et al., 2010; Yasugi et al., 2010). As in larval stages, we found that R9D11-
mCD8-GFP expression coincided with L’sc (Fig. 5.7B). Furthermore, these L’sc+ cells 
exhibited many features of the larval transition zone: they were positive for EGFR signalling 
(Fig. 5.7C-C’), expressed miR-7 (Fig. 5.7D) and downregulated Notch signalling (Fig. 5.7E-
E’). This suggests that common molecular mechanisms regulate the generation of neuroblasts 




Figure 5.7: Transition zone markers are expressed in the embryonic neuroepithelium at sites of 
EON production 
(A) The progression of the proneural wave (grey arrow) converts neuroepithelial cells to neuroblasts at 
the transition zone (highlighted in grey). The transition zone is characterised by the expression of L’sc 
and miR-7 (red), active EGFR signalling (blue) and low Notch signalling (green). 
(B) L’sc (red) is expressed in the neuroepithelium (FasII+, white) at the regions of R9D11-mCD8-GFP 
(green) expression. 
(C-C’) L’sc+ cells in the neuroepithelium (FasII+) are active for EGFR signalling (green), as assessed 
by Pnt-GFP (a downstream effector of the EGFR pathway). 
(D) The transition zone marker microRNA miR-7 (green) is expressed in L’sc+ cells in the 
neuroepithelium (FasII+). 
(E-E’) Notch signalling is downregulated, as assessed by mγ-GFP (green), in neuroepithelial cells 
(FasII+) that express L’sc. 
Single section confocal images. Panel (A) provided by AEH; panels (B-E’) provided by LO. 
 
5.3.3 EONs generate neurons and glia 
We showed that EONs are produced from the neuroepithelium in a similar manner to larval 
optic lobe neuroblasts. In larval stages, asymmetric divisions of optic lobe neuroblasts 
generate GMCs, which undergo a terminal division to produce neurons and glia. We tested if 
EONs divided to generate progeny in the embryo. We found that EONs divided and that 
R9D11-mCD8-GFP encompassed Dpn+ cells (EONs) and Dpn- cells (progeny) (Fig. 5.8A). 
Furthermore, EONs exhibited asymmetric localisation of Pros and Mira, which is a hallmark 
of neuroblast neurogenic divisions (Ikeshima-Kataoka et al., 1997) (Fig. 5.8B). We found that 
the R9D11-mCD8-GFP+ Dpn- cells included GMCs (identified by nuclear Pros, Fig. 5.8C-C’), 
 87 
neurons (identified by Elav, Fig. 5.8D-D’) and glia (identified by Repo, Fig. 5.8E). Taken 
together, these findings indicate that EONs divide in the embryo to generate neurons and glia 
(Fig. 5.8F) (16.1±1.7 neurons and 3.7±1.4 glia per brain lobe at the end of embryogenesis, (n 
= 10 brain lobes). 
 
Figure 5.8: EONs generate neurons and glia 
(A-A’) EONs (Dpn+, red, R9D11-mCD8-GFP+, green) divide, as assessed by immunostaining for pH3 
(white). Dpn- R9D11-mCD8-GFP+ progeny (asterisks) are in close association with EONs. 
(B-B’) EONs show asymmetric localisation of Pros (green) and Mira (red), which is characteristic of 
neurogenic neuroblast divisions. 
(C-C’) Many small, Pros+ (white) cells lie in close contact with EONs (Dpn+, red) and retain R9D11-
mCD8-GFP (green) expression. 
(D-D’) EONs (Dpn+, red, R9D11-mCD8-GFP+, green) give rise to neurons (Elav+, blue) that maintain 
R9D11-mCD8-GFP expression. 
(E-E’) Repo+ cells that also express R9D11-mCD8-GFP (green) and are in close proximity to EONs 
(Dpn+, red, R9D11-mCD8-GFP+), indicating that EONs give rise to glia. 
(F) Schematic depicting the generation of EONs (red) from the embryonic neuroepithlieum. EONs 
divide to generate progeny (blue) that retain R9D11-mCD8-GFP (green) expression. 
Single section confocal images. Panels A-E provided by LO; panel F provided by AEH. 
 
We confirmed the lineage relationship between EONs and neurons using flip-out LexA 
amplification (FLEXAMP), a memory cassette tool (Fig. 5.9A) (Bertet et al., 2014; Yagi et 
al., 2010). FLEXAMP combines the GAL4 and LexA systems, which are independent binary 
transcriptional systems, to allow lineage tracing; GAL4 activates the expression of genes 
under the control of UAS whereas LexA activates genes under the control of lexAop (referred 
to as lexO). The use of FLEXAMP for lineage tracing requires a specific GAL4 for the cells 
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of interest. GAL4 activates the expression of UAS-FLP, which excises a transcriptional stop 
sequence between an act promoter and LHV2. LHV2 is a GAL80-insuppressible LexA 
transcriptional activator (Yagi et al., 2010) that binds to lexO and activates transcription, in 
this case of mCD8-GFP (Fig. 5.9A). Using GAL80ts to restrict GAL4 expression to the 
desired temporal window allows lineage tracing to be initiated at specific developmental 
stages.  
 
Figure 5.9: Lineage tracing confirms that EONs generate neuronal progeny that lie in close 
contact with the larval visual system 
(A) Schematic showing the genetic components of FLEXAMP. At the restrictive temperature for tub-
GAL80ts, R31H09-GAL4 drives the expression of UAS-FLP in the neuroepithelium, which catalyses  
the excision of a transcriptional stop sequence from the “flp-out” cassette. This results in the act 
promoter driving the expression of LHV2 (a GAL80-insuppressible LexA transcriptional activator) 
that binds to and activates transcription from lexO sequences, such as mCD8-GFP for lineage tracing. 
(B) Green arrowheads indicate neurons (Elav+, green) produced by EONs (Dpn+, red) that are labelled 
using FLEXAMP (white) at larval hatching. Image is a single section confocal image. 
(C) In the negative control for FLEXAMP, no cells are labelled by GFP at larval hatching. Embryos 
were kept at 18 ˚C to maintain GAL80ts activity. Image is a projection over 14 µm in z. 
(D) Green arrowheads indicate neurons (Elav+) produced by EONs labelled using FLEXAMP (white), 
which lie in close contact with Bolwig’s nerve (Futsch+, red). Image is a projection over 1 µm in z. 
(E) Schematic depicting the spatial relationship between the neuroepithelium (NE), Bolwig’s nerve 
and EON progeny (green) at larval hatching. 




Unfortunately, we have been unable to identify a GAL4 driver that labels EONs specifically 
and so we were limited to neuroepithelial GAL4 driver lines to perform lineage tracing in 
early developmental time points. Expressing FLEXAMP in the embryonic neuroepithelium 
allowed us to recover labelled neurons (Fig. 5.9B-C) and revealed that a large number of the 
neuronal progeny were in close proximity to Bolwig’s nerve (Fig. 5.9D). Bolwig’s nerve is 
part of the larval visual system (Larderet et al., 2017; Schmucker et al., 1997; Schmucker et 
al., 1992; Tix et al., 1989), the development of which is not well understood, suggesting that 
neurons generated by EONs contribute to the larval visual processing system (Fig. 5.9E). We 
conclude that, like canonical neuroblasts, EONs undergo neurogenic divisions and generate 
differentiated progeny. 
 
Figure 5.10: EONs persist in the larval brain in G0 quiescence 
(A-A’) EONs (Dpn+, red, R9D11-mCD8-GFP+, green) are found in the larval brain in close 
association with the neuroepithelium (FasII+, white). Images are a single frame from a 3D projection. 
(B) Schematic depicting the spatial relationship between EONs (red with green outline) and the 
neuroepithelium at 0 hours ALH. EONs are found medially, towards the centre of the brain, with 
respect to the neuroepithelium. L: lateral; M: medial. 
(C-C’) EONs (Dpn+ and R9D11-mCD8-GFP+) do not express the G2 cyclin (CycA, cyan) at larval 
hatching, demonstrating that EONs are quiescent in G0 phase of the cell cycle. G0 quiescence is rare in 
comparison to G2 quiescence (CycA+, Dpn+) in the larval CNS. (C’) is a magnification of the boxed 
region highlighted in (C). 
(D) The neuroepithelium (FasII+) also undergoes G0 quiescence. The neuroepithelium does not express 
CycA (cyan) at larval hatching, in contrast to the majority of NSCs in the central brain (Dpn+, CycA+). 
Single section confocal images, unless indicated otherwise. All panels provided by AEH. 
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5.4 EONs in the post-embryonic brain 
5.4.1 EONs undergo G0 quiescence and persist into the larval brain 
The majority of the neuroblasts in the CNS enter mitotic quiescence or undergo apoptosis at 
the end of the embryogenesis (Maurange and Gould, 2005; Truman and Bate, 1988; White et 
al., 1994). Quiescent neuroblasts are maintained in the larval brain and re-enter the cell cycle 
in a nutrition-dependent manner to resume neurogenesis (Britton and Edgar, 1998; Chell and 
Brand, 2010; Otsuki and Brand, 2018; Sousa-Nunes et al., 2011; Spéder and Brand, 2014; 
Truman and Bate, 1988). We investigated whether EONs are maintained in the larval brain. 
 
We found that EONs are present in brains from newly hatched larvae. EONs could be 
identified as a cluster of Dpn+ R9D11-mCD8-GFP+ cells in close association with the 
neuroepithelium (EONs were located medially to the neuroepithelium, as in the embryo) (Fig. 
5.10A-B). We observed 10.4±0.6 EONs per brain lobe at 0 hours ALH (n = 31 brain lobes), 
which is comparable to the number found at the end of embryogenesis. Previous studies 
showed that the only neuroblasts that continue to proliferate at larval hatching are the 
mushroom body and lateral neuroblasts (Ito and Hotta, 1992; Prokop and Technau, 1991; 
Truman and Bate, 1988), indicating that EONs are quiescent at this stage. 
 
The Brand Lab discovered recently that neuroblasts can reside in two types of quiescence 
(Otsuki and Brand, 2018); the majority of quiescent neuroblasts arrest in the G2 phase of the 
cell cycle, and the minority in G0. The type of quiescence has functional significance because 
G2 neuroblasts re-enter the cell cycle faster than G0 neuroblasts in response to nutritional 
inputs (Otsuki and Brand, 2018). We found that all EONs undergo G0 quiescence, as they did 
not express the G2 marker CycA at 0 hours ALH (Fig. 5.10C-C’). In addition, we found that 
neuroepithelial cells also become G0 quiescent (Fig. 5.10D) demonstrating that all NSCs in 
the developing visual system undergo G0 quiescence, which is otherwise uncommon in the 
Drosophila brain. 
 
5.4.2 EONs turn off R9D11-mCD8-GFP before they re-enter the cell cycle 
At hatching, EONs were identifiable as Dpn+ R9D11-mCD8-GFP+ CycA- cells adjacent to the 
neuroepithelium (Fig. 5.10). The absence of CycA provided a useful marker to follow EONs 
during early larval development before neuroblasts re-enter the cell cycle. At 6 hours ALH, 
the neuroepithelium and EONs remained associated closely (Fig. 5.11A) and both NSC 
populations were quiescent and negative for CycA (Fig. 5.11A’). At this stage, EONs retained 
R9D11-mCD8-GFP expression but at a lower level (Fig. 5.11A’’). 
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Figure 5.11: EONs turn off R9D11-mCD8-GFP before re-entering the cell cycle 
(A-A’’) At 6 hours ALH, neuroepithelial cells (FasII+, white) and EONs (Dpn+, red) remain quiescent 
(CycA-, cyan). EONs (red asterisks in A’ and A’’) are in close association with neuroepithelium 
(dotted white outline in A’ and A’’) and begin to downregulate R9D11-mCD8-GFP (green). 
(Bi-Bii’) At 12 hours ALH, the neuroepithelium has re-entered the cell cycle (FasII+ CycA+). EONs 
remain quiescent (Dpn+ CycA-) and many show no/extremely weak R9D11-mCD8-GFP expression. 
(Ci-Cii) At 18 hours ALH, neuroepithelial cells (FasII+) continue to express CycA but EONs (Dpn+) 
do not. EONs (red asterisks) no longer express R9D11-mCD8-GFP at this time point. 
(D) EONs are closely associated with the neuroepithelium in the first few hours ALH. Once the 
neuroepithelium has re-entered the cell cycle, EONs are found medial the neuroepithelium and lose 
R9D11-mCD8-GFP expression over time. L: lateral; M: medial; A: anterior; P: posterior. 
Single section confocal images. All panels provided by AEH. 
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Neuroepithelial cells begin symmetric, expansive divisions between 12 and 15 hours ALH 
(Datta, 1995; Ebens et al., 1993; Hofbauer and Campos-Ortega, 1990; Prokop and Technau, 
1994; White and Kankel, 1978). As a consequence, neuroepithelial cells expressed CycA at 
12 hours ALH (Fig. 5.11Bi). In contrast, quiescent neuroblasts remained dormant (Ito and 
Hotta, 1992; Prokop and Technau, 1991; Truman and Bate, 1988) and, accordingly, EONs 
remained CycA negative at 12 hours ALH (Fig. 5.11Bii). Furthermore, the majority of EONs 
exhibited very weak R9D11-mCD8-GFP expression (Fig. 5.11Bii’), but could be identified 
by their lack of CycA expression and medial position to the neuroepithelium. At 18 hours 
ALH, the dividing neuroepithelium continued to express CycA (Fig. 5.11Ci) whereas EONs 
remained quiescent (small, CycA-) (Fig. 5.11Cii). At this stage, R9D11-mCD8-GFP 
expression in EONs was extremely weak or absent entirely and reliable identification of 
EONs was only possible based on their position relative to the neuroepithelium and the lack 
of CycA (Fig. 5.11D). At 24 hours ALH, an average of 4.3±0.5 Dpn+ weak R9D11-mCD8-
GFP+ CycA- cells (n = 11 brain lobes) were present in a medial position to the 
neuroepithelium, suggesting that most EONs had reactivated at this time point. This indicates 
that EONs are amongst the last neuroblasts to reactivate in the brain, consistent with the 
Brand Lab’s previous finding that G0 neuroblasts reactivate after G2 neuroblasts (Otsuki and 
Brand, 2018).  
 
5.4.3 The fate of EONs after reactivation is unclear 
We found that R9D11-mCD8-GFP labels EONs during embryogenesis and soon after larval 
hatching, but this label is turned over during early larval development and so cannot be used 
for long term tracking of EONs or their progeny. We tried to label EONs permanently using 
genetic tools, but all methods tried have proved unsuccessful. R9D11-GAL4 driving UAS-
mCD8-GFP labels EONs at larval hatching, albeit very weakly (Fig. 5.12A) but when 
R9D11-GAL4 is used for lineage tracing, for example using a “flp-out” cassette, EONs are 
not labelled (Fig. 5.12B-B’). Permanent labelling techniques that do label EONs are 
expressed in the neuroepithelium from embryonic stages, which results in all epithelial 
progeny being labelled, and so cannot be used to follow EONs once the neuroepithelium 
resumes cell divisions in larval stages (Fig. 5.12C).  
 
While we have been unable to follow the fate of EONs into later stages of larval development, 
it is likely that they reactivate. This is supported by the observation that all neuroblasts 
surrounding the neuroepithelium have re-entered the cell cycle at 30 hours ALH (Fig. 5.13Ai-
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Aii). Therefore, we have identified a new, embryonic phase of neuroepithelium division that 
generates a small population of neuroblasts that persist in the larval brain (Fig. 5.13B). 
 
Figure 5.12: Tracing the fate of EONs and their progeny is not possible with the tools available 
(A) At 0 hours ALH, R9D11-GAL4>mCD8-GFP (green) is expressed in only a few Dpn+ cells next to 
the neuroepithelium (NE, white dotted outline), i.e. EONs. Strong expression is observed consistently 
in type II lineages (circled). Image is a projection over 13.6 µm in z. 
(B-B’) At 0h ALH, EONs can be identified by the lack of CycA expression (cyan in B) and their 
location in the brain. R9D11-GAL4 driving the expression of an immortalisation cassette 
(act5C>FRT-txnSTOP-FRT>GAL4) does not label any EONs (white dotted outline) but does label 
type II lineages (circled). Image is a projection over 12 µm in z. 
(Ci-Cii) Performing FLEXAMP with R31H09-GAL4 (which labels EONs at hatching, see Fig. 5.9) 
results in labelling of the entire optic lobe (OL) in the adult brain, despite inactivation of the GAL4 
after larval hatching (see Chapter 7 for experimental details). All neurons (Brp, red) and glia (Repo, 
blue) in the lobula (LO), medulla (Me) and lamina (La) appear to be labelled. The boxed region in Ci 
highlights the OL, which is shown in Cii. Single section confocal images. 






Figure 5.13: All neuroblasts surrounding the neuroepithelium re-enter the cell cycle 
(Ai-Aii) At 30 hours ALH, neuroepithelial cells (FasII+, white) continue to express CycA (cyan) as 
they undergo symmetric divisions to expand the neuroepithelium. All neuroblasts found medially to 
the neuroepithelium (i.e. in the EON layer) express CycA at this time, indicating that EONs resume 
cell divisions. Dashed yellow line indicates periphery of the neuroepithelium. 
(B) Schematic showing a revised model in the developing visual system. In the embryo, 
neuroepithelial cells (grey) divide and generate neuroblasts (red). These neuroblasts are maintained in 
the larval brain and remain in close association with the neuroepithelium as symmetric neuroepithelial 
cell divisions begin. At mid-late larval stages, the proneural wave converts neuroepithelial cells to 
neuroblasts, which generate neurons and glial of the adult visual system. 
All panels provided by AEH. 
 
5.5 Early larval neuroblast transition 
In the process of following EONs in early larval stages, which downregulate R9D11-mCD8-
GFP, I observed strong R9D11-mCD8-GFP expression at the edges of the neuroepithelium. 
While EONs are found medially (“under”) the neuroepithelium, the strongly R9D11-mCD8-
GFP+ cells were in the plane of the neuroepithelium. Expression of R9D11-mCD8-GFP in 
this manner could be observed from 12 hours ALH (i.e. neuroepithelium reactivation) 
onwards (Fig. 5.14A).  
 
As R9D11-mCD8-GFP is a marker of the neuroepithelial to neuroblast transition, I assessed if 
the early expression of R9D11-mCD8-GFP corresponded to neuroblast generation. At 12 
hours ALH, no Dpn+ cells were found within strong R9D11-mCD8-GFP+ cells (Fig. 5.14A’). 
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However, at 18 hours ALH, Dpn+ R9D11-mCD8-GFP+ cells could be seen at the edges of the 
neuroepithelium (Fig. 5.14B-B’). This was also the case at 24 (Fig. 5.14C-C’) and 30 hours 
ALH (Fig. 5.14D-D’), with more Dpn+ R9D11-mCD8-GFP+ cells observed over time (Fig. 
5.14E).   
 
Figure 5.14: R9D11-mCD8-GFP labels neuroblasts in close contact with the neuroepithelium 
before the progression of the proneural wave  
(A-A’) Strong R9D11-mCD8-GFP (green) expression in contact with FasII+ cells (white) of the 
neuroepithelium can be observed at 12 hours ALH. At this stage, R9D11-mCD8-GFP+ cells do not 
express Dpn (red). 
(B-B’) At 18 hours ALH, Dpn is expressed in the minority of R9D11-mCD8-GFP+ cells in the plane 
of the neuroepithelium.  
(C-C’) By 24 hours ALH, Dpn+ R9D11-mCD8-GFP+ cells are consistently found in contact with the 
neuroepithelium (FasII+). 
(D-D’) At 30 hours ALH, Dpn+ R9D11-mCD8-GFP+ cells are found in contact with the 
neuroepithelium (FasII+). 
(E) Quantification of the number of Dpn+ R9D11-mCD8-GFP+ cells in contact with the 
neuroepithelium (NE) at 12, 18, 24, and 30 hours ALH. 
Single section confocal images. All panels provided by AEH.  
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5.5.1 Early larval optic lobe neuroblasts come from the wg domains 
Dpn+ R9D11-mCD8-GFP+ cells were observed at the posterior tips of the neuroepithelium, 
which corresponded spatially to the wg+ domains. Assessing wg expression showed that, 
indeed, strong R9D11-mCD8-GFP+ cells in the plane of the neuroepithelium co-expressed wg 
or were in close association with cells that did (Fig. 5.15A-C). This indicated that the wg+ 
domains of the neuroepithelium generate a small number of neuroblasts during early larval 
development, approximately 24 hours before the initiation of the proneural wave (which 
begins ~48 hours ALH). 
 
Figure 5.15: The wg domain expresses the transition zone marker R9D11-mCD8-GFP during 
early larval development 
(A) R9D11-mCD8-GFP expression (green) overlaps with wg-GAL4>myr-mRFP (red) in the 
neuroepithelium (FasII+) at 18 hours ALH. Image is a projection over 2.5 µm in z. 
(B-C) R9D11-mCD8-GFP expression remains restricted to the wg+ domain of the neuroepithelium 
(FasII+) at 24 hours ALH, as assessed by wg-GAL4>myr-mRFP (B) and wg-lacZ (C). 
(D) Weak L’sc expression (arrowheads) is observed in the neuroepithelial cells immediately next to 
R9D11-mCD8-GFP+ cells at 24 hours ALH. 
(E-E’) At 48 hours ALH, R9D11-mCD8-GFP expression overlaps with wg-GAL4>myr-mRFP (red 
and indicated by red dotted lines) in addition to other domains of the neuroepithelium (FasII+ and 
indicate by white dotted lines). The direction of the proneural wave is indicated by the blue dotted 
arrow (between panels E and E’). Images are single frames taken from a 3D projection 
Single section confocal images unless indicated otherwise. All panels provided by AEH. 
 
The mechanisms that regulate this early phase of larval optic lobe neuroblast generation are 
not known. However, preliminary assessment of L’sc showed that a small number of cells (1 
or 2) at the posterior tips of the neuroepithelium express low levels of L’sc (Fig. 5.15D). The 
co-expression of L’sc and R9D11-mCD8-GFP in early larval development is consistent with 
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the transition zones found in the embryo and later in larval development (Fig. 5.15E-E’). 
 
The preliminary observation of neuroblast generation from the optic lobe neuroepithelium 
during early larval development is extremely intriguing. It suggests that the neuroepithelium 
is competent to produce neuroblasts throughout development, in contrast to the view that 
symmetric divisions precede neuroblast generation. Additional support for this observation 
comes from other studies that have identified expression of transition zone markers (L’sc and 
PntP1) at the edges of the neuroepithelium at late second instar stage, before the initiation of 
the proneural wave (Dillard et al., 2018; Sato et al., 2016). 
 
However, due to the fluctuation of R9D11-mCD8-GFP throughout optic lobe development, 
additional genetic tools must be used to profile the generation of early larval optic lobe 
neuroblasts more carefully. This could be achieved by performing lineage tracing during early 
larval stages before the proneural wave is initiated. Lineage tracing could also be used to 
identify the role of these neuroblasts and their progeny. Overall, the re-examination of the 
early development of the neuroepithelium led to the identification of two new phases of 
neuroblast production: an embryonic phase and an early larval phase. This challenges the 
dogma that neuroblast production from neuroepithelial cells is restricted to late larval stages 
and demonstrates that the division mode of the optic lobe neuroepithelium is more dynamic 
than thought previously. 
 
5.6 Chapter 5 discussion 
Type II neuroblasts and the optic lobe neuroepithelium are unique NSCs in the developing 
Drosophila brain that share parallel lineage transitions. R9D11-mCD8-GFP is a reporter of 
erm expression that has been used extensively to follow type II lineage progression (Janssens 
et al., 2014; Weng et al., 2010). I found that this reporter is expressed as neuroepithelial cells 
become neuroblasts, which facilitated the careful re-examination of the division mode and 
neuroblast generation from the neuroepithelium throughout development. This observation 
also suggests that erm could regulate the optic lobe transition zone, but this has not yet been 
explored.  
 
Together with Dr Leo Otsuki, I have discovered that the neuroepithelium generates 
neuroblasts in the embryo and in the early stages of larval development before the initiation of 
the proneural wave (Fig. 5.16). We found that the neuroepithelium divides in the embryo and 
generates EONs. EONs divide in the embryo to generate neurons and glia, but the role of 
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these progeny is not known. However, we found that the neurons generated in the embryo lie 
in close contact with Bolwig’s nerve, which is part of the larval visual system (Tix et al., 
1989). The neuroepithelium generates the adult visual processing system during larval stages 
and so it is an attractive hypothesis that the neuroepithelium divides in the embryo to produce 
the larval visual system.  
 
The discovery of a new phase of neuroblast production from the optic lobe neuroepithelium 
also raises questions about how the neuroepithelial to neuroblast transition is regulated 
throughout development. The proneural wave results in the conversion of neuroepithelial cells 
to neuroblasts, such that there are no neuroepithelial cells remaining at the end of larval 
development. This is not the case for the earlier stages of neuroblast generation, which occur 
in parallel with expansive symmetric neuroepithelial divisions. It will be an interesting topic 
for future study to investigate the mechanisms that regulate the early transition zones such 
that neuroepithelial cells are preserved for neuroblast production later in development.  
 
 
Figure 5.16: Summary of transition zones in the neuroepithelium throughout development 
(A) The embryonic neuroepithelium (grey) generates neuroblasts from spatially distinct transition 
zones (green) in the wg and dVsx1 domains. During early larval development, the wg domains show 
expression of transition zone markers and a small number of neuroblasts are generated. Later in larval 
development, transition zone markers are expressed in all spatial domains as the proneural wave 
converts neuroepithelial cells to neuroblasts. Previous models of neuroepithelium division did not 
include the embryonic or early larval phases of neuroblast generation. 








The maintenance of neural stem cells (NSCs) is essential for generating the correct number of 
neurons and glia during brain development. However, tumours can arise from NSC lineages if 
the division mode of NSCs is disrupted or if differentiation is prevented. Understanding the 
genetic programmes that regulate different NSC populations is central for understanding 
normal development and the diverse causes of tumourigenesis.  
 
The Drosophila central nervous system (CNS) consists of many different types of NSCs that 
work together to create a functioning brain (for a review see (Doe, 2017)). Importantly, 
Drosophila NSCs share many similarities with their mammalian counterparts. For example, 
type II neuroblasts divide in a manner analogous to mammalian NSCs; they divide 
asymmetrically to generate INPs, which maintain the ability to self-renew but which have a 
restricted proliferation capacity (Bello et al., 2008; Boone and Doe, 2008; Bowman et al., 
2008). Similarities also exist between the developing optic lobe and the mammalian cerebral 
cortex, in which symmetrically dividing neuroepithelial cells give rise to asymmetrically 
dividing NSCs (Brand and Livesey, 2011; Egger et al., 2011; Noctor et al., 2004). 
Intriguingly, there is considerable overlap in the molecular mechanisms that regulate different 
NSC lineage transitions in the Drosophila CNS and many of these genes have conserved 
mammalian counterparts.  
 
6.1 Common genetic mechanisms regulate different NSC populations 
The identification of common genetic networks that control distinct populations of NSCs 
within the Drosophila brain suggests that the fundamental mechanisms of NSC regulation 
could be conserved in other species. Investigating how conserved genes act in different 
developmental contexts in Drosophila provides an elegant system to improve our 
understanding of how diverse NSC division modes are regulated throughout development. 
Many transcription factors are expressed in NSCs of both the optic lobe and in type II 
lineages (Fig. 6.1A-A’). For example, expression of the Sp8 factor btd and active Notch 
signalling are common features of neuroepithelial cells and type II neuroblasts (Fig. 6.1B) 
(Egger et al., 2010; Komori et al., 2014a; Li et al., 2016; Xie et al., 2014; Younossi-
Hartenstein et al., 1997). tll is also expressed in the optic lobe neuroepithelium, where it 
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maintains neuroepithelial cell fate (Daniel et al., 1999; Guillermin et al., 2015) and I found 
that tll is required in type II neuroblasts to promote NSC and lineage identity (Fig. 6.1B).  
 
Figure 6.1: Common molecular mechanisms regulate NSC transitions in the developing optic 
lobe and type II neuroblast lineages 
(A) Optic lobe (OL) neuroepithelial cells transform into type I neuroblasts at the transition zone (grey). 
(A’) In type II lineages, neuroblasts give rise to immature INPs (grey) that undergo maturation before 
dividing asymmetrically. There are multiple stages in INP maturation that are represented as a single 
state in this schematic for simplicity. 
(B) Many genes are expressed in OL neuroepithelial cells and in type II neuroblasts. Notch (N) 
signalling (green) is absent from transition zone (Egger et al., 2010; Yasugi et al., 2010) and immature 
INPs (Bowman et al., 2008) but is active in other NSCs; btd-GAL4 (yellow) is expressed in both 
systems (Komori et al., 2014a; Xie et al., 2014; Younossi-Hartenstein et al., 1997); Tll (red) is 
expressed in the neuroepithelium (Guillermin et al., 2015; Younossi-Hartenstein et al., 1997) and in 
type II neuroblasts (this study), but is downregulated as the lineage progress. 
(C) Genes that are expressed at the OL transition zone are also expressed in maturing INPs. PntP1 
(blue) is expressed at the transition zone (Yasugi et al., 2010) and in type II neuroblasts and immature 
INPs (Zhu et al., 2011); L’sc (pink) marks the transition zone (Yasugi et al., 2008) and INP maturation 
(this study); Erm (purple) is a transition zone gene that remains expressed in OL neuroblasts (this 
study) and is also expressed in maturing INPs (Janssens et al., 2014; Weng et al., 2010). 
 
Intriguingly, there is a number of genes that label both the optic lobe transition zone and 
maturing INPs in type II lineages (Fig. 6.1C): L’sc marks the front of the proneural wave 
(Yasugi et al., 2008) and I discovered that this gene is also expressed in immature INPs; 
PntP1 is expressed at the optic lobe transition zone as a downstream effector of EGFR 
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signalling and is also required for INP maturation (Yasugi et al., 2010; Zhu et al., 2011). 
However, the most informative discovery was that Erm, which is expressed in immature INPs 
(Weng et al., 2010), is expressed at the optic lobe transition zone (Fig. 6.1C). Using an erm 
reporter to follow the neuroepithelial to neuroblast transition led to the discovery of a small 
number of neuroblasts that are generated from the optic lobe during embryogenesis (EONs) 
and in the early stages of larval development. The optic lobe has been studied for many years, 
but the identification of new neuroblasts demonstrates that its development is still not fully 
understood.  
 
The Drosophila optic lobe is considered to develop in a manner parallel to the mammalian 
cerebral cortex (Brand and Livesey, 2011) and so the discovery of EONs challenges the 
current dogma that neuroepithelial cells undergo sequential modes of cell division: an initial 
phase of symmetric, proliferative divisions that is followed by asymmetric, neurogenic cell 
divisions. Conserved molecular mechanisms regulate the transition from symmetric to 
asymmetric NSC divisions in Drosophila and mammals, suggesting that the mammalian 
neuroepithelium may also undergo as yet undiscovered neurogenic divisions during early 
developmental stages.  
 
Understanding how different populations of NSCs are regulated throughout development is 
essential for improving our understanding of disorders that affect the nervous system and also 
the cellular events that can give rise to cancer. Interestingly, the most frequent human cancers 
arise from epithelial tissues (such as skin, colon, breast and lung) (Ferlay et al., 2010) and so 
the dynamics of the neuroepithelium are particularly relevant for tumour studies. However, 
the cancer cell of origin is likely to differ between tumour types found within the same tissue 
(reviewed in (Blanpain, 2013; Pisapia, 2017)). For example, neuroepithelial cells give rise to 
neuroblasts that generate post-mitotic neurons; symmetrically dividing neuroepithelial cells 
are the tumour cells of origin in lethal(3)malignant brain tumour (l(3)mbt) mutants (Richter et 
al., 2011) whereas longitudinals lacking (lola) mutations affect the lineages of asymmetrically 
dividing neuroblasts (Southall et al., 2014). Therefore, we must continue to explore how 
NSCs are regulated during development and the molecular mechanisms involved. 
 
6.2 TLX: implications for brain disorders and tumour initiation  
The orphan nuclear receptor TLX is expressed at high levels in aggressive glioblastoma 
multiforme (GBMs) and correlates with poor patient survival (Park et al., 2010; Zou et al., 
2012). Furthermore, TLX is expressed in glioblastoma stem cells (GSCs), which are thought 
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to be resistant to conventional therapies and reinitiate tumour growth (Cui et al., 2016). High 
levels of TLX can also induce NSC expansion in vivo, and generate malignant gliomas when 
combined with additional mutations, suggesting a role for TLX in glioma initiation (Liu et al., 
2010; Park et al., 2010; Zou et al., 2012). TLX is also expressed in endogenous NSCs during 
development and adulthood and is required for NSC self-renewal and proper neurogenesis (Li 
et al., 2008; Liu et al., 2008; Monaghan et al., 1995; Shi et al., 2004; Yu et al., 1994). In 
addition, mice that lack TLX display aggressive behaviour (Monaghan et al., 1997; O’Leary 
et al., 2016; Roy et al., 2002; Young et al., 2002) and TLX is associated with hereditary cases 
of bipolar disorder and schizophrenia in humans (Dick et al., 2003; McQueen et al., 2005; 
Middleton et al., 2004; Wong et al., 2010). However, despite the developmental and clinical 
importance of TLX, the molecular mechanisms through which it controls NSC fate are not 
clear. 
 
Much of the work in this thesis was focussed on investigating the role of Tll, the Drosophila 
counterpart of TLX, in type II neuroblast lineages. I found that Tll is expressed in type II 
neuroblasts and is downregulated as differentiation occurs, which is analogous to the 
expression of TLX in mammalian NSCs (Li et al., 2012; Liu et al., 2008). I followed the 
expression of cell fate markers to show that in the absence of tll, type II neuroblasts transform 
into type I neuroblasts, which have a more restricted self-renewal capacity. As a consequence, 
transit amplifying INPs are no longer generated and the resulting lineages have a lower 
neurogenic potential. Removing INPs from NSC lineages also has implications for cancer; 
mutation in brat or erm results in tumours arising from INPs, but type I lineages are not 
affected (Bowman et al., 2008; Weng et al., 2010). 
 
In addition to behavioural disorders, TLX mutations are associated with microcephaly 
(Kumar et al., 2007b; Kumar et al., 2007a). However, the cell fate and lineage changes that 
occur when TLX function is disrupted in mammalian NSCs are not known. In light of the role 
of Tll in type II neuroblasts, mammalian NSCs with impaired TLX function could transition 
to a more restricted progenitor type that is unable to generate the full cohort of neurons and 
glia required for proper brain growth. It may also be the case that NSCs in different regions of 
the brain respond differently to the loss of TLX, as is the case in Drosophila, and so it would 




6.2.1 A conserved route to tumourigenesis  
I made use of the extensive genetic toolkit available in Drosophila to investigate the cellular 
and molecular mechanisms through which Tll/TLX contributes to tumour initiation from NSC 
lineages. I used the GAL4 system to express Tll at high levels in different cells within NSC 
lineages, which revealed that Tll tumours originated from type II INPs. High levels of Tll 
were sufficient to cause INPs to revert to neuroblast fate, prevent differentiation, and create 
tumours that consisted of type II neuroblasts. Importantly, this highlights the relevance of 
developmental genetic programmes in tumour initiation since Tll promotes type II neuroblast 
fate during development and in tumourigenesis. 
 
Drosophila Tll and human TLX are highly conserved genes and so likely act through 
conserved molecular mechanisms (Jackson et al., 1998). I found that human TLX could also 
induce type II neuroblast tumours from Drosophila INPs, which indicates that Tll and TLX 
regulate common target genes and may recruit conserved cofactors in order to do so. These 
findings implicate NSC-derived intermediate progenitors as one possible cell of origin for 
TLX-induced tumours. Intriguingly, intermediate progenitors have been implicated in glioma 
initiation previously. Oligodendrocyte progenitor cells give rise to gliomas even when tumour 
suppressor mutations are present in the parent NSCs (Liu et al., 2011). It seems that 
intermediate progenitors present a genetic weak point in NSC lineages because they maintain 
many properties of NSCs and are susceptible to aberrant reactivation of the NSC genetic 
programme. I showed that TLX is an example of an oncogene that can initiate tumours from 
intermediate progenitors and this route to tumourigenesis should be investigated in 
mammalian glioblastoma models.  
 
High levels of TLX are not only sufficient to induce glioma tumours from NSC lineages but 
high TLX expression has also been identified in glioblastoma stem cells (GSCs) (Cui et al., 
2016; Liu et al., 2010; Park et al., 2010; Zhu et al., 2014). The relationship between NSCs and 
GSCs is still being explored and it is not clear if TLX regulates common genes in both cell 
types. One of my most intriguing findings was the regulatory relationship between TLX/Tll 
and ase. I found that Tll represses ase in type II neuroblasts during development and that 
tumours induced by Tll or TLX consisted of NSCs that lacked ase expression. This suggested 
that the repression of ase is central to the mechanism through which Tll/TLX controls NSC 
fate and tumour initiation. Drosophila ase is closely related to mammalian gene ASCL1 and 
both genes are expressed in neural precursors to promote differentiation (Guillemot and 
Joyner, 1993; Johnson et al., 1990; Torii et al., 1999).  
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Intriguingly, a recent study identified that a subtype of GSCs isolated from patient GBM 
tumours showed downregulation of ASCL1, which influenced the survival of GSCs (Park et 
al., 2017). GSCs with high ASCL1 expression were stimulated to produce neurons when 
Notch signalling was inhibited, but those with low ASCL1 expression were not and continued 
to undergo self-renewal (Park et al., 2017). However, GSCs with low endogenous ASCL1 
expression could be stimulated to produce neurons if ASCL1 was induced ectopically, which 
inhibited the self-renewal capacity of GSCs and attenuated tumourgenicity (Fig. 6.2) (Park et 
al., 2017). Given the relationship between Tll/TLX and ase in Drosophila NSC tumours, it is 
tempting to speculate that GSCs with low levels of ASCL1 correspond to those with high TLX 
expression and that introducing ASCL1 could restrict the growth of these GSCs. In support of 
this, I found that expressing ase ectopically in Tll-induced tumours could prevent tumour 
initiation and restore differentiation. It would be interesting to investigate if ectopic 
expression of ase prevents TLX-induced tumours in a similar manner, which would allow this 
regulatory relationship to be studied in vivo. 
 
Fig. 6.2: Targeting GSCs with differentiation therapy 
Glioblastoma stem cells (GSCs) were found to have (i) high or (ii) low ASCL1 expression. GSCs with 
high ASCL1 differentiated to neuronal fate when Notch signalling was blocked, but this did not occur 
in ASCL1 low GSCs. Ectopic expression of ASCL1 was required for induce neuronal fate from low 
ASCL1 GSCs. Promoting neuronal differentiation inhibited GSC self-renewal and cultures reduced in 
size. Ectopic neurons are predicted to die in vivo due to the lack of synaptic partners. 
Based on data from (Park et al., 2017). 
 
The ability of ASCL1-mediated neurogenesis to attenuate GSC self-renewal suggests that 
differentiation therapy could be an effective means of targeting GSCs. GSCs are thought to be 
one of the main sources of tumour regrowth following surgery and so targeting these tumour 
reinitiating cells will be an important therapeutic advance. However, the success of using 
neuronal differentiation as a means to remove GSCs is reliant on the resulting neurons being 
resistant to tumourigenic transformation. Promisingly, I found that neither TLX nor Tll were 
able to induce NSC fate or tumours from neurons, indicating that post-mitotic cells are not 



















competent to respond to ectopic expression of these genes. If differentiation therapy was 
implemented in vivo, it is proposed that the ectopic neurons generated would not form 
functional synapses and so would undergo apoptosis. In this way, GSCs could be removed 
from tumours in vivo by stimulating them to differentiate into neurons, which are resistant to 
tumourigenesis. 
 
6.2.2 TLX as a therapeutic target 
TLX is an attractive therapeutic target for brain disorders and cancer. However, the lack of 
understanding surrounding the molecular mechanism of TLX has inhibited the translational 
applications of this gene. For example, TLX mutations are linked to microcephaly and bipolar 
disorder but treating these conditions with ectopic TLX expression carries the risk of inducing 
tumours. In order to realise the full potential of TLX as a therapeutic target for both 
developmental disorders and tumourigenesis, we must learn more about how TLX regulates 
NSCs in vivo. 
 
I used targeted DamID (TaDa) to profile the genome wide binding sites of Tll in type II 
neuroblasts in vivo. These data complemented the genetic experiments and showed that Tll 
could regulate many type II-specific genes directly to promote type II neuroblast fate. 
However, TaDa also revealed that Tll has many target genes throughout the genome (2495, 
see Appendix 2). This is perhaps not surprising give that the transcriptional regulation by Tll 
and TLX is known to be mediated through the recognition of a relatively short consensus 
binding sequence (AAGTCA) and through the recruitment of a number of cofactors (reviewed 
in (Wang and Xiong, 2016)). Performing TaDa with Atrophin, a conserved cofactor of Tll and 
TLX (Wang et al., 2006; Zhi et al., 2015), could reveal common binding sites of Tll and 
Atrophin and so identify coregulated target genes. Furthermore, a bioinformatic approach 
could be used to analyse the sequences within Tll binding regions so as to identify putative 
cofactor binding sites. This approach has been used previously by the Brand Lab to identify 
novel cofactors of the homeodomain transcriptions factor Prospero (Southall et al., 2014).  
 
As such, the Tll TaDa data provide an excellent starting point for improving our 
understanding of Tll/TLX function in NSCs. The Tll binding targets could be compared with 
gene expression changes in NSCs resulting from TLX manipulation (Liu et al., 2010; Qu et 
al., 2010; Zhang et al., 2008). In addition, the Brand Lab has recently developed mammalian 
targeted DamID (MaTaDa) to profile transcription factor binding in mammalian cells in 
culture (Cheetham et al., 2018) and has adapted this system to work in vivo (van den Ameele 
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et al., in preparation). Profiling TLX binding using MaTaDa in embryonic NSCs and in 
malignant GSCs would allow the identification of conserved target genes regulated by Tll and 
TLX during brain development and in tumourigenesis. 
 
6.2.3 Drosophila as a drug screening system 
The diversity of glioblastoma tumours, both between patients and within individual tumours, 
makes developing effective treatments for these cancers extremely challenging. Creating 
simple screening systems to identify drugs, or drug combinations, that target different 
subtypes of GBMs could produce early leads on new therapies. TLX is expressed at high 
levels in a subset of GSCs and expression in these tumours correlates with poor patient 
prognosis (Cui et al., 2016; Liu et al., 2010; Park et al., 2010; Zhu et al., 2014). In this way, 
TLX is a useful diagnostic marker but also a therapeutic target for tumours that have high 
TLX expression. Human TLX can generate large brain tumours from Drosophila NSCs and 
so could provide a novel system to test drugs that target TLX in vivo.  Drug screening in 
Drosophila has been used previously to identify novel drug combinations that target difficult-
to-treat cancers, such as thyroid and lung cancer (Bangi et al., 2016; Das and Cagan, 2013; 
Das et al., 2013; Levine and Cagan, 2016; Sonoshita and Cagan, 2017). While no 
physiological ligand has been identified that regulates the activity of TLX, three small 
molecules have been identified that bind to TLX and modulate its ability to bind to DNA in 
vitro (Benod et al., 2014). This indicates that TLX may be druggable in vivo and suggests that 
further screening could identify additional compounds that bind to and mediate the function 
of TLX or its cofactors in brain tumours. 
 
6.3 Concluding remarks 
This study has identified a novel regulator of type II neuroblasts (Tll) and discovered a new 
population of NSCs (EONs). These findings demonstrate the importance of Drosophila as a 
model system for studying the fundamental mechanisms of NSC regulation and neurogenesis. 
The identification of Tll as a regulator of type II neuroblast fate provides a simple, in vivo 
system in which to investigate the molecular mechanism of Tll and its vertebrate counterpart 
TLX. The genetic tools available in Drosophila allowed me to follow cell fate changes during 
normal development and upon manipulation of Tll. I found that in the absence of Tll type II 
neuroblasts switch to a more restricted progenitor and, conversely, high levels of Tll initiate 
tumours from intermediate progenitors. The cell fate changes that resulted in tumourigenesis 
were conserved with human TLX and suggest that intermediate progenitors could be one 




Materials and methods 
 
Statement on collaboration: Embryo and larval immunostaining protocols for the data 
presented in Chapter 5 were performed in collaboration with Dr Leo Otsuki (contribution to 
each figure in Chapter 5 is indicated in the figure legends). Thanks go to Dr Robert Krautz for 
the bioinformatic analysis of the Tll Targeted DamID sequencing data using his unpublished 
“DamPy” pipeline (section 7.4.2). 
 
7.1 Fly stocks and husbandry 
Drosophila melanogaster were reared in cages at 25 ˚C. Embryos were collected on yeasted 
apple juice plates and stages according to (Campos-Ortega and Hartenstein, 1985). For larval 
experiments, larvae were picked within one hour of hatching and dissected (designated 0 
hours after larval hatching (ALH) or transferred to yeasted food plates and reared at 25 ˚C to 
the desired stage before dissection. Animals for RNAi experiments were transferred to 29 ˚C 
ALH to improve the efficacy of RNAi. For experiments involving GAL80ts, embryos were 
kept at 18 ˚C until hatching (or the time point specified) and then transferred to 29 ˚C before 
dissection. Full details of the genotypes and temperature conditions for each experiment are 
given in Appendix 3. 
 
7.1.1 GAL4 driver lines 
The following GAL4 lines were used: Ay-GAL4 (BL3953), Ay-GAL4,UAS-GFP (BL4411), 
Ay-GAL4,UAS-lacZ (BL4410), btd-GAL4(Xie et al., 2014), GAL4c855a (Manseau et al., 
1997), GMR9D11-GAL4 (Pfeiffer et al., 2008; Weng et al., 2010) (BL40731), GMR29C07-
GAL4 (BL49340),   GMR31D09-GAL4 (BL49676), GMR39A01-GAL4 (BL45667), 
GMR31F04-GAL4 (BL46187), GMR31H09-GAL4 (BL49694), GMR71C09-GAL4 
(BL39575), pntP114-94-GAL4 (Zhu et al., 2011), VGlutOK371-GAL4 (BL26160), VT151-GAL4 
(VDRC 206052) VT152-GAL4 (VDRC 207542), VT153-GAL4 (VDRC 212933), VT156-
GAL4 (VDRC 208104), VT157-GAL4 (VDRC 207543), VT158-GAL4 (VDRC 213852), 
VT159-GAL4 (VDRC 205796), wg[ND382]-GAL4 (Gerlitz and Basler, 2002), wor-GAL4 
(BL56553). tub-GAL80ts (BL7018) was used to restrict GAL4 activity to larval stages as 
indicated. 
 
7.1.2 UAS-driven transgenes 
The following UAS-transgenes were used: UAS-ase (Brand et al., 1993), UAS-brat-RNAi 
(BL34646), UAS-FLP (BL4539 and BL4540), G-TRACE (BL28280), UAS-lacZ (βg4-1-2) 
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(Brand and Perrimon, 1993), UAS-mCD8-GFP (BL5130 and BL5137), UAS-mCD8-
mCherry (BL27391), UAS-myr-mRFP (BL7118 and BL7119), UAS-LT3-NDam (Southall et 
al., 2013), UAS-LT3-NDam-tll (this study), UAS-tll-miRNA[s] (Lin et al., 2009), UAS-tll-
shRNA (VDRC 330031), UAS-tll (Kurusu et al., 2009) Kyoto Stock Center 109-680), UAS-
TLX  (this study). w1118; +; + was used as a reference stock. 
 
7.1.3 Reporter lines 
The following genetic reporter lines were used: 9D11-lacZ (Haenfler et al., 2012), dpp-
lacZExel.2 (BL8411), hh::lacZ (hhP30) (Lee et al., 1992), mγ-GFP (Almeida and Bray, 2005), 
(miR-7)E>GFP (Li et al., 2009), pnt-GFP (BL42680), R9D11-mCD8-GFP (Zhu et al., 2011), 
R9D11-CD4-tdTomato (Han et al., 2011), tll-lacZ (Liaw and Lengyel, 1992), tll-EGFP 
(Venken et al., 2009) (BL30874), and wg-lacZ (1-en-11) (Kassis et al., 1992). 
 
7.1.4 MARCM clones 
For tlll49 mutant clones, virgin female flies carrying hsFLP122; wor-GAL4,UAS-mCD8-
mCherry/(CyOact-GFP); FRT82B,tub-GAL80 were crossed to male flies carrying w; 9D11-
lacZ; FRT82B or w; 9D11-lacZ; FRT82B, tlll49/TM6B. For ase1 mutant clones, male flies 
carrying FRT19A,tub-GAL80,hsFLP1; wor-GAL4,UAS-mCD8-mCherry, R9D11-mCD8-
GFP/(CyO act-GFP); + were crossed to virgin female flies carrying FRT19A; +; + or 
FRT19A, ase1/(FM7Dfd-YFP); +; +. Embryos were collected on apple juice plates at 25 ˚C 
and newly hatched larvae were transferred to yeasted food plates and raised at 25 ˚C. Clones 
were induced by a heat shock in a water bath (5 minutes 37 ˚C, 5 minutes rest at room 
temperature, 1 hour 37 ˚C) at 24 hours ALH and larvae were dissected 72 hours later. 
 
7.1.5 FLEXAMP lineage tracing 
To perform lineage tracing using FLEXAMP, virgin female flies carrying yw; tub-
GAL80ts,UAS-FLP; act >y+> LHv2-86Fb,DeltaRFP/(SM5^TM6B) were crossed to male 
flies carrying w; 13XLexAop2-mCD8-GFP, tub-GAL80ts/CyO act-GFP; GMR31H09-GAL4. 
To label EONs at hatching, embryos were collected on apple juice plates at room temperature 
(~20 ˚C), transferred to 29 ˚C and larvae were dissected 0-2 hours after hatching. Embryos 
were collected on apple juice plates at room temperature (~20 ˚C) and transferred to 29 ˚C 
until larval hatching. New hatched larvae were transferred to yeasted food plates and reared at 
18 ˚C until eclosion (adult flies dissected 1-3 days after eclosion). yw; tub-GAL80ts,UAS-
FLP; act >y+> LHv2-86Fb,DeltaRFP/(SM5^TM6B) flies (Bertet et al., 2014; Yagi et al., 
2010) were provided by Ryota Yagi. Additional fly lines were obtained from Bloomington 
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Drosophila Stock Centre: 13XLexAop2-mCD8-GFP (BL32205), tub-GAL80ts (BL7019), and 
GMR31H09-GAL4 (BL49694). 
 
7.2 Protocols for imaging techniques 
7.2.1 Embryo fixation and immunostaining  
Embryos were transferred from apple juice plates into a nitex basket by washing with distilled 
H2O (dH2O). Embryos were dechorionated in 50 % bleach/dH2O for three minutes, rinsed 
with dH2O, and then fixed on a rolling shaker for 20 minutes in a 6ml glass bottle containing 
3ml of 4 % formaldehyde/phosphate-buffered saline (PBS) and 3ml heptane. After fixation, 
the lower (formaldehyde/PBS) phase of the fixing solution was removed and replaced with 3 
ml methanol. Embryos were shaken vigorously and sunken embryos were transferred to clear 
1.5 ml Eppendorf tubes. Embryos were washed three times with 1 ml methanol and could be 
stored in methanol at -20 ˚C before proceeding to immunostaining protocol.  
 
Fixed embryos were re-hydrated in PBS with 0.3 % Triton X-100 (PBTx) (three five minute 
washes at room temperature) and blocked on a shaker for at least 15 minutes in 10 % normal 
goat serum/PBTx. Embryos were incubated overnight at 4 ˚C with primary antibodies diluted 
in 0.3 % PBTx. See Table 7.1 for details of primary antibodies used. Embryos were washed 
well with PBTx, then incubated overnight at 4 ˚C with secondary antibodies diluted in PBTx.  
 
Secondary antibodies conjugated to Alexa Fluor 405, Alexa Fluor 488, Alexa Fluor 568, 
Alexa Fluor Plus 647  (all 1 in 500, from Invitrogen) or DyLight-405 (1 in 100) Jackson 
Laboratories were used. Samples were washed with PBTx (three five minute washes) to 
remove excess secondary antibodies and then mounted in 50 % glycerol/PBS. 
 
7.2.2 Larval brain fixation and immunostaining 
Brains were dissected in PBS, fixed in 4 % formaldehyde/PBS for 20 minutes at room 
temperature and washed with PBTx for three five minute washes. Samples were blocked with 
10 % normal goat serum/PBTx for at least 15 minutes before overnight incubation with 
primary antibodies diluted in PBTx. See Table 7.1 for details of primary antibodies used. The 
next day, samples were washed with PBTx (three 15 minute washes) at room temperature 
before overnight incubation with secondary antibodies diluted in PBTx. Secondary antibodies 
conjugated to Alexa Fluor 405, Alexa Fluor 488, Alexa Fluor 546, Alexa Fluor 568, Alexa 
Fluor 633 (all 1 in 500, from Invitrogen) or DyLight-405 (1 in 200) Jackson Laboratories 
were used. Samples were washed with PBTx (three five minute washes) to remove excess 
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secondary antibodies and mounted in Vectashield (Vector Laboratories). 
 
7.2.3 Adult brain fixation and immunostaining 
Brains were dissected from 1-3 day old adult flies. Adult flies were anaesthetised with CO2 
and then placed in 100 % ethanol for 1 minute before dissecting brains in PBS. The fixation 
and staining protocol was performed as for larval brains (Section 7.2.2). 
 
Antibody name Host species Dilution Reference/Source 
anti-Ase Rabbit 1 in 2,000 Brand et al., 1993 
anti-Dpn Guinea pig 1 in 5,000 Caygill and Brand, 2017 
anti-Elav Rat 1 in100 DSHB (7E8A10 conc.) 
anti-GFP Chicken 1 in 2,000 abcam (ab13970) 
anti-Pros Mouse 1 in 30 DSHB (MR1A conc.) 
anti-Tll Rabbit 1 in 300 
Asian distribution centre for 
segmentation antibodies (Kosman et al., 
1998) 
anti-Erm Rabbit 1 in 50 Janssens et al., 2014 
anti-L’sc Guinea Pig 1 in 1,000 Hakes, Otsuki and Brand, 2018 
anti-L’sc Rat  Caygill and Brand, 2017 
anti-pH3 Rabbit 1 in 100 Merck Millipore (06-570) 
anti-pH3 Rat 1 in 200 abcam (ab10543) 
anti-FasII Mouse 1 in 20 DSHB (1D4 conc.) 
anti-CycA Rabbit 1 in 100 
Whitfield et al., 1990 (rb270) 
Kind gift of Yuu Kimata, University of 
Cambridge, UK 
anti-RFP Rabbit 1 in 1000 abcam (ab62341) 
anti-Eya Mouse 1 in 75 DSHB (10H6) 
anti-dVsx1 Guinea pig 1 in 1,000 Erclik et al., 2008 
anti-βGal Chicken 1 in 1,000 abcam (ab9361) 
anti-βGal Rabbit 1 in 10,000 MP Biomedicals (55976) 
anti-Optix Rabbit 1 in 500 Kenyon et al., 2005 
anti-Mira Rat 1 in 500 
Kind gift of Chris Q. Doe, University of 
Oregon, USA 
anti-Repo Rabbit 1 in 10,000 
Kind gift of Benjamin Altenhein, Unversity 
of Cologne, Germany 
anti-Futsch Mouse 1 in 50 DSHB (22C10) 
anti-Brp Mouse 1 in 10 DSHB (nc82) 
anti-PntP1 Rabbit 1 in 500 Alvarez et al., 2003 
Table 7.1: Primary antibodies used for immunostaining. 
 
7.2.4 tll RNA FISH 
A set of 38 Stellaris FISH probes was designed against the tll coding sequence and labeled 
with Quasar 570. Third instar larval brains were fixed in 4 % formaldehyde/PBS for 45 
minutes at room temperature and then permeabilized in 70 % ethanol/PBS for 6 hours at 4 ˚C. 
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Brains were washed with Wash Buffer (10 % formamide, 2 x nuclease free saline-sodium 
citrate (SSC)) for 5 minutes before being incubated with probes (125 nM) in Hybridisation 
Buffer (100 mg/mL dextran sulfate, 10 % formamide, 2 x SSC) overnight at 45 ˚C. Brains 
were washed with Wash Buffer and mounted in Vectashield (Vector Laboratories).  
 
7.2.5 Image acquisition and processing 
Fluorescent images were acquired using a Leica SP8 confocal microscope. Images were 
analysed using Fiji (Schindelin et al., 2012), which was also used to adjust brightness and 
contrast in images. Adobe Illustrator was used to compile figures.  
 
7.2.6 Quantification and statistical analysis 
GraphPad Prism version 7.00 for Mac OS X was used for statistical analysis. The 
Kolmogorov-Smirnov test was used to compare samples with unequal variance and the 
Mann-Whitney U-test was used to compare samples with equal variance. Statistical analysis 
of data in Chapter 5 by Dr Leo Otsuki (indicated in figure legends) was performed using R. 
No data were excluded. 
 
7.3 Drosophila transgenesis 
7.3.1 Generation of UAS-TLX  
The coding sequence of human TLX (Jackson et al., 1998) was amplified from human cDNA 
prepared from H9 ESCs (kindly provided by Dr Tomoki Otani, Livesey Lab) using the 
primers Forward: 5’-agatgaattcATGAGCAAGCCAGCCGG-3’ and Reverse: 5’-
atgactcgagTTAGATATCACTGGATTTGTACATATCTGAAAGCAGTC-3’. PCR 
amplification was performed using the Q5 High-Fidelity DNA Polymerase PCR kit (New 
England BioLabs, NEB), as described below: 
 
PCR reaction mix     PCR programme 
Q5 Buffer (5X)  5 µl   Heated lid 105 ˚C 
dNTPs (10 mM)  0.5 µl   98 ˚C for 5 min 
Primers (10 µM mix)  1 µl   98 ˚C for 15 s   
Q5 DNA Polymerase  0.5 µl   60 ˚C for 30 s    40X 
cDNA    4 µl   72 ˚C for 2 min 15 s 
DEPC H2O   15 µl   72 ˚C 15 min 
    25 µl 
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PCR products were visualised using gel electrophoresis on a 1 % agarose gel and the band 
corresponding to human TLX was extracted using a QIAquick Gel Extraction Kit (Qiagen). 
The PCR product was cut with restriction enzymes EcoR1 and XhoI, purified using a 
QIAquick PCR Purification Kit (Qiagen), and ligated into cut pUAST-attB vector 
{Bischof:2007cb} with a T4 Ligase Kit (NEB). Transgenic flies carrying this construct were 
generated by germline injection of pUAST-attB-humanTLX into embryos carrying y,v, nos-
phiC integrase; attP40; + (BL25709) (Ringrose, 2009). 
 
7.3.2 Generation of UAS-LT3-NDam-tll 
The coding sequence of tll was amplified from an embryonic cDNA library using the primers 
Forward: 5’-cagaaactcatctctgaagaggatctgcgagatctaATGCAGTCGTCGGAGG-3’ and 
Reverse: 5’ acagaagtaaggttccttcacaaagatcctctagaTCAGATCTTGCGCTGACT 3’. PCR 
amplification was performed using the Phusion High-Fidelity PCR kit (NEB). 
 
PCR reaction mix     PCR programme 
Phusion HF Buffer (5x) 10 µl   Heated lid 110 ˚C 
dNTPs (10 mM)  1 µl   90˚C for 30 s 
Primers (10 µM mix)  2 µl   98 ˚C for 10 s 
Phusion Polymerase  1 µl   60 ˚C for 30s      35X 
cDNA    5 µl   72 ˚C for 2 min 15 s 
DEPC H2O   31 µl   72 ˚C 10 min 
    50 µl 
 
The amplified product was treated with Antarctic Phosphatase (NEB) at 37 ˚C for 1 hour, 
followed by heat inactivation at 70 ˚C for 5 minutes, and purified using a QIAquick PCR 
Purification Kit (Qiagen). pUASTattB-LT3-NDam (Southall et al., 2013) vector was cut with 
BglII and XbaI and then purified using a QIAquick Gel Extraction Kit (Qiagen). Ligation of 
the amplified tll coding sequence into cut pUASTattB-LT3-NDam was performed using 
Gibson Assembly Master Mix (NEB), as per manufacturer’s instructions. Transgenic flies 
carrying this construct were generated by germline injection of pUASTattB-LT3-NDam-tll 




7.4 Targeted DamID 
7.4.1 Drosophila genetics for Targeted DamID 
Virgin female flies carriying dpn>KDRTs-stop-KDRTs>GAL4; ase-GAL80/CyOact-GFP; + 
were crossed to male flies carrying w; UAS-LT3-NDam-tll; stg14-kd or w; UAS-LT3-NDam; 
stg14-kd males. Embryos were collected on yeasted apple juice plates at 25 ˚C and larvae 
were transferred to yeasted food plates within an hour of hatching. Larvae were reared at 25˚C 
and dissected 50 hours ALH (to match conditions from (Yang et al., 2016)). dpn>KDRTs-
stop-KDRTs>GAL4 and stg14-kd flies (Yang et al., 2016) were provided by Tzumin Lee and 
ase-GAL80 flies (Neumüller et al., 2011) by Jurgen Knoblich . 
 
7.4.2 Targeted DamID protocol 
An average of 45 larval brains were dissected for each Targeted DamID replicate and stored 
at -80 ˚C. The protocol for Targeted DamID for use with next-generation sequencing (NGS) 
was performed as described in (Marshall et al., 2016). Genomic DNA was extracted from 
dissected brains using the QIAamp DNA Micro Kit (Qiagen) and eluted in 50 µl AE buffer. 
43.5 µl of genomic DNA was incubated 5 µl CutSmart Buffer (NEB) and 1.5 µl DpnI enzyme 
(NEB) overnight at 37 ˚C to cut methylated GATC sites. DNA was purified using a QIAquick 
PCR Purification Kit (Qiagen) and eluted in 32 µl DEPC H2O. 15 µl of DNA was incubated 
with 4 µl Adaptor Ligation Buffer (0.8 µl adaptors (50 µM); 2 µl T4 Ligase Buffer (NEB), 
1.2 µl DEPC H2O) and 1 µl T4 DNA Ligase (NEB) at 16 ˚C for 2 hours, followed by heat 
inactivation at 65 ˚C for 10 minutes. Samples were incubated with 19 µl DpnII Buffer (NEB) 
and 1 µl DpnII enzyme (NEB) at 37 ˚C for 2 hours to cut unmethylated GATC sites, followed 
by heat inactivation at 65 ˚C for 20 minutes. DNA was purified using Sera-Mag SpeedBeads 
(Fisher Scientific) as per manufacturer’s instructions and eluted in 30 µl DEPC H2O.18.5 µl 
MyTaq Master Mix (10 µl 5X MyTaq Reaction Buffer (Bioline); 2.5 µl 50 µM DamID-PCR 
primers; 6 µl DEPC H2O) and 1.5 µl MyTaq HS DNA Polymerase (Bioline) was added to 
each 30 µl sample and the following PCR programme was run. 
 
DamID PCR Programme 
Heated lid 110 ˚C 
72 ˚C for 10 min 
95 ˚C for 30 s 
65 ˚C for 5 min 
72 ˚C for 15 min 
-- 
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95 ˚C for 30 s 
65 ˚C for 1 min 3X 
72 ˚C for 10 min 
-- 
95 ˚C for 30 s 
65 ˚C for 1 min 17X 
72 ˚C for 2 min 
-- 
72 ˚C for 5 min 
 
Amplified DNA was purified using a QIAquick PCR Purification Kit (Qiagen) and eluted in 
32 µl of DEPC H2O. 2 µg of DNA was added to 10 µl CutSmart Buffer (NEB) and made up 
to 100 µl total volume with DEPC H2O. Samples were sonicated using a Bioruptor 
(Diagenode) on high power for 8 cycles (30 s on; 30 s off) to achieve an average fragment 
size of ~300 bp and then incubated with 1 µl of Awl1 enzyme overnight at 37 ˚C to cleave off 
DamID adaptors. 
 
To begin library preparation, DNA was purified using Sera-Mag SpeedBeads (Fisher 
Scientific) as per manufacturer’s instructions and eluted in 25 µl Resuspension Buffer (10 
mM Tris-HCl, pH 8; 0.1 mM EDTA). 200 ng DNA (in 20 µl Resuspension Buffer) was 
incubated with 7.5 µl End Repair Buffer (3 µl 10X T4 Ligase Buffer (NEB); 1.2 µl 10 mM 
dNTPs; 3.3 µl DEPC H2O) and 2.5 µl End Repair Enzymes (1.14 µl T4 DNA Polymerase 
(NEB); 0.23 µl Klenow Fragment (NEB); 1.14 µl T4 Polynucleotide Kinase (NEB)) at 30 ˚C 
for 30 minutes, followed by heat inactivation at 75 ˚C for 20 minutes. Samples were 
incubated with 0.75 µl Klenow 3′–5′ exo-enzyme (NEB) at 37 ˚C for 30 minutes and then 
incubated with 2.5 µl of the relevant sequencing adaptor and 2.5 µl Quick Ligase enzyme 
(NEB) at 30 ˚C for 10 minutes before the addition of 5 µl Stop Buffer (0.5 M EDTA). DNA 
was purified using Sera-Mag SpeedBeads (Fisher Scientific) as per manufacturer’s 
instructions and eluted in 50 µl Resuspension Buffer, followed by a second Sera-Mag 
SpeedBeads purification with sample elution in 22.5 µl Resuspension Buffer. DNA fragments 
were enriched by a final PCR step; 20 µl of sample was added to 5 µl PCR Primer Cocktail 
(25 µl 100 µM PCR1 primer; 25 µl 100 µM PCR2 primer; 50 µl DEPC H2O) and 25 µl 




Fragment enrichment PCR programme 
98 ˚C for 30 s 
98 ˚C for 10 s 
60 ˚C for 30 s          6X 
72 ˚C for 30 s 
72 ˚C for 5 min 
 
Amplified fragments were purified using Sera-Mag SpeedBeads (Fisher Scientific) as per 
manufacturer’s instructions and eluted in 30 µl Resuspension Buffer before multiplexing 
libraries for NGS sequencing. DNA sequencing was performed by the Gurdon Institute NGS 
Core using an Illumina HiSeq 1500.  
 
7.4.3 Targeted DamID analysis 
Tll-Dam read counts were normalized to Dam-only read counts to generate Tll binding 
profiles; bioinformatic analysis was performed by Dr Robert Krautz  (using the “DamPy” 
pipeline, Krautz and Brand, in preparation). The Integrative Genomics Viewer (IGV, version 
2.3.68) was used to visualise binding tracks aligned to release 6 of the Drosophila genome. 
Figures were compiled in Adobe Illustrator, in which Tll binding (Tll-Dam/Dam) was 
represented as scores in GATC fragments on an untransformed scale (y-axis). DamID peaks 
were identified using customized scripts based on MACS2 by Dr Robert Krautz. Peaks were 
determined at a threshold q-value (q = 1/1050) and were only considered if they occurred in 
more than half of all replicates. Peaks were represented as maximum coordinates of the 
overlapping peaks across replicates and were associated with the ‘nearest neighbour’-genes 
via bedtools to determine Tll target genes (the full gene list is provided as Appendix 2). 
 
Gene Ontology (GO) analysis was conducted using GO::TERMFINDER (Boyle et al., 2004) 
and the top ten GO terms are shown in Table 3.1. Drosophila orthologues of mouse TLX 
target genes were identified using DIOPT (Drosophila RNAi Screening 
Center Integrative Ortholog Prediction Tool) (Hu et al., 2011). Orthologues bound by Tll in 







Appendix 1:  
Sequence conservation between human TLX and Drosophila Tll 
 
Sequence alignment of human TLX (hTLX) (Jackson et al., 1998) and Drosophila Tll (dTll) 
performed using EMBOSS Needle and UniProt alignment tools. The DBD consists of a P box, D box, 
T/A box. Amino acid residues of the LBD required for Atrophin binding are highlighted in bold. 
Sequence comparison is annotated with: “*” for identical amino acids; “:” for conserved substitutions; 
“.” for semi-conserved substitutions. 
hTLX 0 - - - - - - - - - - - - - - - - - M S K P A G S T S R I L - D I P C K V C G D R 22
: . : : * * * * . : * * * * * * :
dTll 0 M Q S S E G S P D M M D Q K Y N S V R L S P A A S S R I L Y H V P C K V C R D H 40
hTLX 23 S S G K H Y G V Y A C D G C S G F F K R S I R R N R T Y V C K S G N Q G G C P V 62
* * * * * * * : * * * * * * : * * * * * * * * * . * * * * * * : * * * *
dTll 41 S S G K H Y G I Y A C D G C A G F F K R S I R R S R Q Y V C K S Q K Q G L C V V 80
hTLX 63 D K T H R N Q C R A C R L K K C L E V N M N K D A V Q H E R G P R T S T I R K Q 102
* * * * * * * * * * * * * : * * : * * . * * * * * * * * * * * * * . * * : * : :
dTll 81 D K T H R N Q C R A C R L R K C F E V G M N K D A V Q H E R G P R N S T L R R H 120
hTLX 103 V A L Y F R G H K E E N - - - - - - - - - - - - - G A A A H F P S A A L P A P A 129
: * : * . . . * : * * . . : * * .
dTll 121 M A M Y K D A M M G A G E M P Q I P A E I L M N T A A L T G F P G V P M P M P G 160
hTLX 130 F F T A V T Q L E P H G L E L A A V S T T P E R Q T L V S L - - - - - - - - - - 159
: . : * . : * * . . * . : : : . *
dTll 161 L P Q R A G H - - - H P A H M A A F Q P P P S A A A V L D L S V P R V P H H P V 197
hTLX 160 - - - - - - - A Q P T P K Y P H E V N - - G T P M Y L Y E V A T E S V C E S A A 190
. * * * : : . * : * : * : * : * *
dTll 198 H Q G H H G F F S P T A A Y M N A L A T R A L P P T P P L M A A E H I K E T A A 237
hTLX 191 R L L F M S I K W A K S V P A F S T L S L Q D Q L M L L E D A W R E L F V L G I 230
. * * . : : * * * * * * : * : * * * : * * * : : * : * : * : * . :
dTll 238 E H L F K N V N W I K S V R A F T E L P M P D Q L L L L E E S W K E F F I L A M 277
hTLX 231 A Q W A I P V D A N T L L A V S G M N G D N T D S Q K L N K I I S E I Q A L Q E 270
* * : : * : : * * * : * : : : : . : * : : * : * *
dTll 278 A Q Y L M P M N F A Q L L F V Y E S - - E N A N R E I M G M V T R E V H A F Q E 315
hTLX 271 V V A R F R Q L R L D A T E F A C L K C I V T F K A V P - - - - - - - - - - - - 298
* : : : : * . : * : * * : * * : . * * : *
dTll 316 V L N Q L C H L N I D S T E Y E C L R A I S L F R K S P P S A S S T E D L A N S 355
hTLX 299 - - - T H S G S - - - - - - - E L R S F R N A A A I A A L Q D E A Q L T L N S Y 328
* * * * * * . : : : . : * * : : : : * : : * : . *
dTll 356 S I L T G S G S P N S S A S A E S R G L L E S G K V A A M H N D A R S A L H N Y 395
hTLX 329 I H T R Y P T Q P C R F G K L L L L L P A L R S I S P S T I E E V F F K K T I G 368
* : : * : * * * * . * * : : : : . : * * * * * : * * : * * * *
dTll 396 I Q R T H P S Q P M R F Q T L L G V V Q L M H K V S S F T I E E L F F R K T I G 435
hTLX 369 N V P I T R L L S D M Y K S S D I 385
: : * . * * : * * * * . . . *
dTll 436 D I T I V R L I S D M Y S Q R K I 452


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Drosophila genotypes and temperature conditions 
 
Figure Panel GAL4 line Crossed to Temperature 
Fig. 2.1 C – E w; +; pntP1-GAL4 w; tll-EGFP,UAS-myr-
mRFP/(CyOact-GFP); + 
25 ˚C 
 F – 
G’ 
N/A w; +; tll-lacZ 25 ˚C 
Fig. 2.2 A – B yw,UAS-mCD8-GFP; 
pntP1-GAL4 
N/A 25 ˚C 
Fig. 2.3 B w; +; GMR39A01-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 C w; +; GMR31H09-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 D w; +; GMR31F04-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 E w; +; GMR31D09-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 F w; +; VT151-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 G w; +; VT152-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 H w; +; VT153-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 I w; +; VT156-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 J w; +; VT157-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 K w; +; VT158-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 L w; +; VT159-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
Fig. 2.4 B w; +; GMR31F04-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 C w; +; VT153-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 D w; +; VT151-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 E w; +; VT159-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
Fig. 2.5 C, C’ w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; + 
18 ˚C until 
hatching, 
shift to 29 ˚C 
for 3 days 
 D, D’ w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
tll-shRNA: w; tll-shRNA; + 
18 ˚C until 
hatching, 
shift to 29 ˚C 
for 3 days 




w; 9D11-lacZ; FRT82B 25 ˚C 
37 ˚C heat 
shock 24 
hours ALH 




w; 9D11-lacZ; FRT82B,tlll49 25 ˚C 
37 ˚C heat 
shock 24 
hours ALH 
Fig. 2.7 A yw,UAS-mCD8-GFP; 
pntP1-GAL4 
w; +; R9D11-CD4-tdTomato 25 ˚C 





w; +; UAS-FLP 25 ˚C until 
hatching then 
shift to 29 ˚C 
 D, D’ w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4 
w; +; UAS-FLP 25 ˚C until 
hatching then 
shift to 29 ˚C 
Fig. 2.8 A, C w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4,R9D11-
CD4-tdTomato 
Control: w; +; UAS-FLP 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; UAS-FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 
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 B w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4 
Control: w; +; UAS-FLP 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; UAS-FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 
 D(i) w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4,R9D11-
CD4-tdTomato 
Control: w; +; UAS-FLP 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; UAS-FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 







25 ˚C until 
hatching then 
shift to 29 ˚C 
Fig. 2.9 B w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w; UAS-lacZ; UAS-
mCD8-GFP 
brat RNAi: w; UAS-lacZ; 
UAS-brat-RNAi 
brat RNAi and tll-miRNA[s]: 
w; UAS-tll-miRNA[s]; UAS-
brat-RNAi 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 2.10 A – B w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4,R9D11-
CD4-tdTomato 
Control: w; +; UAS-FLP 
Ase OE: w; UAS-ase; UAS-
FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 
 C w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4,R9D11-
CD4-tdTomato 
Control: w; +; UAS-FLP 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; UAS-FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 
Fig. 3.2 A w; +; pntP1-GAL4 yw; UAS-mCD8-GFP; + 25 ˚C 
 B btd-
GAL4,FRT19A/FM7act-
GFP; +; + 
yw; UAS-mCD8-GFP; + 25 ˚C 
Fig. 3.3 B dpn>KDRTs-stop-




















25 ˚C until 
hatching then 
shift to 29 ˚C 
Fig. 3.7 B, E w; Ay-GAL4,UAS-GFP; 
pntP1-GAL4,R9D11-
CD4-tdTomato 
Control: w; +; UAS-FLP 
tll-miRNA[s]: w; UAS-tll-
miRNA[s]; UAS-FLP 
25 ˚C until 
hatching then 
shift to 29 ˚C 
Fig. 4.1 B, C btd-
GAL4,FRT19A/FM7act-
GFP; +; tub-GAL80ts 
w; R9D11-mCD8-GFP; UAS-
myr-mRFP/TM6B 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 4.2 A btd-
GAL4,FRT19A/FM7act-
GFP; +; tub-GAL80ts 
Control: w; R9D11-mCD8-
GFP; UAS-myr-mRFP/TM6B 
Tll OE: w; R9D11-mCD8-
GFP; UAS-tll,UAS-myr-
mRFP/TM6B 
18 ˚C until 
hatching 




GFP; +; tub-GAL80ts 
Control: w; +; UAS-myr-
mRFP/TM6B 
Tll OE: w; +; UAS-tll,UAS-
myr-mRFP/TM6B 
18 ˚C until 
hatching 
then shift to 
29 ˚C 




Control: w1118; +; + 




















Tll OE: w; UAS-FLP/(CyOact-
GFP); UAS-tll/(TM6B) 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 4.8 A – B’ w; +; GMR9D11-
GAL4,UAS-mCD8-GFP 
Control: w1118; +; + 
TLX OE: w; UAS-TLX; + 
25 ˚C 










Fig. 4.10 C w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
18 ˚C for 6 
days 
then shift to 
29 ˚C until 
eclosion 
 D w; wor-GAL4,R9D11-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 4.11 A-A’’’ w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 4.12 A – B w; wor-GAL4; tub-
GAL80ts 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
18 ˚C for 6 
days 
then shift to 
29 ˚C for 24 
hours 
 C – F  btd-
GAL4,FRT19A/FM7act-
GFP; +; tub-GAL80ts 
Control: w; +; UAS-myr-
mRFP/TM6B 
Tll OE: w; +; UAS-tll,UAS-
myr-mRFP/TM6B 
18 ˚C for 6.5 
days 
then shift to 
29 ˚C for 16 
hours 










37 ˚C heat 
shock 24 
hours ALH 
Fig. 4.14 A – B btd-
GAL4,FRT19A/FM7act-
GFP; +; tub-GAL80ts 
Control: w; +; UAS-myr-
mRFP/TM6B 
Tll OE: w; +; UAS-tll,UAS-
myr-mRFP/TM6B 
18 ˚C until 
hatching 





Fig. 4.15 A – C w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w; UAS-lacZ; UAS-
mCD8-GFP 
Tll OE: w; UAS-lacZ/(CyOact-
GFP); UAS-tll/(TM6B) 
Ase rescue: w; UAS-
ase/(CyOact-GFP); UAS-
tll/(TM6B) 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
Fig. 4.16 A w; +; GMR71C09-
GAL4, UAS-mCD8-GFP 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
25 ˚C 
 B w; vGlut-GAL40k371, 
UAS-mCD8-GFP, 
FRTG13/(CyO); + 
Control: w1118; +; + 
Tll OE: w; +; UAS-tll/(TM6B) 
25 ˚C 
Fig. 4.17 A – C w; wor-GAL4,UAS-
mCD8-GFP; tub-
GAL80ts 
Control: w1118; +; + 
TLX OE: w; UAS-TLX; + 
18 ˚C until 
hatching 
then shift to 
29 ˚C 
 D w; +; GMR71C09-
GAL4, UAS-mCD8-GFP 
Control: w1118; +; + 
TLX OE: w; UAS-TLX; + 
25 ˚C 
 E w; vGLUT-GAL40k371, 
UAS-mCD8-GFP, 
FRTG13/(CyO); + 
Control: w1118; +; + 
TLX OE: w; UAS-TLX; + 
25 ˚C 
Fig. 5.2 A – 
C’’ 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 
Fig. 5.4 Ai-iii 
Ci-iii 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 
Fig. 5.5 A, C 
Ei-iii 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 
 B, B’ w; +; GMR31H09-GAL4 w; R9D11-mCD8-GFP; UAS-
myr-mRFP/TM6B 
25 ˚C 
Fig. 5.6 C N/A w; R9D11-mCD8-GFP; + 25 ˚C 
 D, D’ N/A w; +; R9D11-CD4-tdTomato    
x  yw,hsFLP122; Sp/CyO; 
hh[p30]/(TM2) 
25 ˚C 




 F N/A w; R9D11-mCD8-GFP; + 25 ˚C 
 G N/A w; R9D11-mCD8-GFP; +    x 
yw; dpp-lacZ.Exel.2; + 
25 ˚C 
Fig. 5.7 B N/A w; R9D11-mCD8-GFP; + 25 ˚C 
 C, C’ N/A w1118; pnt-GFP.FPTB; + 25 ˚C 
 D N/A w; +; 
P{(miR7)EGFP}38R/TM6B 
25 ˚C 
 E, E’ N/A w; +; mγ-GFP/(TM6B) 25 ˚C 
Fig. 5.8 A – 
D’ 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 









Fig. 5.10 A, A’ 
C – D 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 
Fig. 5.11 A – 
Cii 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 
Fig. 5.12 A w; +; R9D11-
GAL4,UAS-mCD8-GFP 
w; +; Fz3-RFP/(TM6B) 25 ˚C 
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29 ˚C until 
hatching then 
shift to 18 ˚C 
Fig. 5.13 Ai, Aii N/A w; R9D11-mCD8-GFP; + 25 ˚C 
Fig. 5.14 A – 
D’ 
N/A w; R9D11-mCD8-GFP; + 25 ˚C 











 D N/A w; R9D11-mCD8-GFP; + 25 ˚C 




STEM CELLS AND REGENERATION RESEARCH REPORT
A newly discovered neural stem cell population is generated
by the optic lobe neuroepithelium during embryogenesis
in Drosophila melanogaster
Anna E. Hakes‡, Leo Otsuki*,‡ and Andrea H. Brand§
ABSTRACT
Neural stem cells must balance symmetric and asymmetric cell
divisions to generate a functioning brain of the correct size. In both the
developingDrosophila visual system andmammalian cerebral cortex,
symmetrically dividing neuroepithelial cells transform gradually into
asymmetrically dividing progenitors that generate neurons and glia.
As a result, it has been widely accepted that stem cells in these
tissues switch from a symmetric, expansive phase of cell divisions to
a later neurogenic phase of cell divisions. In theDrosophila optic lobe,
this switch is thought to occur during larval development. However,
we have found that neuroepithelial cells start to produce neuroblasts
during embryonic development, demonstrating a much earlier role for
neuroblasts in the developing visual system. These neuroblasts
undergo neurogenic divisions, enter quiescence and are retained
post-embryonically, together with neuroepithelial cells. Later in
development, neuroepithelial cells undergo further cell divisions
before transforming into larval neuroblasts. Our results demonstrate
that the optic lobe neuroepithelium gives rise to neurons and glia over
60 h earlier than was thought previously.
KEY WORDS: Neural stem cell, Neuroepithelium, Neuroblast,
Stem cell divisions, Symmetric/Asymmetric division, Brain
INTRODUCTION
Neural stem cells in the developing brain must regulate their
proliferation precisely to generate a functional nervous system. An
imbalance between symmetric and asymmetric stem cell divisions
can lead to the inadequate production of differentiated progeny or,
conversely, to tumour formation. Importantly, work in Drosophila
has shown that specific brain tumours arise from the mis-regulation
of distinct populations of neural stem cells. In brain tumour (brat)
mutants, asymmetrically dividing Type II neuroblasts generate
aberrant lineages, whereas symmetrically dividing neuroepithelial
cells are the tumour cells of origin in lethal(3)malignant brain
tumour [l(3)mbt] mutants (Bowman et al., 2008; Richter et al.,
2011). Thus, identifying different types of neural stem cells and
their functions is central to understanding both normal brain
development and the diverse causes of tumourigenesis.
The Drosophila optic lobe, which forms the visual processing
system of the adult brain, is an established system for studying
neural stem cells in vivo (Egger et al., 2011). The development of the
medulla, the largest visual ganglion, shares many parallels with the
development of the mammalian cerebral cortex (Brand and Livesey,
2011; Egger et al., 2011). In both tissues, symmetrically dividing
neural stem cells (neuroepithelial cells) expand the stem cell pool
before transforming into asymmetrically dividing neural stem cells
(also called neuroblasts in Drosophila) that produce neurons and
glia (Fig. S1A) (Egger et al., 2007; Noctor et al., 2004). Previous
studies of neuroepithelial cells and neuroblasts in the optic lobe have
focussed largely on larval stages (Egger et al., 2011, 2010; Yasugi
et al., 2010, 2008). Neuroepithelial cells divide symmetrically
in the early larva before a proneural wave sweeps across the
neuroepithelium at mid-larval stages, converting neuroepithelial
cells into neuroblasts (Yasugi et al., 2008). Here, we demonstrate
that this transition begins much earlier, and that neuroepithelial cells
and neuroblasts co-exist from embryonic stages.
RESULTS AND DISCUSSION
Neuroepithelial cells divide in the embryo
The optic lobe primordium is first apparent as a dense patch of cells
in the head ectoderm of stage 11 embryos (Hartenstein and Campos-
Ortega, 1984; Poulsen, 1950; Turner and Mahowald, 1979). These
cells undergo four cell divisions before invaginating from the
ectoderm as a neuroepithelial sheet and attaching to the lateral
surface of the brain between embryonic stages 12 and 13 (Fig. 1A)
(Green et al., 1993).
Neuroepithelial cells can be identified by their expression of
Fasciclin II (FasII), the orthologue of neural cell adhesion molecule
(NCAM) (Grenningloh et al., 1991; Younossi-Hartenstein et al.,
1997). To determine the proliferation pattern of neuroepithelial cells
in the embryo, we co-stained for FasII and the cell division marker
phospho-histone H3 (pH3). We found pH3+ neuroepithelial cells at
all developmental stages between optic primordium invagination
and the end of embryogenesis (Fig. 1Bi-iii and Fig. S1B). Thus, the
neuroepithelium divides throughout embryogenesis, in contrast to a
previous suggestion that the optic primordium is dormant in the
embryo (Green et al., 1993).
Why was the embryonic neuroepithelium suggested to be
dormant? BrdU incorporation assays had shown that
neuroepithelial cells do not undergo S phase after invagination
(Green et al., 1993). We tested the phase of the cell cycle in which
neuroepithelial cells reside as they undergo invagination. We
assessed expression of Cyclin A (CycA), a G2-phase cyclin protein,
and found that neuroepithelial cells were all CycA+ when theyReceived 29 March 2018; Accepted 24 August 2018
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invaginated from the ectoderm (Fig. 1Ci). Neuroepithelial cells lost
CycA expression over time, concomitant with cell divisions, until
they were all CycA− at the end of embryogenesis (Fig. 1Ci-iii).
Thus, we found that neuroepithelial cells invaginate in G2 before
dividing, explaining both our results and previous observations
(Green et al., 1993). As neuroepithelial cells do not undergo S phase
in the embryo after invagination (Green et al., 1993), we infer that
they divide once each (Fig. 1F).
The embryonic neuroepithelium generates neuroblasts
We next assessed the role of neuroepithelial cell divisions in the
embryo. We found no significant increase in the number of
neuroepithelial cells over time (Fig. S1C), indicating that these cell
divisions do not serve to increase the size of the neuroepithelium.We
therefore tested whether the embryonic neuroepithelium produces
neuroblasts, in a similar manner to the late larval neuroepithelium.
We stained for the Hes family transcription factor Deadpan
(Dpn), which labels all identified neuroblasts in the Drosophila
brain (Bier et al., 1992). We found Dpn+ cells in close proximity to
the neuroepithelium beginning at embryonic stage 12 (Fig. 1D). To
test the lineage relationship between neuroepithelial cells and these
neuroblasts, we expressed red fluorescent protein (RFP) in the
neuroepithelium and assessed whether RFP was inherited by the
Dpn+ cells. Interestingly, we found that GAL4c855a and ogre-GAL4,
two GAL4 drivers that label the larval neuroepithelium (Dillard
et al., 2018; Egger et al., 2007), did not express in the embryonic
neuroepithelium (data not shown). We therefore identified a GAL4
driver, R31H09-GAL4, that labels the embryonic neuroepithelium
(Fig. 1E). When we expressed RFP using R31H09-GAL4, we found
that RFP was inherited by the Dpn+ cells (Fig. 1E). We conclude
that the embryonic neuroepithelium produces neuroblasts, and refer
to these neuroblasts as EONs (embryonic optic neuroblasts).
We identified a ∼4 kb fragment of the earmuff (erm) enhancer
(R9D11) that drives expression in EONs consistently, allowing us to
track the production of EONs from the embryonic neuroepithelium.
(Fig. 1E′). Using R9D11-mCD8-GFP (R9D11 driving expression
Fig. 1. Embryonic neuroepithelial cells divide
and generate EONs. (A) Schematic depicting
the position of the neuroepithelium (purple) as it
invaginates from the head ectoderm and attaches
to the side of the brain lobe in the embryo. A,
anterior; P, posterior; D, dorsal; V, ventral.
(Bi-iii) Neuroepithelial cells (FasII+, white)
co-stained for the mitosis marker pH3 (red) at the
indicated embryonic stages. Arrowheads indicate
dividing neuroepithelial cells. (Ci-iii)
Neuroepithelial cells (white) co-stained for the
S/G2 cyclin CycA (blue) at the indicated embryonic
stages. Neuroepithelial cells lose CycA expression
progressively. Arrowheads in Cii indicate individual
neuroepithelial cells that express CycA. (D) Dpn+
cells (red, arrowed) appear in close proximity to the
neuroepithelium (white) during embryogenesis.
(E,E′) RFP expressed using R31H09-GAL4 (cyan
in E) labels the embryonic neuroepithelium (white
in E′). RFP is inherited by neighbouring Dpn+ cells
(red, arrowed). These Dpn+ cells express R9D11-
mCD8-GFP (green). (F) EON production from the
embryonic neuroepithelium. The optic primordium
invaginates while in G2 (CycA+, blue) to give rise to
the embryonic neuroepithelium. Neuroepithelial
cells undergo mitosis once, losing CycA
expression, to produce EONs (green and red).
Surface ectoderm cells are indicated in yellow.
Brain surface is downwards; interior is upwards.
(Bi-E′) Single section confocal images.
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of membrane-targeted GFP) (Pfeiffer et al., 2008; Zhu et al., 2011),
we found that EONs are produced continuously between stage 12
and stage 17 of embryogenesis, with a final number of 8.6±0.7
EONs per brain lobe (Fig. S1D,Ei-iii). EONs were first apparent in
the neuroepithelial layer (FasII+ Dpn+ R9D11+) and were extruded
medially into the brain, where they downregulated FasII expression
(Fig. S1Ei-iii). Importantly, our results demonstrate that
neuroepithelial cells produce neuroblasts much earlier (∼60 h
earlier) than thought previously (mid-larval stage) (Fig. 1F).
EONs derive from two spatial domains of the
neuroepithelium
We noticed that EONs were generated at specific discontinuous
points along the embryonic neuroepithelium. In the larval brain, the
neuroepithelium is patterned into spatial domains along the anterior-
posterior axis by expression of Vsx1, Optix, decapentaplegic (dpp)
and wingless (wg) (Fig. S2A) (Erclik et al., 2008; Gold and Brand,
2014; Kaphingst and Kunes, 1994; reviewed by Bertet, 2017). In
addition, the ventral (but not dorsal) half of the neuroepithelium
expresses hedgehog (hh) (Fig. S2A) (Chen et al., 2016; Evans et al.,
2009). All spatial domains of the neuroepithelium generate
neuroblasts in the larva. As we did not find a continuous band of
EONs in the embryo, we reasoned that they might arise from a
subset of spatial domains of the neuroepithelium.
We found that almost all EONs are produced by the Vsx1+
(central) domain of the embryonic neuroepithelium, straddling the
presumptive dorsal-ventral boundary (Fig. 2A-B, Fig. S2B,B′).
These EONs themselves expressed Vsx1 (Fig. 2B). We observed
that thewg+ tips of the neuroepithelium produce a minority of EONs
as assessed usingwg-LacZ, a reporter inserted at the endogenouswg
locus (Kassis et al., 1992) (Fig. S2C,C′). Thus, we conclude that the
central domain, and to a lesser extent the tips of the embryonic
neuroepithelium, produces neuroblasts. Interestingly, we found
no evidence for Optix or dpp expression in the embryonic
neuroepithelium (Fig. 2A, Fig. S2D-E′), suggesting that these
domains become patterned and start to produce neuroblasts later
in development.
The embryonic neuroepithelium expresses transition
zone markers
In the larval brain, neuroepithelial cells are transformed into
neuroblasts at a transition zone. The transition zone expresses the
proneural gene lethal of scute [l(1)sc] and the microRNAmiR-7 and
is regulated by signalling pathways, including the EGFR and Notch
pathways (Fig. S3A) (Caygill and Brand, 2017; Egger et al., 2010;
Yasugi et al., 2008, 2010). We found discrete regions of L(1)sc
expression in the embryonic neuroepithelium that corresponded
spatially with EON production (Fig. 2C). L(1)sc+ cells exhibited
many features of the larval transition zone: they were positive
for EGFR signalling (Fig. 2D-D′), had low Notch signalling
(Fig. 2E-E′) and expressed miR-7 (Fig. S3B). Consistent with
a neuroepithelium to neuroblast transition, EONs expressed the
neuroepithelial cell markers E-Cadherin (E-Cad) and FasII as they
were generated but later downregulated expression of these genes
(Fig. S3C-D″).
EONs generate neurons and glia
Neuroblasts in the larval brain divide asymmetrically to generate
intermediate progenitor cells (called ganglion mother cells,
GMCs) that, in turn, divide once to produce neurons and glia.
We found that, like larval neuroblasts, EONs were positive for
Wor (Worniu, Fig. S4A,A′) and Mira (Miranda, Fig. 3A,A′),
localised Pros (Prospero) and Mira asymmetrically at mitosis
(Ikeshima-Kataoka et al., 1997) (Fig. S4B,B′), and divided
asymmetrically to generate Dpn− progeny (Fig. 3B,B′). EON
lineages were identifiable as R9D11-mCD8-GFP+ cells contacting
EONs (Fig. 3B,B′). To identify the cell types produced by EONs,
we stained for markers specific to GMCs, neurons or glia. We
found cells with nuclear Pros (Fig. S4C,C′), Elav (Embryonically
lethal abnormal vision, Fig. 3C,C′) or Repo (Reversed polarity,
Fig. 3D-D′) next to EONs, corresponding to GMCs, neurons and
glia, respectively. By the end of embryogenesis, we found an
average of 16.1±1.7 neurons and 3.7±1.4 glia per brain lobe that
were in contact with EONs and expressed R9D11-mCD8-GFP
(n=10 brain lobes).
Fig. 2. The embryonic neuroepithelium expresses transition zone markers and produces EONs at specific spatial domains. (A) Spatial patterning
domains in the embryonic neuroepithelium and neuroblast generation (compare with Fig. S2A). The Vsx1+,wg+ and hh+ domains are present, but the Optix+ and
dpp+ domains are not yet established. The Vsx1+ domain generates most EONs; thewg+ tips generate aminority of EONs. Axes as in Fig. 1F. (B) EONs (R9D11-
mCD8-GFP+, green) are produced from the Vsx1+ domain (red) of the neuroepithelium (outlined). Arrow indicates EON generation. Maximum intensity projection
of five 1 µm slices in z. (C) Neuroepithelial cells (FasII+, white) express L(1)sc (red, arrowhead) in close proximity to EONs (green, arrow). (D,D′) L(1)sc+ cells (red)
in the neuroepithelium (white) have high EGFR signalling, as assessed using the Pnt-GFP reporter (green) (Boisclair Lachance et al., 2014). (E,E′) L(1)sc+ cells
(red) in the neuroepithelium (white) have low Notch signalling, as assessed using the HLHmγ-GFP reporter (green) (Almeida and Bray, 2005). (B-E′) Single
section confocal images.
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We confirmed the lineage relationship between EONs and
neurons using the FLEXAMP (flip-out LexA amplification)
technique, a memory cassette tool (Bertet et al., 2014). We found
that neurons were labelled when we expressed FLEXAMP in EONs
during embryogenesis (Fig. S4D-E). We conclude that, like
canonical neuroblasts, EONs undergo neurogenic divisions and
generate differentiated progeny.
EONs undergo G0 quiescence and persist into the larval
brain
At the end of embryogenesis, the majority of neuroblasts in the
central brain and ventral nerve cord enter mitotic quiescence or are
eliminated by apoptosis (Maurange and Gould, 2005; Truman and
Bate, 1988; White et al., 1994). Quiescent neuroblasts persist into
the larval brain and later become reactivated in a nutrition-
dependent manner to generate neurons and glia in a second round
of neurogenesis (Britton and Edgar, 1998; Chell and Brand, 2010;
Otsuki and Brand, 2018; Sousa-Nunes et al., 2011; Spéder and
Brand, 2014; Truman and Bate, 1988). We assessed whether EONs
undergo quiescence or apoptosis at the end of embryogenesis.
We found that EONs persist into the larval brain, identifiable as a
cluster of Dpn+ R9D11-mCD8-GFP+ cells. As in the embryo,
EONs are located below the neuroepithelium, medial in the brain
(Fig. 4A-B,Movie 1).We observed 10.4±0.6 EONs per brain lobe at
0 h after larval hatching (ALH) (n=31 brain lobes), in close
agreement with the final number detected in the embryo. The only
neuroblasts known to proliferate at larval hatching are themushroom
body and lateral neuroblasts (Ito and Hotta, 1992; Prokop and
Technau, 1991; Truman and Bate, 1988), indicating that EONs are
quiescent at this stage. It has been shown that quiescent neuroblasts
in the brain lobes and ventral nerve cord do not express Wor or Mira
(Lai and Doe, 2014; Otsuki and Brand, 2018; Tomancak et al.,
2007). In agreement with this, we found that EONs did not express
Wor or Mira at 0 h ALH (Fig. S5A-B′), despite expressing these
genes previously in the embryo (Fig. 3A,A′, Fig. S4A,A′).
We discovered recently that neuroblasts can undergo two types of
quiescence (Otsuki and Brand, 2018). Most quiescent neuroblasts
arrest in G2, and only a minority in G0 in the ventral nerve cord. G2
and G0 are two functionally distinct types of stem cell quiescence,
as G2 neuroblasts become activated faster than G0 neuroblasts in
response to nutritional inputs (Otsuki and Brand, 2018). We found
that all EONs undergo G0 quiescence, as they did not express the G2
marker CycA at 0 h ALH (Fig. S5C,C′). We also found that
neuroepithelial cells, having divided throughout embryogenesis,
eventually become G0 quiescent prior to larval hatching (Fig. S5D).
Thus, all neural stem cells in the visual system undergo G0
quiescence, which is otherwise uncommon in the Drosophila brain.
EONs reactivate post-embryonically
The neuroepithelial cells that were generated in the embryo
reactivate and begin symmetric divisions during the first larval
instar (12-15 h ALH) (Datta, 1995; Nassif et al., 2003). We tested
when EONs, which lie below the plane of the neuroepithelium,
reactivate. We found that EONs were among the last neuroblasts to
reactivate in the brain, consistent with our previous finding that G0
neuroblasts reactivate after G2 neuroblasts (Otsuki and Brand,
Fig. 3. EONs generate neurons and glia. (A,A′) EONs (Dpn+/R9D11-mCD8-GFP+, red and green, arrowheads) express the gene Mira (cyan), which is
expressed by neuroblasts. (B,B′) EONs (red and green) divide and generate Dpn− progeny (asterisks). Arrowheads indicate a dividing EON, assessed by
co-staining for pH3 (white). (C,C′) EONs (red and green) generate Elav+ neurons (blue, arrowheads). (D,D′) EONs (red and green) generate Repo+ glia (white,
arrowheads). Maximum intensity projection of three 1 µm slices in z. (A-C′) Single section confocal images.
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2018). EONs were quiescent (small, CycA− and pH3−) at 18 h
ALH, in contrast to most other neuroblasts in the brain (Fig. 4Ci,ii,
D). EONs no longer expressed R9D11-mCD8-GFP at this stage;
however, they were readily identifiable based on their position
relative to the neuroepithelium. We found that EONs reactivate by
30 h ALH, as all neuroblasts surrounding the neuroepithelium have
re-entered the cell cycle (Fig. S5Ei,ii). Thus, we have shown that
EONs generate progeny in the embryo, undergo quiescence and
become reactivated post-embryonically.
Switches in stem cell division mode are thought to drive the
development of both the mammalian cerebral cortex and the
Drosophila visual system (Fig. S1A). Symmetrically dividing
neuroepithelial cells transform into asymmetrically dividing
neuroblasts in the Drosophila optic lobe during larval
development. Here, we have shown that neuroepithelial cells
begin to produce neuroblasts in the embryo, demonstrating a much
earlier function for both types of neural stem cell in the developing
visual system (Fig. 4E). Our discovery that both symmetrically and
asymmetrically dividing stem cells are present in the embryo is
important given that the mis-regulation of each type of stem cell
gives rise to tumours through distinct mechanisms (Bowman et al.,
2008; Richter et al., 2011). Our results have implications for
understanding the susceptibility of the brain to different types of
tumours during embryonic development, with relevance for the
progression of childhood tumours (Marshall et al., 2014).
Although embryonic neuroepithelial cells appear to generate
neuroblasts in a similar manner to larval neuroepithelial cells, we
uncovered several striking differences between the embryonic and
larval neuroepithelia. We found that GAL4 drivers commonly used
to label the larval neuroepithelium (GAL4c855a and ogre-GAL4) are
not expressed in the embryonic neuroepithelium. Larval
neuroepithelial cells divide repeatedly and are eventually
depleted, in contrast to embryonic neuroepithelial cells that divide
once each before becoming quiescent. The larval neuroepithelium
Fig. 4. EONs persist into the post-embryonic brain. (A,A′) At 0 h ALH, EONs are associated closely with the neuroepithelium (FasII+, white and outlined).
EONs express R9D11-mCD8-GFP (green) in A and Dpn (red, circled) in A′. Single frame of a 3D reconstruction over a 17 µm confocal stack. The entire 3D
reconstruction is available asMovie 1. (B) 3D schematic depicting the spatial relationship between the neuroepithelium andEONs at 0 h ALH. L, lateral; M,medial.
(Ci,ii) Single section confocal images taken at indicated depths relative to the neuroepithelium at 18 h ALH. EONs are located medial to the neuroepithelium. (Ci)
The neuroepithelium (white) has reactivated and expresses CycA (cyan). (Cii) EONs (red, circled) do not express CycA and are G0 quiescent, in contrast to
neighbouring neuroblasts (red and cyan). (D) 3D schematic depicting the spatial relationship between the neuroepithelium and EONs at 18 h ALH. A, anterior; P,
posterior; L, lateral; M, medial. (E) Revised model of optic lobemedulla development. Neuroepithelial cells (grey) divide and generate neuroblasts (red and green)
in the embryo. After larval hatching, these neuroepithelial cells begin symmetric divisions. From mid-larval stages neuroepithelial cells transform into
asymmetrically dividing larval neuroblasts (red and not green). Medial-lateral axis is left-right; brain surface is towards the bottom of the schematic. Compare
to Fig. S1A.
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produces neuroblasts from all spatial domains, whereas only the
Vsx1+ and wg+ domains produce neuroblasts in the embryo.
Importantly, our results explain recent observations that the larval
neuroepithelium expresses L(1)sc, which marks the transition zone,
much before the generation of larval neuroblasts (Dillard et al.,
2018; Sato et al., 2016). It has been proposed that the transition zone
is established at an early stage, ready to induce the neuroepithelium
to neuroblast transition later in development (Dillard et al., 2018).
Instead, our results demonstrate that L(1)sc expression in the early
larval neuroepithelium is a continuation of a neuroepithelium to
neuroblast transition that commenced in the embryo.
EONs express R9D11-mCD8-GFP as they are generated by
neuroepithelial cells, but later downregulate expression.
Intriguingly, we found that R9D11-mCD8-GFP is also expressed
at the transition zone in the late larval brain (Fig. S6A). Thus,
R9D11-mCD8-GFP expression is common to newly born optic lobe
neuroblasts in both the embryo and larva. As R9D11 is a fragment of
the erm enhancer (Pfeiffer et al., 2008), ermmight have a function in
the transition from neuroepithelial cell to neuroblast.
We have discovered an embryonic phase of neurogenesis
originating from the optic lobe neuroepithelium. Although the
identities of the neurons born during this embryonic phase are as yet
unknown, we find that they lie in close proximity to Bolwig’s nerve:
part of the larval visual system (Fig. S7A). Tracking the contribution
of EONs to the adult brain was not possible in this study because
the genetic tools that label EONs, although specific in early
development, become widely expressed later in development. The
functional contributions of EON lineages to the larval and adult
visual systems will be an intriguing topic for future study.
MATERIALS AND METHODS
Fly stocks and husbandry
Drosophila melanogaster were reared in cages at 25°C, unless indicated
otherwise. Embryos were collected onto freshly yeasted apple juice plates
overnight and staged according to Campos-Ortega and Hartenstein (1985).
For larval experiments, larvae were picked within 1 h of hatching
[designated 0 h after larval hatching (ALH)], transferred to a yeasted food
plate and reared to the desired stage before dissection.
The following stockswere used:w1118, GAL4c855a (Manseau et al., 1997),
R9D11-mCD8-GFP (Zhu et al., 2011), R9D11-CD4-tdTomato (Han et al.,
2011), (miR-7)E>GFP (Li et al., 2009), wg-LacZ (1-en-11) (Kassis et al.,
1992), hhP30 (Lee et al., 1992) and HLHmγ-GFP (Almeida and Bray, 2005).
The following stocks were obtained from the Bloomington Drosophila
Stock Center: dpp-lacZExel.2 (#8411), UAS-myr-mRFP (#7119), R31H09-
GAL4 (#49694), R29C07-GAL4 (‘ogre-GAL4’, #49340) and pnt-
GFP.FPTB (#42680). To perform FLEXAMP, we crossed flies carrying
yw; tub-Gal80ts, UAS-flp; act>y+>LHV2deltaRFP-86Fb (LexA) (Yagi et al.,
2010) to flies carrying 13XLexAOp2-mCD8-GFP (Bloomington #32205),
R31H09-GAL4 and tub-GAL80ts (Bloomington #7019).
Sample fixation
Embryos were washed into a nitex basket with distilled water and
dechorionated in 50% bleach/water for 3 min. After rinsing with water,
embryos were fixed on a rolling shaker for 20 min in a 6 ml glass bottle
containing 3 ml of 4% formaldehyde/PBS and 3 ml heptane. Fixed embryos
were washed and stored in methanol at −20°C until ready to immunostain.
Larval brains were dissected in PBS and fixed on a shaker for 20 min in
4% formaldehyde/PBS. Fixed brains werewashed well with PBS containing
0.3% Triton-X (PBTx) before immediate immunostaining.
Immunostaining
Fixed embryos were re-hydrated in 0.3% PBTx and blocked on a shaker for
at least 15 min in 10% normal goat serum/PBS. Embryos were incubated
overnight at 4°C with primary antibodies diluted in 0.3% PBTx. Embryos
were washed well with 0.3% PBTx, then incubated overnight at 4°C with
secondary antibodies diluted in 0.3% PBTx. Embryos were washed well
with 0.3% PBTx then mounted in 50% glycerol/PBS. Larval brains were
processed identically to embryos, with the following alterations: (1) the re-
hydration step was omitted and (2) brains were mounted in Vectashield
(Vector laboratories).
The following primary antisera were used: mouse 22C10 1:50 (DSHB),
chicken anti-βgal 1:1000 (Abcam, ab9361), rabbit anti-CycA 1:100
(Whitfield et al., 1990; rb270), guinea pig anti-Dpn 1:5000 (Caygill and
Brand, 2017), rat anti-Dpn 1:100 (Abcam, 11D1BC7, ab195173), rat anti-
E-Cad 1:20 (DSHB, DCAD2 conc.), rat anti-Elav 1:100 (DSHB, 7E8A10
conc.), mouse anti-FasII 1:20 (DSHB, 1D4 conc.), chick anti-GFP 1:2000
(Abcam, ab13970), rat anti-Mira 1:500 (a kind gift from C. Q. Doe,
University of Oregon, USA), rabbit anti-Optix 1:500 (Kenyon et al.,
2005), mouse anti-Pros 1:30 (DSHB, MR1A conc.), rabbit anti-pH3 1:100
(Merck Millipore, 06-570), rat anti-pH3 1:200 (Abcam, ab10543), rabbit
anti-Repo 1:10,000 (a kind gift from B. Altenhein, University of Cologne,
Germany), guinea pig anti-Vsx1 1:1000 (Erclik et al., 2008) and rat anti-
Wor 1:100 (Abcam, 5A3AD2, ab196362). Guinea pig anti-L(1)sc
(1:1000) was generated by C. M. Davidson, E. E. Caygill and A.H.B.
using constructs that were a kind gift from J. Skeath (Washington
University, USA). Primary antibodies were detected using Alexa Fluor-
conjugated secondary antibodies (Thermo Fisher Scientific) diluted 1:500
in 0.3% PBTx.
Lineage tracing with FLEXAMP
To perform FLEXAMP, we crossed flies carrying yw; tub-Gal80ts, UAS-flp;
act>y+>LHV2deltaRFP-86Fb (LexA) to flies carrying 13XLexAOp2-mCD8-
GFP, R31H09-GAL4 and tub-GAL80ts. Embryos were collected for 3 h at
room temperature, then raised at 29°C (test) or 18°C (control) until larval
hatching. Larval brains were dissected at 0 h ALH and stained for GFP,
Dpn, Elav and/or 22C10 as appropriate.
Image acquisition and processing
Fluorescent images were acquired using a Leica SP8 confocal microscope.
Images were analysed using Fiji (Schindelin et al., 2012). Adobe Photoshop
was used to adjust brightness and contrast in images. Adobe Illustrator was
used to compile figures.
Quantification and statistical analysis
R was used for statistical analysis. No data were excluded.
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